AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|AGE|RACE|SEX|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
142.4|148.6|145.5|8503|All ICCC Groups Combined|58588724|0-14|All Races|Male and Female|1999|||
43.6|47.1|45.3|2651|I Leukemias, myeloproliferative & myelodysplastic diseases|58588724|0-14|All Races|Male and Female|1999|||
34.0|37.1|35.5|2080|I(a) Lymphoid leukemias|58588724|0-14|All Races|Male and Female|1999|||
6.9|8.3|7.6|442|I(b) Acute myeloid leukemias|58588724|0-14|All Races|Male and Female|1999|||
0.4|0.9|0.6|36|I(c) Chronic myeloproliferative diseases|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|58588724|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.4|82|I(e) Unspecified and other specified leukemias|58588724|0-14|All Races|Male and Female|1999|||
14.3|16.4|15.3|897|II Lymphomas and reticuloendothelial neoplasms|58588724|0-14|All Races|Male and Female|1999|||
4.9|6.1|5.5|320|II(a) Hodgkin lymphomas|58588724|0-14|All Races|Male and Female|1999|||
5.4|6.6|6.0|349|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|58588724|0-14|All Races|Male and Female|1999|||
2.1|3.0|2.5|148|II(c) Burkitt lymphoma|58588724|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|52|II(d) Miscellaneous lymphoreticular neoplasms|58588724|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|28|II(e) Unspecified lymphomas|58588724|0-14|All Races|Male and Female|1999|||
30.2|33.1|31.6|1855|III CNS and misc intracranial and intraspinal neoplasms|58588724|0-14|All Races|Male and Female|1999|||
2.6|3.5|3.0|176|III(a) Ependymomas and choroid plexus tumor|58588724|0-14|All Races|Male and Female|1999|||
13.5|15.4|14.4|846|III(b) Astrocytomas|58588724|0-14|All Races|Male and Female|1999|||
7.1|8.6|7.8|460|III(c) Intracranial and intraspinal embryonal tumors|58588724|0-14|All Races|Male and Female|1999|||
4.6|5.8|5.1|302|III(d) Other gliomas|58588724|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|30|III(e) Other specified intracranial & intraspinal neoplasms|58588724|0-14|All Races|Male and Female|1999|||
0.5|1.0|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|58588724|0-14|All Races|Male and Female|1999|||
9.8|11.5|10.6|617|IV Neuroblastoma and other peripheral nervous cell tumors|58588724|0-14|All Races|Male and Female|1999|||
9.6|11.3|10.4|607|IV(a) Neuroblastoma and ganglioneuroblastoma|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|58588724|0-14|All Races|Male and Female|1999|||
8.7|10.3|9.5|554|IX Soft tissue and other extraosseous sarcomas|58588724|0-14|All Races|Male and Female|1999|||
4.4|5.5|4.9|289|IX(a) Rhabdomyosarcomas|58588724|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|55|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|IX(c) Kaposi sarcoma|58588724|0-14|All Races|Male and Female|1999|||
2.3|3.1|2.7|156|IX(d) Other specified soft tissue sarcomas|58588724|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|53|IX(e) Unspecified soft tissue sarcomas|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.4|0.3|16|Not classified by ICCC|58588724|0-14|All Races|Male and Female|1999|||
3.7|4.8|4.2|245|V Retinoblastoma|58588724|0-14|All Races|Male and Female|1999|||
7.3|8.8|8.0|467|VI Renal tumors|58588724|0-14|All Races|Male and Female|1999|||
6.9|8.3|7.6|442|VI(a) Nephroblastoma and other nonepithelial renal tumors|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|22|VI(b) Renal carcinomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|58588724|0-14|All Races|Male and Female|1999|||
1.8|2.5|2.1|123|VII Hepatic tumors|58588724|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.7|101|VII(a) Hepatoblastoma|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|22|VII(b) Hepatic carcinomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|58588724|0-14|All Races|Male and Female|1999|||
6.5|7.9|7.2|420|VIII Malignant bone tumors|58588724|0-14|All Races|Male and Female|1999|||
3.7|4.8|4.2|246|VIII(a) Osteosarcomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(b) Chondrosarcomas|58588724|0-14|All Races|Male and Female|1999|||
2.0|2.8|2.3|137|VIII(c) Ewing tumor and related sarcomas of bone|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|19|VIII(d) Other specified malignant bone tumors|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|58588724|0-14|All Races|Male and Female|1999|||
4.4|5.6|5.0|289|X Germ cell, trophoblastic tumors & neoplasms of gonads|58588724|0-14|All Races|Male and Female|1999|||
1.0|1.6|1.3|75|X(a) Intracranial & intraspinal germ cell tumors|58588724|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.3|78|X(b) Malignant extracranial & extragonadal germ cell tumors|58588724|0-14|All Races|Male and Female|1999|||
1.8|2.5|2.1|124|X(c) Malignant gonadal germ cell tumors|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(d) Gonadal carcinomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|58588724|0-14|All Races|Male and Female|1999|||
5.2|6.5|5.8|339|XI Other malignant epithelial neoplasms and malignant melanomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(a) Adrenocortical carcinomas|58588724|0-14|All Races|Male and Female|1999|||
1.5|2.2|1.9|109|XI(b) Thyroid carcinomas|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|22|XI(c) Nasopharyngeal carcinomas|58588724|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.8|102|XI(d) Malignant melanomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(e) Skin carcinomas|58588724|0-14|All Races|Male and Female|1999|||
1.2|1.9|1.5|89|XI(f) Other and unspecified carcinomas|58588724|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|30|XII Other and unspecified malignant neoplasms|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|XII(a) Other specified malignant tumors|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|58588724|0-14|All Races|Male and Female|1999|||
146.8|153.1|149.9|8812|All ICCC Groups Combined|58914904|0-14|All Races|Male and Female|2000|||
44.3|47.7|46.0|2697|I Leukemias, myeloproliferative & myelodysplastic diseases|58914904|0-14|All Races|Male and Female|2000|||
35.5|38.7|37.1|2174|I(a) Lymphoid leukemias|58914904|0-14|All Races|Male and Female|2000|||
5.9|7.3|6.6|387|I(b) Acute myeloid leukemias|58914904|0-14|All Races|Male and Female|2000|||
0.6|1.0|0.8|45|I(c) Chronic myeloproliferative diseases|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|58914904|0-14|All Races|Male and Female|2000|||
1.1|1.7|1.4|81|I(e) Unspecified and other specified leukemias|58914904|0-14|All Races|Male and Female|2000|||
15.5|17.6|16.5|976|II Lymphomas and reticuloendothelial neoplasms|58914904|0-14|All Races|Male and Female|2000|||
5.2|6.5|5.8|345|II(a) Hodgkin lymphomas|58914904|0-14|All Races|Male and Female|2000|||
5.4|6.6|6.0|353|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|58914904|0-14|All Races|Male and Female|2000|||
2.4|3.3|2.8|166|II(c) Burkitt lymphoma|58914904|0-14|All Races|Male and Female|2000|||
1.0|1.6|1.3|75|II(d) Miscellaneous lymphoreticular neoplasms|58914904|0-14|All Races|Male and Female|2000|||
0.4|0.9|0.6|37|II(e) Unspecified lymphomas|58914904|0-14|All Races|Male and Female|2000|||
31.8|34.8|33.3|1957|III CNS and misc intracranial and intraspinal neoplasms|58914904|0-14|All Races|Male and Female|2000|||
2.3|3.1|2.7|158|III(a) Ependymomas and choroid plexus tumor|58914904|0-14|All Races|Male and Female|2000|||
16.1|18.3|17.2|1011|III(b) Astrocytomas|58914904|0-14|All Races|Male and Female|2000|||
6.9|8.3|7.6|445|III(c) Intracranial and intraspinal embryonal tumors|58914904|0-14|All Races|Male and Female|2000|||
4.1|5.2|4.7|274|III(d) Other gliomas|58914904|0-14|All Races|Male and Female|2000|||
0.3|0.7|0.5|27|III(e) Other specified intracranial & intraspinal neoplasms|58914904|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|42|III(f) Unspecified intracranial and intraspinal neoplasms|58914904|0-14|All Races|Male and Female|2000|||
9.2|10.9|10.0|587|IV Neuroblastoma and other peripheral nervous cell tumors|58914904|0-14|All Races|Male and Female|2000|||
9.1|10.8|9.9|580|IV(a) Neuroblastoma and ganglioneuroblastoma|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|58914904|0-14|All Races|Male and Female|2000|||
9.6|11.3|10.4|615|IX Soft tissue and other extraosseous sarcomas|58914904|0-14|All Races|Male and Female|2000|||
4.7|5.9|5.3|309|IX(a) Rhabdomyosarcomas|58914904|0-14|All Races|Male and Female|2000|||
0.7|1.2|1.0|56|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|IX(c) Kaposi sarcoma|58914904|0-14|All Races|Male and Female|2000|||
2.7|3.7|3.2|188|IX(d) Other specified soft tissue sarcomas|58914904|0-14|All Races|Male and Female|2000|||
0.8|1.3|1.0|61|IX(e) Unspecified soft tissue sarcomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|Not classified by ICCC|58914904|0-14|All Races|Male and Female|2000|||
3.9|5.0|4.4|256|V Retinoblastoma|58914904|0-14|All Races|Male and Female|2000|||
8.1|9.6|8.8|515|VI Renal tumors|58914904|0-14|All Races|Male and Female|2000|||
7.7|9.2|8.4|492|VI(a) Nephroblastoma and other nonepithelial renal tumors|58914904|0-14|All Races|Male and Female|2000|||
0.2|0.6|0.4|22|VI(b) Renal carcinomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|58914904|0-14|All Races|Male and Female|2000|||
1.8|2.6|2.2|129|VII Hepatic tumors|58914904|0-14|All Races|Male and Female|2000|||
1.6|2.3|1.9|113|VII(a) Hepatoblastoma|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(b) Hepatic carcinomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|58914904|0-14|All Races|Male and Female|2000|||
5.9|7.2|6.6|388|VIII Malignant bone tumors|58914904|0-14|All Races|Male and Female|2000|||
3.1|4.1|3.6|211|VIII(a) Osteosarcomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(b) Chondrosarcomas|58914904|0-14|All Races|Male and Female|2000|||
2.3|3.1|2.7|157|VIII(c) Ewing tumor and related sarcomas of bone|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|58914904|0-14|All Races|Male and Female|2000|||
4.4|5.5|4.9|291|X Germ cell, trophoblastic tumors & neoplasms of gonads|58914904|0-14|All Races|Male and Female|2000|||
1.2|1.8|1.5|86|X(a) Intracranial & intraspinal germ cell tumors|58914904|0-14|All Races|Male and Female|2000|||
0.9|1.4|1.1|66|X(b) Malignant extracranial & extragonadal germ cell tumors|58914904|0-14|All Races|Male and Female|2000|||
1.8|2.6|2.2|128|X(c) Malignant gonadal germ cell tumors|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(d) Gonadal carcinomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|58914904|0-14|All Races|Male and Female|2000|||
5.2|6.4|5.8|343|XI Other malignant epithelial neoplasms and malignant melanomas|58914904|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|18|XI(a) Adrenocortical carcinomas|58914904|0-14|All Races|Male and Female|2000|||
1.6|2.3|1.9|113|XI(b) Thyroid carcinomas|58914904|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|58914904|0-14|All Races|Male and Female|2000|||
1.5|2.2|1.8|105|XI(d) Malignant melanomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|XI(e) Skin carcinomas|58914904|0-14|All Races|Male and Female|2000|||
1.1|1.8|1.4|85|XI(f) Other and unspecified carcinomas|58914904|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|44|XII Other and unspecified malignant neoplasms|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|XII(a) Other specified malignant tumors|58914904|0-14|All Races|Male and Female|2000|||
0.4|0.7|0.5|31|XII(b) Other unspecified malignant tumors|58914904|0-14|All Races|Male and Female|2000|||
153.0|159.3|156.1|9331|All ICCC Groups Combined|59815030|0-14|All Races|Male and Female|2001|||
48.7|52.3|50.5|3002|I Leukemias, myeloproliferative & myelodysplastic diseases|59815030|0-14|All Races|Male and Female|2001|||
37.1|40.3|38.7|2294|I(a) Lymphoid leukemias|59815030|0-14|All Races|Male and Female|2001|||
6.6|8.0|7.3|437|I(b) Acute myeloid leukemias|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|100|I(c) Chronic myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.6|96|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|75|I(e) Unspecified and other specified leukemias|59815030|0-14|All Races|Male and Female|2001|||
15.0|17.1|16.0|965|II Lymphomas and reticuloendothelial neoplasms|59815030|0-14|All Races|Male and Female|2001|||
5.3|6.5|5.9|356|II(a) Hodgkin lymphomas|59815030|0-14|All Races|Male and Female|2001|||
5.8|7.1|6.5|388|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59815030|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.3|135|II(c) Burkitt lymphoma|59815030|0-14|All Races|Male and Female|2001|||
0.8|1.3|1.0|61|II(d) Miscellaneous lymphoreticular neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.3|0.6|0.4|25|II(e) Unspecified lymphomas|59815030|0-14|All Races|Male and Female|2001|||
31.4|34.3|32.8|1959|III CNS and misc intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
2.4|3.2|2.8|166|III(a) Ependymomas and choroid plexus tumor|59815030|0-14|All Races|Male and Female|2001|||
15.3|17.4|16.3|975|III(b) Astrocytomas|59815030|0-14|All Races|Male and Female|2001|||
6.6|8.0|7.3|434|III(c) Intracranial and intraspinal embryonal tumors|59815030|0-14|All Races|Male and Female|2001|||
4.8|6.0|5.4|321|III(d) Other gliomas|59815030|0-14|All Races|Male and Female|2001|||
0.5|0.9|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|21|III(f) Unspecified intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
10.7|12.5|11.6|693|IV Neuroblastoma and other peripheral nervous cell tumors|59815030|0-14|All Races|Male and Female|2001|||
10.6|12.3|11.4|685|IV(a) Neuroblastoma and ganglioneuroblastoma|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59815030|0-14|All Races|Male and Female|2001|||
9.7|11.3|10.5|629|IX Soft tissue and other extraosseous sarcomas|59815030|0-14|All Races|Male and Female|2001|||
4.6|5.8|5.2|308|IX(a) Rhabdomyosarcomas|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|IX(c) Kaposi sarcoma|59815030|0-14|All Races|Male and Female|2001|||
2.6|3.5|3.1|185|IX(d) Other specified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001|||
0.8|1.3|1.0|60|IX(e) Unspecified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|Not classified by ICCC|59815030|0-14|All Races|Male and Female|2001|||
3.9|5.0|4.4|266|V Retinoblastoma|59815030|0-14|All Races|Male and Female|2001|||
7.9|9.4|8.6|510|VI Renal tumors|59815030|0-14|All Races|Male and Female|2001|||
7.5|9.0|8.2|488|VI(a) Nephroblastoma and other nonepithelial renal tumors|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59815030|0-14|All Races|Male and Female|2001|||
1.8|2.5|2.1|126|VII Hepatic tumors|59815030|0-14|All Races|Male and Female|2001|||
1.4|2.0|1.7|100|VII(a) Hepatoblastoma|59815030|0-14|All Races|Male and Female|2001|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59815030|0-14|All Races|Male and Female|2001|||
6.3|7.7|7.0|421|VIII Malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
3.3|4.3|3.8|230|VIII(a) Osteosarcomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(b) Chondrosarcomas|59815030|0-14|All Races|Male and Female|2001|||
2.3|3.1|2.7|160|VIII(c) Ewing tumor and related sarcomas of bone|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
4.5|5.6|5.0|304|X Germ cell, trophoblastic tumors & neoplasms of gonads|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|79|X(a) Intracranial & intraspinal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
1.1|1.7|1.4|85|X(b) Malignant extracranial & extragonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
1.7|2.4|2.0|121|X(c) Malignant gonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(d) Gonadal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59815030|0-14|All Races|Male and Female|2001|||
6.0|7.3|6.6|400|XI Other malignant epithelial neoplasms and malignant melanomas|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|17|XI(a) Adrenocortical carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.3|140|XI(b) Thyroid carcinomas|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.7|2.4|2.0|121|XI(d) Malignant melanomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(e) Skin carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|100|XI(f) Other and unspecified carcinomas|59815030|0-14|All Races|Male and Female|2001|||
0.5|1.0|0.7|43|XII Other and unspecified malignant neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|22|XII(a) Other specified malignant tumors|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.4|21|XII(b) Other unspecified malignant tumors|59815030|0-14|All Races|Male and Female|2001|||
152.0|158.3|155.1|9294|All ICCC Groups Combined|59931314|0-14|All Races|Male and Female|2002|||
47.7|51.2|49.4|2950|I Leukemias, myeloproliferative & myelodysplastic diseases|59931314|0-14|All Races|Male and Female|2002|||
35.5|38.6|37.0|2205|I(a) Lymphoid leukemias|59931314|0-14|All Races|Male and Female|2002|||
7.2|8.6|7.9|475|I(b) Acute myeloid leukemias|59931314|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|95|I(c) Chronic myeloproliferative diseases|59931314|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59931314|0-14|All Races|Male and Female|2002|||
1.1|1.7|1.3|80|I(e) Unspecified and other specified leukemias|59931314|0-14|All Races|Male and Female|2002|||
14.7|16.7|15.7|947|II Lymphomas and reticuloendothelial neoplasms|59931314|0-14|All Races|Male and Female|2002|||
4.9|6.1|5.5|336|II(a) Hodgkin lymphomas|59931314|0-14|All Races|Male and Female|2002|||
5.5|6.7|6.1|366|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59931314|0-14|All Races|Male and Female|2002|||
2.3|3.2|2.7|164|II(c) Burkitt lymphoma|59931314|0-14|All Races|Male and Female|2002|||
0.9|1.5|1.1|69|II(d) Miscellaneous lymphoreticular neoplasms|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|II(e) Unspecified lymphomas|59931314|0-14|All Races|Male and Female|2002|||
33.1|36.1|34.5|2062|III CNS and misc intracranial and intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002|||
3.1|4.1|3.6|214|III(a) Ependymomas and choroid plexus tumor|59931314|0-14|All Races|Male and Female|2002|||
15.4|17.5|16.4|982|III(b) Astrocytomas|59931314|0-14|All Races|Male and Female|2002|||
6.8|8.2|7.4|443|III(c) Intracranial and intraspinal embryonal tumors|59931314|0-14|All Races|Male and Female|2002|||
5.4|6.6|6.0|355|III(d) Other gliomas|59931314|0-14|All Races|Male and Female|2002|||
0.5|1.0|0.7|43|III(e) Other specified intracranial & intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002|||
0.3|0.6|0.4|25|III(f) Unspecified intracranial and intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002|||
10.2|11.9|11.1|662|IV Neuroblastoma and other peripheral nervous cell tumors|59931314|0-14|All Races|Male and Female|2002|||
10.1|11.8|10.9|654|IV(a) Neuroblastoma and ganglioneuroblastoma|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59931314|0-14|All Races|Male and Female|2002|||
10.0|11.7|10.8|650|IX Soft tissue and other extraosseous sarcomas|59931314|0-14|All Races|Male and Female|2002|||
4.8|6.0|5.4|320|IX(a) Rhabdomyosarcomas|59931314|0-14|All Races|Male and Female|2002|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|IX(c) Kaposi sarcoma|59931314|0-14|All Races|Male and Female|2002|||
3.0|3.9|3.4|207|IX(d) Other specified soft tissue sarcomas|59931314|0-14|All Races|Male and Female|2002|||
0.7|1.2|0.9|54|IX(e) Unspecified soft tissue sarcomas|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.4|21|Not classified by ICCC|59931314|0-14|All Races|Male and Female|2002|||
3.3|4.3|3.8|225|V Retinoblastoma|59931314|0-14|All Races|Male and Female|2002|||
7.6|9.0|8.3|492|VI Renal tumors|59931314|0-14|All Races|Male and Female|2002|||
7.3|8.8|8.1|479|VI(a) Nephroblastoma and other nonepithelial renal tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(b) Renal carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59931314|0-14|All Races|Male and Female|2002|||
1.6|2.3|1.9|114|VII Hepatic tumors|59931314|0-14|All Races|Male and Female|2002|||
1.2|1.9|1.5|92|VII(a) Hepatoblastoma|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|21|VII(b) Hepatic carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59931314|0-14|All Races|Male and Female|2002|||
6.2|7.6|6.9|416|VIII Malignant bone tumors|59931314|0-14|All Races|Male and Female|2002|||
3.2|4.2|3.7|223|VIII(a) Osteosarcomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(b) Chondrosarcomas|59931314|0-14|All Races|Male and Female|2002|||
2.2|3.0|2.6|157|VIII(c) Ewing tumor and related sarcomas of bone|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|21|VIII(d) Other specified malignant bone tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59931314|0-14|All Races|Male and Female|2002|||
4.7|5.9|5.2|318|X Germ cell, trophoblastic tumors & neoplasms of gonads|59931314|0-14|All Races|Male and Female|2002|||
1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|59931314|0-14|All Races|Male and Female|2002|||
1.2|1.8|1.5|88|X(b) Malignant extracranial & extragonadal germ cell tumors|59931314|0-14|All Races|Male and Female|2002|||
1.9|2.6|2.2|134|X(c) Malignant gonadal germ cell tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(d) Gonadal carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59931314|0-14|All Races|Male and Female|2002|||
6.0|7.3|6.6|401|XI Other malignant epithelial neoplasms and malignant melanomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(a) Adrenocortical carcinomas|59931314|0-14|All Races|Male and Female|2002|||
1.7|2.4|2.0|124|XI(b) Thyroid carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|59931314|0-14|All Races|Male and Female|2002|||
1.9|2.7|2.3|140|XI(d) Malignant melanomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(e) Skin carcinomas|59931314|0-14|All Races|Male and Female|2002|||
1.4|2.0|1.7|103|XI(f) Other and unspecified carcinomas|59931314|0-14|All Races|Male and Female|2002|||
0.4|0.8|0.6|36|XII Other and unspecified malignant neoplasms|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|21|XII(a) Other specified malignant tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XII(b) Other unspecified malignant tumors|59931314|0-14|All Races|Male and Female|2002|||
149.1|155.4|152.2|9250|All ICCC Groups Combined|60628650|0-14|All Races|Male and Female|2003|||
46.0|49.5|47.7|2883|I Leukemias, myeloproliferative & myelodysplastic diseases|60628650|0-14|All Races|Male and Female|2003|||
34.5|37.5|36.0|2167|I(a) Lymphoid leukemias|60628650|0-14|All Races|Male and Female|2003|||
6.8|8.2|7.5|457|I(b) Acute myeloid leukemias|60628650|0-14|All Races|Male and Female|2003|||
1.2|1.8|1.5|89|I(c) Chronic myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003|||
1.5|2.2|1.8|111|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003|||
0.7|1.3|1.0|59|I(e) Unspecified and other specified leukemias|60628650|0-14|All Races|Male and Female|2003|||
15.2|17.2|16.2|986|II Lymphomas and reticuloendothelial neoplasms|60628650|0-14|All Races|Male and Female|2003|||
5.3|6.6|5.9|364|II(a) Hodgkin lymphomas|60628650|0-14|All Races|Male and Female|2003|||
5.7|7.0|6.3|383|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60628650|0-14|All Races|Male and Female|2003|||
2.3|3.2|2.7|163|II(c) Burkitt lymphoma|60628650|0-14|All Races|Male and Female|2003|||
0.9|1.4|1.1|69|II(d) Miscellaneous lymphoreticular neoplasms|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|II(e) Unspecified lymphomas|60628650|0-14|All Races|Male and Female|2003|||
31.4|34.3|32.9|1988|III CNS and misc intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|152|III(a) Ependymomas and choroid plexus tumor|60628650|0-14|All Races|Male and Female|2003|||
15.3|17.4|16.3|988|III(b) Astrocytomas|60628650|0-14|All Races|Male and Female|2003|||
6.6|7.9|7.2|436|III(c) Intracranial and intraspinal embryonal tumors|60628650|0-14|All Races|Male and Female|2003|||
5.0|6.2|5.6|339|III(d) Other gliomas|60628650|0-14|All Races|Male and Female|2003|||
0.6|1.1|0.9|52|III(e) Other specified intracranial & intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|21|III(f) Unspecified intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
9.9|11.6|10.7|653|IV Neuroblastoma and other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003|||
9.8|11.4|10.6|643|IV(a) Neuroblastoma and ganglioneuroblastoma|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003|||
9.9|11.5|10.7|650|IX Soft tissue and other extraosseous sarcomas|60628650|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|307|IX(a) Rhabdomyosarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.8|1.3|1.0|63|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|IX(c) Kaposi sarcoma|60628650|0-14|All Races|Male and Female|2003|||
3.1|4.1|3.6|220|IX(d) Other specified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.7|1.2|0.9|58|IX(e) Unspecified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|Not classified by ICCC|60628650|0-14|All Races|Male and Female|2003|||
3.6|4.6|4.1|250|V Retinoblastoma|60628650|0-14|All Races|Male and Female|2003|||
7.8|9.3|8.5|516|VI Renal tumors|60628650|0-14|All Races|Male and Female|2003|||
7.4|8.9|8.1|491|VI(a) Nephroblastoma and other nonepithelial renal tumors|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|21|VI(b) Renal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60628650|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|152|VII Hepatic tumors|60628650|0-14|All Races|Male and Female|2003|||
1.7|2.4|2.0|124|VII(a) Hepatoblastoma|60628650|0-14|All Races|Male and Female|2003|||
0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60628650|0-14|All Races|Male and Female|2003|||
6.0|7.3|6.6|408|VIII Malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
3.2|4.2|3.7|227|VIII(a) Osteosarcomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(b) Chondrosarcomas|60628650|0-14|All Races|Male and Female|2003|||
1.9|2.6|2.2|137|VIII(c) Ewing tumor and related sarcomas of bone|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.4|0.3|17|VIII(d) Other specified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|313|X Germ cell, trophoblastic tumors & neoplasms of gonads|60628650|0-14|All Races|Male and Female|2003|||
0.9|1.5|1.2|73|X(a) Intracranial & intraspinal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
1.2|1.8|1.4|88|X(b) Malignant extracranial & extragonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|136|X(c) Malignant gonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(d) Gonadal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60628650|0-14|All Races|Male and Female|2003|||
5.7|6.9|6.3|390|XI Other malignant epithelial neoplasms and malignant melanomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|134|XI(b) Thyroid carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.6|2.3|1.9|119|XI(d) Malignant melanomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(e) Skin carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.5|2.1|1.8|110|XI(f) Other and unspecified carcinomas|60628650|0-14|All Races|Male and Female|2003|||
0.6|1.0|0.8|48|XII Other and unspecified malignant neoplasms|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|60628650|0-14|All Races|Male and Female|2003|||
0.3|0.7|0.5|28|XII(b) Other unspecified malignant tumors|60628650|0-14|All Races|Male and Female|2003|||
156.8|163.2|160.0|9745|All ICCC Groups Combined|60651802|0-14|All Races|Male and Female|2004|||
49.4|53.1|51.2|3107|I Leukemias, myeloproliferative & myelodysplastic diseases|60651802|0-14|All Races|Male and Female|2004|||
37.3|40.4|38.8|2349|I(a) Lymphoid leukemias|60651802|0-14|All Races|Male and Female|2004|||
7.2|8.7|7.9|485|I(b) Acute myeloid leukemias|60651802|0-14|All Races|Male and Female|2004|||
1.3|1.9|1.6|97|I(c) Chronic myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.2|1.9|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|83|I(e) Unspecified and other specified leukemias|60651802|0-14|All Races|Male and Female|2004|||
15.1|17.1|16.1|982|II Lymphomas and reticuloendothelial neoplasms|60651802|0-14|All Races|Male and Female|2004|||
4.7|5.9|5.3|324|II(a) Hodgkin lymphomas|60651802|0-14|All Races|Male and Female|2004|||
6.2|7.6|6.9|419|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60651802|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.4|147|II(c) Burkitt lymphoma|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.6|1.3|80|II(d) Miscellaneous lymphoreticular neoplasms|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|II(e) Unspecified lymphomas|60651802|0-14|All Races|Male and Female|2004|||
33.6|36.6|35.1|2124|III CNS and misc intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
2.6|3.4|3.0|181|III(a) Ependymomas and choroid plexus tumor|60651802|0-14|All Races|Male and Female|2004|||
16.5|18.7|17.6|1064|III(b) Astrocytomas|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|470|III(c) Intracranial and intraspinal embryonal tumors|60651802|0-14|All Races|Male and Female|2004|||
4.8|6.0|5.4|325|III(d) Other gliomas|60651802|0-14|All Races|Male and Female|2004|||
0.6|1.1|0.8|49|III(e) Other specified intracranial & intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.4|0.8|0.6|35|III(f) Unspecified intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
10.2|11.9|11.0|676|IV Neuroblastoma and other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
10.0|11.6|10.8|661|IV(a) Neuroblastoma and ganglioneuroblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
9.8|11.4|10.6|647|IX Soft tissue and other extraosseous sarcomas|60651802|0-14|All Races|Male and Female|2004|||
4.1|5.2|4.7|283|IX(a) Rhabdomyosarcomas|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.5|1.2|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IX(c) Kaposi sarcoma|60651802|0-14|All Races|Male and Female|2004|||
3.2|4.2|3.6|224|IX(d) Other specified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.8|1.3|1.0|62|IX(e) Unspecified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|Not classified by ICCC|60651802|0-14|All Races|Male and Female|2004|||
3.8|4.9|4.3|267|V Retinoblastoma|60651802|0-14|All Races|Male and Female|2004|||
7.4|8.9|8.1|495|VI Renal tumors|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|472|VI(a) Nephroblastoma and other nonepithelial renal tumors|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|23|VI(b) Renal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60651802|0-14|All Races|Male and Female|2004|||
2.3|3.1|2.7|163|VII Hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.3|144|VII(a) Hepatoblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(b) Hepatic carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
6.5|7.8|7.1|437|VIII Malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
3.6|4.7|4.1|254|VIII(a) Osteosarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.7|2.3|143|VIII(c) Ewing tumor and related sarcomas of bone|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
5.0|6.2|5.6|348|X Germ cell, trophoblastic tumors & neoplasms of gonads|60651802|0-14|All Races|Male and Female|2004|||
1.3|1.9|1.6|96|X(a) Intracranial & intraspinal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.3|83|X(b) Malignant extracranial & extragonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.4|149|X(c) Malignant gonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(d) Gonadal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60651802|0-14|All Races|Male and Female|2004|||
6.5|7.9|7.2|442|XI Other malignant epithelial neoplasms and malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.2|3.1|2.6|161|XI(b) Thyroid carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.5|152|XI(d) Malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|XI(e) Skin carcinomas|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|83|XI(f) Other and unspecified carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.5|0.9|0.7|43|XII Other and unspecified malignant neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|18|XII(a) Other specified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
0.3|0.6|0.4|25|XII(b) Other unspecified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
152.8|159.1|155.9|9488|All ICCC Groups Combined|60519046|0-14|All Races|Male and Female|2005|||
47.5|51.0|49.2|2989|I Leukemias, myeloproliferative & myelodysplastic diseases|60519046|0-14|All Races|Male and Female|2005|||
35.9|39.0|37.4|2270|I(a) Lymphoid leukemias|60519046|0-14|All Races|Male and Female|2005|||
6.6|8.0|7.3|445|I(b) Acute myeloid leukemias|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.8|1.4|87|I(c) Chronic myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.4|2.0|1.7|101|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|86|I(e) Unspecified and other specified leukemias|60519046|0-14|All Races|Male and Female|2005|||
15.6|17.7|16.6|1012|II Lymphomas and reticuloendothelial neoplasms|60519046|0-14|All Races|Male and Female|2005|||
5.3|6.5|5.9|359|II(a) Hodgkin lymphomas|60519046|0-14|All Races|Male and Female|2005|||
5.8|7.1|6.4|391|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60519046|0-14|All Races|Male and Female|2005|||
2.2|3.0|2.6|155|II(c) Burkitt lymphoma|60519046|0-14|All Races|Male and Female|2005|||
1.2|1.9|1.5|93|II(d) Miscellaneous lymphoreticular neoplasms|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|II(e) Unspecified lymphomas|60519046|0-14|All Races|Male and Female|2005|||
31.7|34.6|33.1|2002|III CNS and misc intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|200|III(a) Ependymomas and choroid plexus tumor|60519046|0-14|All Races|Male and Female|2005|||
15.7|17.7|16.7|1010|III(b) Astrocytomas|60519046|0-14|All Races|Male and Female|2005|||
6.3|7.7|7.0|421|III(c) Intracranial and intraspinal embryonal tumors|60519046|0-14|All Races|Male and Female|2005|||
4.5|5.7|5.1|307|III(d) Other gliomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|35|III(e) Other specified intracranial & intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
10.9|12.7|11.8|725|IV Neuroblastoma and other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
10.8|12.5|11.6|716|IV(a) Neuroblastoma and ganglioneuroblastoma|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
9.8|11.5|10.6|645|IX Soft tissue and other extraosseous sarcomas|60519046|0-14|All Races|Male and Female|2005|||
4.7|5.9|5.3|321|IX(a) Rhabdomyosarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IX(c) Kaposi sarcoma|60519046|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|203|IX(d) Other specified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.6|1.1|0.8|50|IX(e) Unspecified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|18|Not classified by ICCC|60519046|0-14|All Races|Male and Female|2005|||
3.4|4.4|3.9|240|V Retinoblastoma|60519046|0-14|All Races|Male and Female|2005|||
7.5|9.0|8.2|501|VI Renal tumors|60519046|0-14|All Races|Male and Female|2005|||
7.2|8.6|7.8|478|VI(a) Nephroblastoma and other nonepithelial renal tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|145|VII Hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
1.6|2.3|1.9|116|VII(a) Hepatoblastoma|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.6|0.4|27|VII(b) Hepatic carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
6.2|7.5|6.8|415|VIII Malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
3.3|4.2|3.7|227|VIII(a) Osteosarcomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(b) Chondrosarcomas|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|147|VIII(c) Ewing tumor and related sarcomas of bone|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
4.9|6.1|5.5|338|X Germ cell, trophoblastic tumors & neoplasms of gonads|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.3|2.0|1.6|100|X(b) Malignant extracranial & extragonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.9|2.6|2.2|138|X(c) Malignant gonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(d) Gonadal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60519046|0-14|All Races|Male and Female|2005|||
6.2|7.6|6.9|422|XI Other malignant epithelial neoplasms and malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.8|2.6|2.2|135|XI(b) Thyroid carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
2.1|2.9|2.4|148|XI(d) Malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(e) Skin carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.6|2.3|1.9|116|XI(f) Other and unspecified carcinomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|36|XII Other and unspecified malignant neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
155.5|161.9|158.7|9657|All ICCC Groups Combined|60516709|0-14|All Races|Male and Female|2006|||
49.7|53.4|51.5|3133|I Leukemias, myeloproliferative & myelodysplastic diseases|60516709|0-14|All Races|Male and Female|2006|||
37.3|40.5|38.9|2358|I(a) Lymphoid leukemias|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.8|480|I(b) Acute myeloid leukemias|60516709|0-14|All Races|Male and Female|2006|||
1.4|2.1|1.7|106|I(c) Chronic myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.4|2.1|1.8|107|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.1|1.7|1.3|82|I(e) Unspecified and other specified leukemias|60516709|0-14|All Races|Male and Female|2006|||
15.7|17.8|16.7|1016|II Lymphomas and reticuloendothelial neoplasms|60516709|0-14|All Races|Male and Female|2006|||
5.5|6.8|6.2|374|II(a) Hodgkin lymphomas|60516709|0-14|All Races|Male and Female|2006|||
5.8|7.1|6.4|390|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60516709|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.5|151|II(c) Burkitt lymphoma|60516709|0-14|All Races|Male and Female|2006|||
1.2|1.8|1.5|89|II(d) Miscellaneous lymphoreticular neoplasms|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|II(e) Unspecified lymphomas|60516709|0-14|All Races|Male and Female|2006|||
32.6|35.5|34.0|2059|III CNS and misc intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
2.6|3.5|3.0|185|III(a) Ependymomas and choroid plexus tumor|60516709|0-14|All Races|Male and Female|2006|||
15.3|17.4|16.3|990|III(b) Astrocytomas|60516709|0-14|All Races|Male and Female|2006|||
7.0|8.4|7.7|467|III(c) Intracranial and intraspinal embryonal tumors|60516709|0-14|All Races|Male and Female|2006|||
5.2|6.4|5.7|345|III(d) Other gliomas|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.7|0.5|31|III(e) Other specified intracranial & intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.5|0.9|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
9.5|11.1|10.3|634|IV Neuroblastoma and other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.4|11.0|10.2|629|IV(a) Neuroblastoma and ganglioneuroblastoma|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.8|11.5|10.6|645|IX Soft tissue and other extraosseous sarcomas|60516709|0-14|All Races|Male and Female|2006|||
4.3|5.5|4.9|296|IX(a) Rhabdomyosarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.8|1.4|1.1|67|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IX(c) Kaposi sarcoma|60516709|0-14|All Races|Male and Female|2006|||
3.1|4.0|3.5|214|IX(d) Other specified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.8|1.4|1.1|66|IX(e) Unspecified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|Not classified by ICCC|60516709|0-14|All Races|Male and Female|2006|||
3.6|4.6|4.1|253|V Retinoblastoma|60516709|0-14|All Races|Male and Female|2006|||
7.6|9.0|8.3|504|VI Renal tumors|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60516709|0-14|All Races|Male and Female|2006|||
2.2|3.0|2.6|160|VII Hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
1.8|2.5|2.1|133|VII(a) Hepatoblastoma|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
6.4|7.7|7.0|424|VIII Malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
3.5|4.5|4.0|242|VIII(a) Osteosarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(b) Chondrosarcomas|60516709|0-14|All Races|Male and Female|2006|||
2.0|2.9|2.4|146|VIII(c) Ewing tumor and related sarcomas of bone|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
4.6|5.7|5.1|314|X Germ cell, trophoblastic tumors & neoplasms of gonads|60516709|0-14|All Races|Male and Female|2006|||
1.0|1.6|1.3|77|X(a) Intracranial & intraspinal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.2|1.9|1.5|95|X(b) Malignant extracranial & extragonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.7|2.5|2.1|126|X(c) Malignant gonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(d) Gonadal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60516709|0-14|All Races|Male and Female|2006|||
6.8|8.2|7.5|459|XI Other malignant epithelial neoplasms and malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.3|3.1|2.7|163|XI(b) Thyroid carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.0|2.8|2.4|147|XI(d) Malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(e) Skin carcinomas|60516709|0-14|All Races|Male and Female|2006|||
1.5|2.2|1.9|113|XI(f) Other and unspecified carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.5|1.0|0.7|45|XII Other and unspecified malignant neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.6|0.4|27|XII(a) Other specified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|XII(b) Other unspecified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
159.0|165.4|162.1|9910|All ICCC Groups Combined|60681615|0-14|All Races|Male and Female|2007|||
50.3|53.9|52.1|3180|I Leukemias, myeloproliferative & myelodysplastic diseases|60681615|0-14|All Races|Male and Female|2007|||
38.4|41.6|40.0|2437|I(a) Lymphoid leukemias|60681615|0-14|All Races|Male and Female|2007|||
7.0|8.4|7.7|473|I(b) Acute myeloid leukemias|60681615|0-14|All Races|Male and Female|2007|||
1.4|2.0|1.7|102|I(c) Chronic myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
1.2|1.9|1.5|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.5|1.2|73|I(e) Unspecified and other specified leukemias|60681615|0-14|All Races|Male and Female|2007|||
15.7|17.8|16.7|1012|II Lymphomas and reticuloendothelial neoplasms|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.1|5.5|332|II(a) Hodgkin lymphomas|60681615|0-14|All Races|Male and Female|2007|||
6.4|7.7|7.0|425|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60681615|0-14|All Races|Male and Female|2007|||
2.3|3.1|2.7|160|II(c) Burkitt lymphoma|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|82|II(d) Miscellaneous lymphoreticular neoplasms|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|II(e) Unspecified lymphomas|60681615|0-14|All Races|Male and Female|2007|||
33.8|36.8|35.3|2145|III CNS and misc intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
2.5|3.4|2.9|178|III(a) Ependymomas and choroid plexus tumor|60681615|0-14|All Races|Male and Female|2007|||
15.8|17.9|16.9|1024|III(b) Astrocytomas|60681615|0-14|All Races|Male and Female|2007|||
7.1|8.5|7.7|471|III(c) Intracranial and intraspinal embryonal tumors|60681615|0-14|All Races|Male and Female|2007|||
5.9|7.2|6.5|395|III(d) Other gliomas|60681615|0-14|All Races|Male and Female|2007|||
0.5|1.0|0.7|45|III(e) Other specified intracranial & intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.4|0.7|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
11.0|12.7|11.8|736|IV Neuroblastoma and other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.8|12.5|11.6|724|IV(a) Neuroblastoma and ganglioneuroblastoma|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.2|11.9|11.0|672|IX Soft tissue and other extraosseous sarcomas|60681615|0-14|All Races|Male and Female|2007|||
5.1|6.3|5.7|345|IX(a) Rhabdomyosarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.5|1.2|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IX(c) Kaposi sarcoma|60681615|0-14|All Races|Male and Female|2007|||
2.9|3.8|3.3|202|IX(d) Other specified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.6|1.1|0.8|51|IX(e) Unspecified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|Not classified by ICCC|60681615|0-14|All Races|Male and Female|2007|||
3.8|4.8|4.3|271|V Retinoblastoma|60681615|0-14|All Races|Male and Female|2007|||
7.9|9.4|8.6|530|VI Renal tumors|60681615|0-14|All Races|Male and Female|2007|||
7.5|8.9|8.2|503|VI(a) Nephroblastoma and other nonepithelial renal tumors|60681615|0-14|All Races|Male and Female|2007|||
0.3|0.6|0.4|26|VI(b) Renal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|159|VII Hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.7|2.3|141|VII(a) Hepatoblastoma|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|18|VII(b) Hepatic carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
6.2|7.5|6.9|415|VIII Malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
3.2|4.2|3.7|223|VIII(a) Osteosarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(b) Chondrosarcomas|60681615|0-14|All Races|Male and Female|2007|||
2.1|2.9|2.5|151|VIII(c) Ewing tumor and related sarcomas of bone|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.1|5.5|337|X Germ cell, trophoblastic tumors & neoplasms of gonads|60681615|0-14|All Races|Male and Female|2007|||
1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|157|X(c) Malignant gonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(d) Gonadal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60681615|0-14|All Races|Male and Female|2007|||
6.0|7.3|6.6|401|XI Other malignant epithelial neoplasms and malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.6|2.2|136|XI(b) Thyroid carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.8|2.6|2.2|131|XI(d) Malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(e) Skin carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.4|2.0|1.7|101|XI(f) Other and unspecified carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.5|0.9|0.7|42|XII Other and unspecified malignant neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
161.5|167.9|164.7|10105|All ICCC Groups Combined|60907384|0-14|All Races|Male and Female|2008|||
52.1|55.8|53.9|3311|I Leukemias, myeloproliferative & myelodysplastic diseases|60907384|0-14|All Races|Male and Female|2008|||
39.5|42.7|41.1|2517|I(a) Lymphoid leukemias|60907384|0-14|All Races|Male and Female|2008|||
7.3|8.7|8.0|491|I(b) Acute myeloid leukemias|60907384|0-14|All Races|Male and Female|2008|||
1.8|2.5|2.1|132|I(c) Chronic myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
1.4|2.0|1.7|104|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
0.8|1.4|1.1|67|I(e) Unspecified and other specified leukemias|60907384|0-14|All Races|Male and Female|2008|||
16.1|18.2|17.2|1042|II Lymphomas and reticuloendothelial neoplasms|60907384|0-14|All Races|Male and Female|2008|||
5.7|7.0|6.3|383|II(a) Hodgkin lymphomas|60907384|0-14|All Races|Male and Female|2008|||
6.1|7.4|6.7|408|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60907384|0-14|All Races|Male and Female|2008|||
2.3|3.1|2.7|163|II(c) Burkitt lymphoma|60907384|0-14|All Races|Male and Female|2008|||
0.9|1.5|1.2|74|II(d) Miscellaneous lymphoreticular neoplasms|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|II(e) Unspecified lymphomas|60907384|0-14|All Races|Male and Female|2008|||
34.0|37.0|35.5|2167|III CNS and misc intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
2.3|3.1|2.7|163|III(a) Ependymomas and choroid plexus tumor|60907384|0-14|All Races|Male and Female|2008|||
16.5|18.6|17.6|1070|III(b) Astrocytomas|60907384|0-14|All Races|Male and Female|2008|||
7.5|8.9|8.2|501|III(c) Intracranial and intraspinal embryonal tumors|60907384|0-14|All Races|Male and Female|2008|||
5.4|6.7|6.0|367|III(d) Other gliomas|60907384|0-14|All Races|Male and Female|2008|||
0.5|1.0|0.7|44|III(e) Other specified intracranial & intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.5|0.4|22|III(f) Unspecified intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
10.1|11.8|11.0|686|IV Neuroblastoma and other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
9.9|11.5|10.7|669|IV(a) Neuroblastoma and ganglioneuroblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|IV(b) Other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
10.2|11.9|11.0|675|IX Soft tissue and other extraosseous sarcomas|60907384|0-14|All Races|Male and Female|2008|||
4.8|5.9|5.3|326|IX(a) Rhabdomyosarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.7|1.2|1.0|59|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|IX(c) Kaposi sarcoma|60907384|0-14|All Races|Male and Female|2008|||
3.0|3.9|3.4|210|IX(d) Other specified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
1.0|1.6|1.3|79|IX(e) Unspecified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|Not classified by ICCC|60907384|0-14|All Races|Male and Female|2008|||
3.7|4.8|4.2|267|V Retinoblastoma|60907384|0-14|All Races|Male and Female|2008|||
8.3|9.8|9.0|557|VI Renal tumors|60907384|0-14|All Races|Male and Female|2008|||
7.9|9.3|8.6|532|VI(a) Nephroblastoma and other nonepithelial renal tumors|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|23|VI(b) Renal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.1|2.6|164|VII Hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.6|2.2|140|VII(a) Hepatoblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.3|0.6|0.4|24|VII(b) Hepatic carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
6.2|7.5|6.9|414|VIII Malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
3.4|4.4|3.8|232|VIII(a) Osteosarcomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(b) Chondrosarcomas|60907384|0-14|All Races|Male and Female|2008|||
2.1|2.9|2.4|148|VIII(c) Ewing tumor and related sarcomas of bone|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
4.7|5.9|5.3|325|X Germ cell, trophoblastic tumors & neoplasms of gonads|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.4|89|X(b) Malignant extracranial & extragonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|141|X(c) Malignant gonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(d) Gonadal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60907384|0-14|All Races|Male and Female|2008|||
6.6|8.0|7.2|441|XI Other malignant epithelial neoplasms and malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
0.1|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.0|2.6|157|XI(b) Thyroid carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|140|XI(d) Malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XI(e) Skin carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.5|2.1|1.8|108|XI(f) Other and unspecified carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.4|0.9|0.6|39|XII Other and unspecified malignant neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|24|XII(a) Other specified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XII(b) Other unspecified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
160.0|166.4|163.2|10026|All ICCC Groups Combined|61087581|0-14|All Races|Male and Female|2009|||
50.8|54.4|52.6|3238|I Leukemias, myeloproliferative & myelodysplastic diseases|61087581|0-14|All Races|Male and Female|2009|||
39.5|42.7|41.1|2532|I(a) Lymphoid leukemias|61087581|0-14|All Races|Male and Female|2009|||
6.6|8.0|7.3|447|I(b) Acute myeloid leukemias|61087581|0-14|All Races|Male and Female|2009|||
1.3|1.9|1.6|95|I(c) Chronic myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
1.2|1.9|1.5|94|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.4|1.1|70|I(e) Unspecified and other specified leukemias|61087581|0-14|All Races|Male and Female|2009|||
15.9|17.9|16.9|1027|II Lymphomas and reticuloendothelial neoplasms|61087581|0-14|All Races|Male and Female|2009|||
5.1|6.4|5.7|347|II(a) Hodgkin lymphomas|61087581|0-14|All Races|Male and Female|2009|||
6.3|7.7|7.0|424|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.4|143|II(c) Burkitt lymphoma|61087581|0-14|All Races|Male and Female|2009|||
1.3|2.0|1.6|102|II(d) Miscellaneous lymphoreticular neoplasms|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|II(e) Unspecified lymphomas|61087581|0-14|All Races|Male and Female|2009|||
34.0|37.0|35.5|2174|III CNS and misc intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
2.1|3.0|2.5|156|III(a) Ependymomas and choroid plexus tumor|61087581|0-14|All Races|Male and Female|2009|||
16.6|18.7|17.6|1078|III(b) Astrocytomas|61087581|0-14|All Races|Male and Female|2009|||
7.0|8.4|7.6|469|III(c) Intracranial and intraspinal embryonal tumors|61087581|0-14|All Races|Male and Female|2009|||
6.0|7.4|6.7|407|III(d) Other gliomas|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|34|III(e) Other specified intracranial & intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.7|0.5|30|III(f) Unspecified intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
10.0|11.6|10.8|671|IV Neuroblastoma and other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
9.8|11.5|10.6|661|IV(a) Neuroblastoma and ganglioneuroblastoma|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
9.9|11.6|10.7|656|IX Soft tissue and other extraosseous sarcomas|61087581|0-14|All Races|Male and Female|2009|||
4.0|5.0|4.5|275|IX(a) Rhabdomyosarcomas|61087581|0-14|All Races|Male and Female|2009|||
1.0|1.6|1.3|78|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IX(c) Kaposi sarcoma|61087581|0-14|All Races|Male and Female|2009|||
3.3|4.3|3.8|231|IX(d) Other specified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|72|IX(e) Unspecified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|20|Not classified by ICCC|61087581|0-14|All Races|Male and Female|2009|||
4.0|5.1|4.5|283|V Retinoblastoma|61087581|0-14|All Races|Male and Female|2009|||
8.5|10.0|9.2|574|VI Renal tumors|61087581|0-14|All Races|Male and Female|2009|||
7.9|9.4|8.6|536|VI(a) Nephroblastoma and other nonepithelial renal tumors|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|36|VI(b) Renal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61087581|0-14|All Races|Male and Female|2009|||
1.8|2.6|2.2|137|VII Hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
1.5|2.2|1.9|116|VII(a) Hepatoblastoma|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
6.4|7.7|7.0|427|VIII Malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
3.5|4.5|4.0|241|VIII(a) Osteosarcomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(b) Chondrosarcomas|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.4|144|VIII(c) Ewing tumor and related sarcomas of bone|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.6|0.4|24|VIII(d) Other specified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
4.9|6.1|5.5|334|X Germ cell, trophoblastic tumors & neoplasms of gonads|61087581|0-14|All Races|Male and Female|2009|||
1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|74|X(b) Malignant extracranial & extragonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
2.2|3.0|2.6|160|X(c) Malignant gonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(d) Gonadal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61087581|0-14|All Races|Male and Female|2009|||
6.5|7.9|7.2|436|XI Other malignant epithelial neoplasms and malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61087581|0-14|All Races|Male and Female|2009|||
2.5|3.4|2.9|177|XI(b) Thyroid carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.6|0.4|25|XI(c) Nasopharyngeal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.3|2.0|1.6|100|XI(d) Malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(e) Skin carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.6|2.3|1.9|114|XI(f) Other and unspecified carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.6|1.0|0.8|49|XII Other and unspecified malignant neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.7|0.5|29|XII(b) Other unspecified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
167.3|173.8|170.5|10485|All ICCC Groups Combined|61200646|0-14|All Races|Male and Female|2010|||
52.5|56.2|54.3|3347|I Leukemias, myeloproliferative & myelodysplastic diseases|61200646|0-14|All Races|Male and Female|2010|||
39.4|42.6|41.0|2527|I(a) Lymphoid leukemias|61200646|0-14|All Races|Male and Female|2010|||
7.1|8.5|7.7|476|I(b) Acute myeloid leukemias|61200646|0-14|All Races|Male and Female|2010|||
1.6|2.3|2.0|120|I(c) Chronic myeloproliferative diseases|61200646|0-14|All Races|Male and Female|2010|||
1.6|2.3|1.9|118|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61200646|0-14|All Races|Male and Female|2010|||
1.4|2.1|1.7|106|I(e) Unspecified and other specified leukemias|61200646|0-14|All Races|Male and Female|2010|||
18.9|21.1|20.0|1221|II Lymphomas and reticuloendothelial neoplasms|61200646|0-14|All Races|Male and Female|2010|||
4.8|5.9|5.3|323|II(a) Hodgkin lymphomas|61200646|0-14|All Races|Male and Female|2010|||
6.5|7.9|7.2|436|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61200646|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.5|151|II(c) Burkitt lymphoma|61200646|0-14|All Races|Male and Female|2010|||
4.3|5.5|4.9|301|II(d) Miscellaneous lymphoreticular neoplasms|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|II(e) Unspecified lymphomas|61200646|0-14|All Races|Male and Female|2010|||
35.1|38.1|36.6|2245|III CNS and misc intracranial and intraspinal neoplasms|61200646|0-14|All Races|Male and Female|2010|||
2.9|3.8|3.3|204|III(a) Ependymomas and choroid plexus tumor|61200646|0-14|All Races|Male and Female|2010|||
17.7|19.8|18.7|1149|III(b) Astrocytomas|61200646|0-14|All Races|Male and Female|2010|||
6.7|8.1|7.4|454|III(c) Intracranial and intraspinal embryonal tumors|61200646|0-14|All Races|Male and Female|2010|||
5.6|6.8|6.2|376|III(d) Other gliomas|61200646|0-14|All Races|Male and Female|2010|||
0.5|0.9|0.6|39|III(e) Other specified intracranial & intraspinal neoplasms|61200646|0-14|All Races|Male and Female|2010|||
0.2|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|61200646|0-14|All Races|Male and Female|2010|||
10.4|12.1|11.2|695|IV Neuroblastoma and other peripheral nervous cell tumors|61200646|0-14|All Races|Male and Female|2010|||
10.2|11.9|11.0|685|IV(a) Neuroblastoma and ganglioneuroblastoma|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61200646|0-14|All Races|Male and Female|2010|||
10.7|12.4|11.6|708|IX Soft tissue and other extraosseous sarcomas|61200646|0-14|All Races|Male and Female|2010|||
5.0|6.2|5.6|343|IX(a) Rhabdomyosarcomas|61200646|0-14|All Races|Male and Female|2010|||
0.6|1.1|0.8|49|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|IX(c) Kaposi sarcoma|61200646|0-14|All Races|Male and Female|2010|||
3.4|4.4|3.9|237|IX(d) Other specified soft tissue sarcomas|61200646|0-14|All Races|Male and Female|2010|||
1.0|1.6|1.3|79|IX(e) Unspecified soft tissue sarcomas|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|Not classified by ICCC|61200646|0-14|All Races|Male and Female|2010|||
4.1|5.1|4.6|285|V Retinoblastoma|61200646|0-14|All Races|Male and Female|2010|||
7.8|9.2|8.5|527|VI Renal tumors|61200646|0-14|All Races|Male and Female|2010|||
7.4|8.9|8.1|506|VI(a) Nephroblastoma and other nonepithelial renal tumors|61200646|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61200646|0-14|All Races|Male and Female|2010|||
2.6|3.5|3.0|187|VII Hepatic tumors|61200646|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.5|157|VII(a) Hepatoblastoma|61200646|0-14|All Races|Male and Female|2010|||
0.3|0.7|0.5|29|VII(b) Hepatic carcinomas|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61200646|0-14|All Races|Male and Female|2010|||
6.1|7.4|6.7|409|VIII Malignant bone tumors|61200646|0-14|All Races|Male and Female|2010|||
3.3|4.2|3.7|226|VIII(a) Osteosarcomas|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(b) Chondrosarcomas|61200646|0-14|All Races|Male and Female|2010|||
2.0|2.8|2.4|143|VIII(c) Ewing tumor and related sarcomas of bone|61200646|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61200646|0-14|All Races|Male and Female|2010|||
5.6|6.9|6.2|380|X Germ cell, trophoblastic tumors & neoplasms of gonads|61200646|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|112|X(a) Intracranial & intraspinal germ cell tumors|61200646|0-14|All Races|Male and Female|2010|||
1.1|1.7|1.4|84|X(b) Malignant extracranial & extragonadal germ cell tumors|61200646|0-14|All Races|Male and Female|2010|||
2.2|3.1|2.6|160|X(c) Malignant gonadal germ cell tumors|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|X(d) Gonadal carcinomas|61200646|0-14|All Races|Male and Female|2010|||
0.2|0.4|0.3|16|X(e) Other and unspecified malignant gonadal tumors|61200646|0-14|All Races|Male and Female|2010|||
6.4|7.7|7.0|427|XI Other malignant epithelial neoplasms and malignant melanomas|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61200646|0-14|All Races|Male and Female|2010|||
2.4|3.3|2.8|171|XI(b) Thyroid carcinomas|61200646|0-14|All Races|Male and Female|2010|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|61200646|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|110|XI(d) Malignant melanomas|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(e) Skin carcinomas|61200646|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|110|XI(f) Other and unspecified carcinomas|61200646|0-14|All Races|Male and Female|2010|||
0.4|0.9|0.6|39|XII Other and unspecified malignant neoplasms|61200646|0-14|All Races|Male and Female|2010|||
0.2|0.6|0.4|24|XII(a) Other specified malignant tumors|61200646|0-14|All Races|Male and Female|2010|||
~|~|~|~|XII(b) Other unspecified malignant tumors|61200646|0-14|All Races|Male and Female|2010|||
166.8|173.4|170.1|10445|All ICCC Groups Combined|61169649|0-14|All Races|Male and Female|2011|||
52.4|56.1|54.2|3337|I Leukemias, myeloproliferative & myelodysplastic diseases|61169649|0-14|All Races|Male and Female|2011|||
40.2|43.5|41.8|2577|I(a) Lymphoid leukemias|61169649|0-14|All Races|Male and Female|2011|||
7.0|8.4|7.7|473|I(b) Acute myeloid leukemias|61169649|0-14|All Races|Male and Female|2011|||
1.5|2.2|1.8|111|I(c) Chronic myeloproliferative diseases|61169649|0-14|All Races|Male and Female|2011|||
1.1|1.7|1.3|83|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61169649|0-14|All Races|Male and Female|2011|||
1.2|1.9|1.5|93|I(e) Unspecified and other specified leukemias|61169649|0-14|All Races|Male and Female|2011|||
19.1|21.4|20.2|1235|II Lymphomas and reticuloendothelial neoplasms|61169649|0-14|All Races|Male and Female|2011|||
4.6|5.8|5.2|316|II(a) Hodgkin lymphomas|61169649|0-14|All Races|Male and Female|2011|||
5.8|7.0|6.4|389|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61169649|0-14|All Races|Male and Female|2011|||
2.3|3.1|2.6|161|II(c) Burkitt lymphoma|61169649|0-14|All Races|Male and Female|2011|||
5.2|6.4|5.8|355|II(d) Miscellaneous lymphoreticular neoplasms|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|II(e) Unspecified lymphomas|61169649|0-14|All Races|Male and Female|2011|||
34.4|37.4|35.8|2197|III CNS and misc intracranial and intraspinal neoplasms|61169649|0-14|All Races|Male and Female|2011|||
3.0|3.9|3.4|212|III(a) Ependymomas and choroid plexus tumor|61169649|0-14|All Races|Male and Female|2011|||
17.0|19.1|18.0|1105|III(b) Astrocytomas|61169649|0-14|All Races|Male and Female|2011|||
6.4|7.7|7.0|433|III(c) Intracranial and intraspinal embryonal tumors|61169649|0-14|All Races|Male and Female|2011|||
5.7|7.0|6.3|386|III(d) Other gliomas|61169649|0-14|All Races|Male and Female|2011|||
0.4|0.7|0.5|32|III(e) Other specified intracranial & intraspinal neoplasms|61169649|0-14|All Races|Male and Female|2011|||
0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|61169649|0-14|All Races|Male and Female|2011|||
10.4|12.1|11.2|693|IV Neuroblastoma and other peripheral nervous cell tumors|61169649|0-14|All Races|Male and Female|2011|||
10.2|11.8|11.0|680|IV(a) Neuroblastoma and ganglioneuroblastoma|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61169649|0-14|All Races|Male and Female|2011|||
10.3|12.0|11.1|682|IX Soft tissue and other extraosseous sarcomas|61169649|0-14|All Races|Male and Female|2011|||
4.7|5.8|5.2|321|IX(a) Rhabdomyosarcomas|61169649|0-14|All Races|Male and Female|2011|||
0.8|1.4|1.1|65|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|IX(c) Kaposi sarcoma|61169649|0-14|All Races|Male and Female|2011|||
3.3|4.3|3.7|228|IX(d) Other specified soft tissue sarcomas|61169649|0-14|All Races|Male and Female|2011|||
0.8|1.4|1.1|66|IX(e) Unspecified soft tissue sarcomas|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|Not classified by ICCC|61169649|0-14|All Races|Male and Female|2011|||
3.7|4.7|4.2|261|V Retinoblastoma|61169649|0-14|All Races|Male and Female|2011|||
8.3|9.8|9.0|557|VI Renal tumors|61169649|0-14|All Races|Male and Female|2011|||
7.9|9.4|8.6|534|VI(a) Nephroblastoma and other nonepithelial renal tumors|61169649|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.4|22|VI(b) Renal carcinomas|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61169649|0-14|All Races|Male and Female|2011|||
2.7|3.6|3.2|196|VII Hepatic tumors|61169649|0-14|All Races|Male and Female|2011|||
2.3|3.1|2.7|167|VII(a) Hepatoblastoma|61169649|0-14|All Races|Male and Female|2011|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61169649|0-14|All Races|Male and Female|2011|||
6.8|8.2|7.4|453|VIII Malignant bone tumors|61169649|0-14|All Races|Male and Female|2011|||
3.6|4.7|4.1|250|VIII(a) Osteosarcomas|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(b) Chondrosarcomas|61169649|0-14|All Races|Male and Female|2011|||
2.4|3.3|2.8|173|VIII(c) Ewing tumor and related sarcomas of bone|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61169649|0-14|All Races|Male and Female|2011|||
4.6|5.7|5.1|313|X Germ cell, trophoblastic tumors & neoplasms of gonads|61169649|0-14|All Races|Male and Female|2011|||
1.2|1.9|1.5|94|X(a) Intracranial & intraspinal germ cell tumors|61169649|0-14|All Races|Male and Female|2011|||
0.9|1.5|1.2|74|X(b) Malignant extracranial & extragonadal germ cell tumors|61169649|0-14|All Races|Male and Female|2011|||
1.8|2.6|2.2|132|X(c) Malignant gonadal germ cell tumors|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(d) Gonadal carcinomas|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61169649|0-14|All Races|Male and Female|2011|||
7.0|8.4|7.7|470|XI Other malignant epithelial neoplasms and malignant melanomas|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61169649|0-14|All Races|Male and Female|2011|||
2.9|3.8|3.3|202|XI(b) Thyroid carcinomas|61169649|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|61169649|0-14|All Races|Male and Female|2011|||
1.7|2.5|2.1|126|XI(d) Malignant melanomas|61169649|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(e) Skin carcinomas|61169649|0-14|All Races|Male and Female|2011|||
1.4|2.1|1.7|106|XI(f) Other and unspecified carcinomas|61169649|0-14|All Races|Male and Female|2011|||
0.5|0.9|0.6|39|XII Other and unspecified malignant neoplasms|61169649|0-14|All Races|Male and Female|2011|||
0.2|0.4|0.3|17|XII(a) Other specified malignant tumors|61169649|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.4|22|XII(b) Other unspecified malignant tumors|61169649|0-14|All Races|Male and Female|2011|||
166.1|172.6|169.3|10379|All ICCC Groups Combined|61114199|0-14|All Races|Male and Female|2012|||
50.6|54.3|52.4|3220|I Leukemias, myeloproliferative & myelodysplastic diseases|61114199|0-14|All Races|Male and Female|2012|||
38.6|41.8|40.2|2470|I(a) Lymphoid leukemias|61114199|0-14|All Races|Male and Female|2012|||
6.5|7.9|7.2|441|I(b) Acute myeloid leukemias|61114199|0-14|All Races|Male and Female|2012|||
1.4|2.0|1.7|103|I(c) Chronic myeloproliferative diseases|61114199|0-14|All Races|Male and Female|2012|||
1.4|2.0|1.7|102|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61114199|0-14|All Races|Male and Female|2012|||
1.4|2.1|1.7|104|I(e) Unspecified and other specified leukemias|61114199|0-14|All Races|Male and Female|2012|||
20.5|22.9|21.7|1323|II Lymphomas and reticuloendothelial neoplasms|61114199|0-14|All Races|Male and Female|2012|||
5.2|6.4|5.8|350|II(a) Hodgkin lymphomas|61114199|0-14|All Races|Male and Female|2012|||
6.8|8.1|7.4|453|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61114199|0-14|All Races|Male and Female|2012|||
2.0|2.8|2.3|143|II(c) Burkitt lymphoma|61114199|0-14|All Races|Male and Female|2012|||
5.2|6.4|5.8|353|II(d) Miscellaneous lymphoreticular neoplasms|61114199|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|24|II(e) Unspecified lymphomas|61114199|0-14|All Races|Male and Female|2012|||
33.7|36.7|35.2|2157|III CNS and misc intracranial and intraspinal neoplasms|61114199|0-14|All Races|Male and Female|2012|||
2.5|3.4|3.0|182|III(a) Ependymomas and choroid plexus tumor|61114199|0-14|All Races|Male and Female|2012|||
17.5|19.7|18.6|1138|III(b) Astrocytomas|61114199|0-14|All Races|Male and Female|2012|||
6.5|7.8|7.1|438|III(c) Intracranial and intraspinal embryonal tumors|61114199|0-14|All Races|Male and Female|2012|||
4.7|5.8|5.2|319|III(d) Other gliomas|61114199|0-14|All Races|Male and Female|2012|||
0.4|0.8|0.6|35|III(e) Other specified intracranial & intraspinal neoplasms|61114199|0-14|All Races|Male and Female|2012|||
0.5|1.0|0.7|45|III(f) Unspecified intracranial and intraspinal neoplasms|61114199|0-14|All Races|Male and Female|2012|||
10.6|12.4|11.5|707|IV Neuroblastoma and other peripheral nervous cell tumors|61114199|0-14|All Races|Male and Female|2012|||
10.4|12.1|11.2|692|IV(a) Neuroblastoma and ganglioneuroblastoma|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61114199|0-14|All Races|Male and Female|2012|||
10.2|11.9|11.1|676|IX Soft tissue and other extraosseous sarcomas|61114199|0-14|All Races|Male and Female|2012|||
4.5|5.6|5.0|309|IX(a) Rhabdomyosarcomas|61114199|0-14|All Races|Male and Female|2012|||
0.9|1.5|1.2|71|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|IX(c) Kaposi sarcoma|61114199|0-14|All Races|Male and Female|2012|||
3.1|4.1|3.6|218|IX(d) Other specified soft tissue sarcomas|61114199|0-14|All Races|Male and Female|2012|||
1.0|1.5|1.2|75|IX(e) Unspecified soft tissue sarcomas|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|Not classified by ICCC|61114199|0-14|All Races|Male and Female|2012|||
3.9|5.0|4.4|273|V Retinoblastoma|61114199|0-14|All Races|Male and Female|2012|||
7.9|9.4|8.6|530|VI Renal tumors|61114199|0-14|All Races|Male and Female|2012|||
7.5|8.9|8.2|505|VI(a) Nephroblastoma and other nonepithelial renal tumors|61114199|0-14|All Races|Male and Female|2012|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61114199|0-14|All Races|Male and Female|2012|||
2.9|3.8|3.3|205|VII Hepatic tumors|61114199|0-14|All Races|Male and Female|2012|||
2.4|3.3|2.8|175|VII(a) Hepatoblastoma|61114199|0-14|All Races|Male and Female|2012|||
0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61114199|0-14|All Races|Male and Female|2012|||
6.6|8.0|7.3|442|VIII Malignant bone tumors|61114199|0-14|All Races|Male and Female|2012|||
3.9|5.0|4.4|267|VIII(a) Osteosarcomas|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|VIII(b) Chondrosarcomas|61114199|0-14|All Races|Male and Female|2012|||
1.9|2.6|2.2|136|VIII(c) Ewing tumor and related sarcomas of bone|61114199|0-14|All Races|Male and Female|2012|||
0.2|0.5|0.3|19|VIII(d) Other specified malignant bone tumors|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61114199|0-14|All Races|Male and Female|2012|||
4.6|5.8|5.2|315|X Germ cell, trophoblastic tumors & neoplasms of gonads|61114199|0-14|All Races|Male and Female|2012|||
1.1|1.7|1.4|84|X(a) Intracranial & intraspinal germ cell tumors|61114199|0-14|All Races|Male and Female|2012|||
1.2|1.9|1.5|93|X(b) Malignant extracranial & extragonadal germ cell tumors|61114199|0-14|All Races|Male and Female|2012|||
1.7|2.4|2.0|124|X(c) Malignant gonadal germ cell tumors|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|X(d) Gonadal carcinomas|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61114199|0-14|All Races|Male and Female|2012|||
7.0|8.4|7.7|467|XI Other malignant epithelial neoplasms and malignant melanomas|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61114199|0-14|All Races|Male and Female|2012|||
2.8|3.7|3.3|198|XI(b) Thyroid carcinomas|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61114199|0-14|All Races|Male and Female|2012|||
1.6|2.3|2.0|119|XI(d) Malignant melanomas|61114199|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(e) Skin carcinomas|61114199|0-14|All Races|Male and Female|2012|||
1.6|2.3|2.0|119|XI(f) Other and unspecified carcinomas|61114199|0-14|All Races|Male and Female|2012|||
0.6|1.1|0.8|51|XII Other and unspecified malignant neoplasms|61114199|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|25|XII(a) Other specified malignant tumors|61114199|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|26|XII(b) Other unspecified malignant tumors|61114199|0-14|All Races|Male and Female|2012|||
171.9|174.8|173.3|53024|All ICCC Groups Combined|305217663|0-14|All Races|Male and Female|2012-2016|||
51.9|53.5|52.7|16151|I Leukemias, myeloproliferative & myelodysplastic diseases|305217663|0-14|All Races|Male and Female|2012-2016|||
39.0|40.4|39.7|12168|I(a) Lymphoid leukemias|305217663|0-14|All Races|Male and Female|2012-2016|||
7.4|8.1|7.7|2369|I(b) Acute myeloid leukemias|305217663|0-14|All Races|Male and Female|2012-2016|||
1.6|1.9|1.7|532|I(c) Chronic myeloproliferative diseases|305217663|0-14|All Races|Male and Female|2012-2016|||
1.4|1.7|1.5|471|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|305217663|0-14|All Races|Male and Female|2012-2016|||
1.8|2.2|2.0|611|I(e) Unspecified and other specified leukemias|305217663|0-14|All Races|Male and Female|2012-2016|||
21.8|22.9|22.4|6820|II Lymphomas and reticuloendothelial neoplasms|305217663|0-14|All Races|Male and Female|2012-2016|||
5.4|6.0|5.7|1732|II(a) Hodgkin lymphomas|305217663|0-14|All Races|Male and Female|2012-2016|||
7.5|8.1|7.8|2371|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|305217663|0-14|All Races|Male and Female|2012-2016|||
2.3|2.6|2.5|752|II(c) Burkitt lymphoma|305217663|0-14|All Races|Male and Female|2012-2016|||
5.9|6.4|6.1|1880|II(d) Miscellaneous lymphoreticular neoplasms|305217663|0-14|All Races|Male and Female|2012-2016|||
0.2|0.3|0.3|85|II(e) Unspecified lymphomas|305217663|0-14|All Races|Male and Female|2012-2016|||
34.7|36.1|35.4|10823|III CNS and misc intracranial and intraspinal neoplasms|305217663|0-14|All Races|Male and Female|2012-2016|||
2.8|3.2|3.0|928|III(a) Ependymomas and choroid plexus tumor|305217663|0-14|All Races|Male and Female|2012-2016|||
17.7|18.6|18.1|5539|III(b) Astrocytomas|305217663|0-14|All Races|Male and Female|2012-2016|||
6.8|7.4|7.1|2163|III(c) Intracranial and intraspinal embryonal tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
5.6|6.2|5.9|1798|III(d) Other gliomas|305217663|0-14|All Races|Male and Female|2012-2016|||
0.6|0.8|0.7|219|III(e) Other specified intracranial & intraspinal neoplasms|305217663|0-14|All Races|Male and Female|2012-2016|||
0.5|0.7|0.6|176|III(f) Unspecified intracranial and intraspinal neoplasms|305217663|0-14|All Races|Male and Female|2012-2016|||
11.4|12.2|11.8|3632|IV Neuroblastoma and other peripheral nervous cell tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
11.2|12.0|11.6|3567|IV(a) Neuroblastoma and ganglioneuroblastoma|305217663|0-14|All Races|Male and Female|2012-2016|||
0.2|0.3|0.2|65|IV(b) Other peripheral nervous cell tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
10.8|11.5|11.1|3400|IX Soft tissue and other extraosseous sarcomas|305217663|0-14|All Races|Male and Female|2012-2016|||
4.9|5.5|5.2|1592|IX(a) Rhabdomyosarcomas|305217663|0-14|All Races|Male and Female|2012-2016|||
1.0|1.2|1.1|343|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|305217663|0-14|All Races|Male and Female|2012-2016|||
~|~|~|~|IX(c) Kaposi sarcoma|305217663|0-14|All Races|Male and Female|2012-2016|||
3.5|3.9|3.7|1120|IX(d) Other specified soft tissue sarcomas|305217663|0-14|All Races|Male and Female|2012-2016|||
1.0|1.2|1.1|338|IX(e) Unspecified soft tissue sarcomas|305217663|0-14|All Races|Male and Female|2012-2016|||
0.2|0.3|0.3|78|Not classified by ICCC|305217663|0-14|All Races|Male and Female|2012-2016|||
4.2|4.7|4.4|1368|V Retinoblastoma|305217663|0-14|All Races|Male and Female|2012-2016|||
8.7|9.4|9.0|2772|VI Renal tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
8.2|8.9|8.6|2633|VI(a) Nephroblastoma and other nonepithelial renal tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
0.3|0.5|0.4|125|VI(b) Renal carcinomas|305217663|0-14|All Races|Male and Female|2012-2016|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
2.9|3.3|3.1|960|VII Hepatic tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
2.5|2.9|2.7|834|VII(a) Hepatoblastoma|305217663|0-14|All Races|Male and Female|2012-2016|||
0.3|0.5|0.4|120|VII(b) Hepatic carcinomas|305217663|0-14|All Races|Male and Female|2012-2016|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
7.3|7.9|7.6|2318|VIII Malignant bone tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
4.0|4.4|4.2|1271|VIII(a) Osteosarcomas|305217663|0-14|All Races|Male and Female|2012-2016|||
0.2|0.3|0.2|61|VIII(b) Chondrosarcomas|305217663|0-14|All Races|Male and Female|2012-2016|||
2.5|2.9|2.7|813|VIII(c) Ewing tumor and related sarcomas of bone|305217663|0-14|All Races|Male and Female|2012-2016|||
0.4|0.5|0.4|133|VIII(d) Other specified malignant bone tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
0.1|0.2|0.1|40|VIII(e) Unspecified malignant bone tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
5.3|5.9|5.6|1706|X Germ cell, trophoblastic tumors & neoplasms of gonads|305217663|0-14|All Races|Male and Female|2012-2016|||
1.5|1.7|1.6|485|X(a) Intracranial & intraspinal germ cell tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
1.3|1.6|1.4|439|X(b) Malignant extracranial & extragonadal germ cell tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
2.1|2.4|2.3|693|X(c) Malignant gonadal germ cell tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
0.1|0.1|0.1|29|X(d) Gonadal carcinomas|305217663|0-14|All Races|Male and Female|2012-2016|||
0.2|0.3|0.2|60|X(e) Other and unspecified malignant gonadal tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
8.8|9.5|9.1|2769|XI Other malignant epithelial neoplasms and malignant melanomas|305217663|0-14|All Races|Male and Female|2012-2016|||
0.1|0.2|0.2|54|XI(a) Adrenocortical carcinomas|305217663|0-14|All Races|Male and Female|2012-2016|||
3.3|3.7|3.5|1071|XI(b) Thyroid carcinomas|305217663|0-14|All Races|Male and Female|2012-2016|||
0.2|0.3|0.2|69|XI(c) Nasopharyngeal carcinomas|305217663|0-14|All Races|Male and Female|2012-2016|||
1.9|2.3|2.1|637|XI(d) Malignant melanomas|305217663|0-14|All Races|Male and Female|2012-2016|||
~|~|~|~|XI(e) Skin carcinomas|305217663|0-14|All Races|Male and Female|2012-2016|||
2.9|3.2|3.0|925|XI(f) Other and unspecified carcinomas|305217663|0-14|All Races|Male and Female|2012-2016|||
0.6|0.8|0.7|227|XII Other and unspecified malignant neoplasms|305217663|0-14|All Races|Male and Female|2012-2016|||
0.4|0.5|0.4|136|XII(a) Other specified malignant tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
0.2|0.4|0.3|91|XII(b) Other unspecified malignant tumors|305217663|0-14|All Races|Male and Female|2012-2016|||
168.5|175.1|171.8|10506|All ICCC Groups Combined|61069460|0-14|All Races|Male and Female|2013|||
49.3|52.9|51.1|3131|I Leukemias, myeloproliferative & myelodysplastic diseases|61069460|0-14|All Races|Male and Female|2013|||
36.4|39.5|37.9|2325|I(a) Lymphoid leukemias|61069460|0-14|All Races|Male and Female|2013|||
7.2|8.6|7.8|480|I(b) Acute myeloid leukemias|61069460|0-14|All Races|Male and Female|2013|||
1.4|2.0|1.7|102|I(c) Chronic myeloproliferative diseases|61069460|0-14|All Races|Male and Female|2013|||
1.2|1.8|1.5|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61069460|0-14|All Races|Male and Female|2013|||
1.8|2.6|2.2|132|I(e) Unspecified and other specified leukemias|61069460|0-14|All Races|Male and Female|2013|||
20.5|22.9|21.7|1324|II Lymphomas and reticuloendothelial neoplasms|61069460|0-14|All Races|Male and Female|2013|||
4.9|6.1|5.5|336|II(a) Hodgkin lymphomas|61069460|0-14|All Races|Male and Female|2013|||
6.7|8.0|7.3|447|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61069460|0-14|All Races|Male and Female|2013|||
1.9|2.7|2.3|140|II(c) Burkitt lymphoma|61069460|0-14|All Races|Male and Female|2013|||
5.7|7.0|6.3|387|II(d) Miscellaneous lymphoreticular neoplasms|61069460|0-14|All Races|Male and Female|2013|||
~|~|~|~|II(e) Unspecified lymphomas|61069460|0-14|All Races|Male and Female|2013|||
35.0|38.1|36.5|2234|III CNS and misc intracranial and intraspinal neoplasms|61069460|0-14|All Races|Male and Female|2013|||
2.7|3.6|3.1|190|III(a) Ependymomas and choroid plexus tumor|61069460|0-14|All Races|Male and Female|2013|||
18.1|20.3|19.2|1172|III(b) Astrocytomas|61069460|0-14|All Races|Male and Female|2013|||
6.3|7.6|6.9|422|III(c) Intracranial and intraspinal embryonal tumors|61069460|0-14|All Races|Male and Female|2013|||
5.6|6.8|6.2|376|III(d) Other gliomas|61069460|0-14|All Races|Male and Female|2013|||
0.5|1.0|0.7|44|III(e) Other specified intracranial & intraspinal neoplasms|61069460|0-14|All Races|Male and Female|2013|||
0.3|0.7|0.5|30|III(f) Unspecified intracranial and intraspinal neoplasms|61069460|0-14|All Races|Male and Female|2013|||
11.3|13.1|12.2|746|IV Neuroblastoma and other peripheral nervous cell tumors|61069460|0-14|All Races|Male and Female|2013|||
11.0|12.7|11.9|728|IV(a) Neuroblastoma and ganglioneuroblastoma|61069460|0-14|All Races|Male and Female|2013|||
0.2|0.5|0.3|18|IV(b) Other peripheral nervous cell tumors|61069460|0-14|All Races|Male and Female|2013|||
10.4|12.1|11.2|683|IX Soft tissue and other extraosseous sarcomas|61069460|0-14|All Races|Male and Female|2013|||
4.7|5.9|5.3|324|IX(a) Rhabdomyosarcomas|61069460|0-14|All Races|Male and Female|2013|||
1.0|1.5|1.2|74|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61069460|0-14|All Races|Male and Female|2013|||
~|~|~|~|IX(c) Kaposi sarcoma|61069460|0-14|All Races|Male and Female|2013|||
3.2|4.2|3.7|224|IX(d) Other specified soft tissue sarcomas|61069460|0-14|All Races|Male and Female|2013|||
0.8|1.3|1.0|60|IX(e) Unspecified soft tissue sarcomas|61069460|0-14|All Races|Male and Female|2013|||
0.1|0.4|0.3|16|Not classified by ICCC|61069460|0-14|All Races|Male and Female|2013|||
3.8|4.9|4.3|265|V Retinoblastoma|61069460|0-14|All Races|Male and Female|2013|||
8.3|9.8|9.0|552|VI Renal tumors|61069460|0-14|All Races|Male and Female|2013|||
7.8|9.3|8.5|525|VI(a) Nephroblastoma and other nonepithelial renal tumors|61069460|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|24|VI(b) Renal carcinomas|61069460|0-14|All Races|Male and Female|2013|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61069460|0-14|All Races|Male and Female|2013|||
2.5|3.3|2.9|176|VII Hepatic tumors|61069460|0-14|All Races|Male and Female|2013|||
2.1|2.8|2.4|149|VII(a) Hepatoblastoma|61069460|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|61069460|0-14|All Races|Male and Female|2013|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61069460|0-14|All Races|Male and Female|2013|||
6.7|8.0|7.3|446|VIII Malignant bone tumors|61069460|0-14|All Races|Male and Female|2013|||
3.3|4.3|3.8|229|VIII(a) Osteosarcomas|61069460|0-14|All Races|Male and Female|2013|||
~|~|~|~|VIII(b) Chondrosarcomas|61069460|0-14|All Races|Male and Female|2013|||
2.4|3.3|2.8|173|VIII(c) Ewing tumor and related sarcomas of bone|61069460|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|26|VIII(d) Other specified malignant bone tumors|61069460|0-14|All Races|Male and Female|2013|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61069460|0-14|All Races|Male and Female|2013|||
5.2|6.4|5.8|353|X Germ cell, trophoblastic tumors & neoplasms of gonads|61069460|0-14|All Races|Male and Female|2013|||
1.4|2.1|1.7|103|X(a) Intracranial & intraspinal germ cell tumors|61069460|0-14|All Races|Male and Female|2013|||
1.1|1.6|1.3|81|X(b) Malignant extracranial & extragonadal germ cell tumors|61069460|0-14|All Races|Male and Female|2013|||
2.1|2.9|2.4|148|X(c) Malignant gonadal germ cell tumors|61069460|0-14|All Races|Male and Female|2013|||
~|~|~|~|X(d) Gonadal carcinomas|61069460|0-14|All Races|Male and Female|2013|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61069460|0-14|All Races|Male and Female|2013|||
8.2|9.7|8.9|541|XI Other malignant epithelial neoplasms and malignant melanomas|61069460|0-14|All Races|Male and Female|2013|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61069460|0-14|All Races|Male and Female|2013|||
3.2|4.1|3.6|220|XI(b) Thyroid carcinomas|61069460|0-14|All Races|Male and Female|2013|||
0.2|0.6|0.4|23|XI(c) Nasopharyngeal carcinomas|61069460|0-14|All Races|Male and Female|2013|||
1.8|2.6|2.2|132|XI(d) Malignant melanomas|61069460|0-14|All Races|Male and Female|2013|||
~|~|~|~|XI(e) Skin carcinomas|61069460|0-14|All Races|Male and Female|2013|||
2.1|2.9|2.5|153|XI(f) Other and unspecified carcinomas|61069460|0-14|All Races|Male and Female|2013|||
0.5|0.9|0.6|39|XII Other and unspecified malignant neoplasms|61069460|0-14|All Races|Male and Female|2013|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|61069460|0-14|All Races|Male and Female|2013|||
0.1|0.4|0.3|16|XII(b) Other unspecified malignant tumors|61069460|0-14|All Races|Male and Female|2013|||
172.0|178.6|175.3|10720|All ICCC Groups Combined|61055697|0-14|All Races|Male and Female|2014|||
50.2|53.9|52.0|3186|I Leukemias, myeloproliferative & myelodysplastic diseases|61055697|0-14|All Races|Male and Female|2014|||
37.4|40.5|38.9|2385|I(a) Lymphoid leukemias|61055697|0-14|All Races|Male and Female|2014|||
7.2|8.7|7.9|485|I(b) Acute myeloid leukemias|61055697|0-14|All Races|Male and Female|2014|||
1.2|1.9|1.5|93|I(c) Chronic myeloproliferative diseases|61055697|0-14|All Races|Male and Female|2014|||
1.3|2.0|1.6|98|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61055697|0-14|All Races|Male and Female|2014|||
1.7|2.4|2.0|125|I(e) Unspecified and other specified leukemias|61055697|0-14|All Races|Male and Female|2014|||
22.3|24.7|23.5|1431|II Lymphomas and reticuloendothelial neoplasms|61055697|0-14|All Races|Male and Female|2014|||
5.0|6.2|5.5|336|II(a) Hodgkin lymphomas|61055697|0-14|All Races|Male and Female|2014|||
7.8|9.2|8.5|517|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61055697|0-14|All Races|Male and Female|2014|||
2.4|3.2|2.8|170|II(c) Burkitt lymphoma|61055697|0-14|All Races|Male and Female|2014|||
5.8|7.0|6.4|390|II(d) Miscellaneous lymphoreticular neoplasms|61055697|0-14|All Races|Male and Female|2014|||
0.2|0.5|0.3|18|II(e) Unspecified lymphomas|61055697|0-14|All Races|Male and Female|2014|||
34.6|37.6|36.1|2205|III CNS and misc intracranial and intraspinal neoplasms|61055697|0-14|All Races|Male and Female|2014|||
2.8|3.7|3.2|198|III(a) Ependymomas and choroid plexus tumor|61055697|0-14|All Races|Male and Female|2014|||
17.4|19.6|18.5|1130|III(b) Astrocytomas|61055697|0-14|All Races|Male and Female|2014|||
6.7|8.0|7.3|448|III(c) Intracranial and intraspinal embryonal tumors|61055697|0-14|All Races|Male and Female|2014|||
5.0|6.2|5.6|343|III(d) Other gliomas|61055697|0-14|All Races|Male and Female|2014|||
0.6|1.1|0.8|50|III(e) Other specified intracranial & intraspinal neoplasms|61055697|0-14|All Races|Male and Female|2014|||
0.4|0.8|0.6|36|III(f) Unspecified intracranial and intraspinal neoplasms|61055697|0-14|All Races|Male and Female|2014|||
11.1|12.9|12.0|735|IV Neuroblastoma and other peripheral nervous cell tumors|61055697|0-14|All Races|Male and Female|2014|||
10.9|12.6|11.7|722|IV(a) Neuroblastoma and ganglioneuroblastoma|61055697|0-14|All Races|Male and Female|2014|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61055697|0-14|All Races|Male and Female|2014|||
10.3|12.0|11.2|682|IX Soft tissue and other extraosseous sarcomas|61055697|0-14|All Races|Male and Female|2014|||
4.4|5.5|4.9|302|IX(a) Rhabdomyosarcomas|61055697|0-14|All Races|Male and Female|2014|||
0.9|1.5|1.2|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61055697|0-14|All Races|Male and Female|2014|||
~|~|~|~|IX(c) Kaposi sarcoma|61055697|0-14|All Races|Male and Female|2014|||
3.4|4.4|3.8|234|IX(d) Other specified soft tissue sarcomas|61055697|0-14|All Races|Male and Female|2014|||
0.9|1.5|1.2|72|IX(e) Unspecified soft tissue sarcomas|61055697|0-14|All Races|Male and Female|2014|||
0.2|0.5|0.3|20|Not classified by ICCC|61055697|0-14|All Races|Male and Female|2014|||
3.8|4.9|4.3|266|V Retinoblastoma|61055697|0-14|All Races|Male and Female|2014|||
8.4|10.0|9.2|563|VI Renal tumors|61055697|0-14|All Races|Male and Female|2014|||
8.0|9.5|8.7|535|VI(a) Nephroblastoma and other nonepithelial renal tumors|61055697|0-14|All Races|Male and Female|2014|||
0.3|0.6|0.4|26|VI(b) Renal carcinomas|61055697|0-14|All Races|Male and Female|2014|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61055697|0-14|All Races|Male and Female|2014|||
2.6|3.5|3.0|186|VII Hepatic tumors|61055697|0-14|All Races|Male and Female|2014|||
2.2|3.0|2.6|160|VII(a) Hepatoblastoma|61055697|0-14|All Races|Male and Female|2014|||
0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|61055697|0-14|All Races|Male and Female|2014|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61055697|0-14|All Races|Male and Female|2014|||
7.3|8.8|8.0|487|VIII Malignant bone tumors|61055697|0-14|All Races|Male and Female|2014|||
3.9|5.0|4.4|269|VIII(a) Osteosarcomas|61055697|0-14|All Races|Male and Female|2014|||
~|~|~|~|VIII(b) Chondrosarcomas|61055697|0-14|All Races|Male and Female|2014|||
2.4|3.2|2.8|169|VIII(c) Ewing tumor and related sarcomas of bone|61055697|0-14|All Races|Male and Female|2014|||
0.3|0.7|0.5|28|VIII(d) Other specified malignant bone tumors|61055697|0-14|All Races|Male and Female|2014|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61055697|0-14|All Races|Male and Female|2014|||
5.2|6.4|5.8|352|X Germ cell, trophoblastic tumors & neoplasms of gonads|61055697|0-14|All Races|Male and Female|2014|||
1.2|1.8|1.5|90|X(a) Intracranial & intraspinal germ cell tumors|61055697|0-14|All Races|Male and Female|2014|||
1.4|2.0|1.7|103|X(b) Malignant extracranial & extragonadal germ cell tumors|61055697|0-14|All Races|Male and Female|2014|||
1.9|2.7|2.2|137|X(c) Malignant gonadal germ cell tumors|61055697|0-14|All Races|Male and Female|2014|||
~|~|~|~|X(d) Gonadal carcinomas|61055697|0-14|All Races|Male and Female|2014|||
0.2|0.4|0.3|16|X(e) Other and unspecified malignant gonadal tumors|61055697|0-14|All Races|Male and Female|2014|||
8.6|10.1|9.3|567|XI Other malignant epithelial neoplasms and malignant melanomas|61055697|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61055697|0-14|All Races|Male and Female|2014|||
3.4|4.4|3.8|234|XI(b) Thyroid carcinomas|61055697|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61055697|0-14|All Races|Male and Female|2014|||
1.9|2.7|2.2|137|XI(d) Malignant melanomas|61055697|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(e) Skin carcinomas|61055697|0-14|All Races|Male and Female|2014|||
2.4|3.3|2.8|171|XI(f) Other and unspecified carcinomas|61055697|0-14|All Races|Male and Female|2014|||
0.5|0.9|0.7|40|XII Other and unspecified malignant neoplasms|61055697|0-14|All Races|Male and Female|2014|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|61055697|0-14|All Races|Male and Female|2014|||
0.2|0.4|0.3|17|XII(b) Other unspecified malignant tumors|61055697|0-14|All Races|Male and Female|2014|||
173.6|180.3|176.9|10822|All ICCC Groups Combined|61002024|0-14|All Races|Male and Female|2015|||
52.5|56.2|54.3|3326|I Leukemias, myeloproliferative & myelodysplastic diseases|61002024|0-14|All Races|Male and Female|2015|||
39.5|42.7|41.0|2514|I(a) Lymphoid leukemias|61002024|0-14|All Races|Male and Female|2015|||
7.2|8.6|7.9|483|I(b) Acute myeloid leukemias|61002024|0-14|All Races|Male and Female|2015|||
1.6|2.3|1.9|119|I(c) Chronic myeloproliferative diseases|61002024|0-14|All Races|Male and Female|2015|||
1.2|1.8|1.5|90|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61002024|0-14|All Races|Male and Female|2015|||
1.6|2.3|2.0|120|I(e) Unspecified and other specified leukemias|61002024|0-14|All Races|Male and Female|2015|||
21.9|24.3|23.0|1404|II Lymphomas and reticuloendothelial neoplasms|61002024|0-14|All Races|Male and Female|2015|||
5.3|6.6|5.9|359|II(a) Hodgkin lymphomas|61002024|0-14|All Races|Male and Female|2015|||
6.7|8.1|7.4|451|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61002024|0-14|All Races|Male and Female|2015|||
2.1|3.0|2.5|154|II(c) Burkitt lymphoma|61002024|0-14|All Races|Male and Female|2015|||
6.3|7.6|6.9|423|II(d) Miscellaneous lymphoreticular neoplasms|61002024|0-14|All Races|Male and Female|2015|||
0.2|0.4|0.3|17|II(e) Unspecified lymphomas|61002024|0-14|All Races|Male and Female|2015|||
33.3|36.3|34.8|2124|III CNS and misc intracranial and intraspinal neoplasms|61002024|0-14|All Races|Male and Female|2015|||
2.6|3.5|3.1|188|III(a) Ependymomas and choroid plexus tumor|61002024|0-14|All Races|Male and Female|2015|||
16.6|18.7|17.7|1078|III(b) Astrocytomas|61002024|0-14|All Races|Male and Female|2015|||
6.6|7.9|7.2|443|III(c) Intracranial and intraspinal embryonal tumors|61002024|0-14|All Races|Male and Female|2015|||
5.1|6.3|5.7|348|III(d) Other gliomas|61002024|0-14|All Races|Male and Female|2015|||
0.5|0.9|0.7|40|III(e) Other specified intracranial & intraspinal neoplasms|61002024|0-14|All Races|Male and Female|2015|||
0.3|0.6|0.4|27|III(f) Unspecified intracranial and intraspinal neoplasms|61002024|0-14|All Races|Male and Female|2015|||
11.3|13.1|12.2|751|IV Neuroblastoma and other peripheral nervous cell tumors|61002024|0-14|All Races|Male and Female|2015|||
11.1|12.9|12.0|739|IV(a) Neuroblastoma and ganglioneuroblastoma|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61002024|0-14|All Races|Male and Female|2015|||
10.3|12.0|11.1|680|IX Soft tissue and other extraosseous sarcomas|61002024|0-14|All Races|Male and Female|2015|||
4.6|5.8|5.2|317|IX(a) Rhabdomyosarcomas|61002024|0-14|All Races|Male and Female|2015|||
0.8|1.4|1.1|66|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|IX(c) Kaposi sarcoma|61002024|0-14|All Races|Male and Female|2015|||
3.3|4.2|3.7|227|IX(d) Other specified soft tissue sarcomas|61002024|0-14|All Races|Male and Female|2015|||
0.9|1.4|1.1|69|IX(e) Unspecified soft tissue sarcomas|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|Not classified by ICCC|61002024|0-14|All Races|Male and Female|2015|||
4.3|5.5|4.9|302|V Retinoblastoma|61002024|0-14|All Races|Male and Female|2015|||
9.0|10.6|9.7|599|VI Renal tumors|61002024|0-14|All Races|Male and Female|2015|||
8.6|10.1|9.3|573|VI(a) Nephroblastoma and other nonepithelial renal tumors|61002024|0-14|All Races|Male and Female|2015|||
0.3|0.6|0.4|24|VI(b) Renal carcinomas|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61002024|0-14|All Races|Male and Female|2015|||
2.8|3.7|3.2|199|VII Hepatic tumors|61002024|0-14|All Races|Male and Female|2015|||
2.4|3.2|2.8|172|VII(a) Hepatoblastoma|61002024|0-14|All Races|Male and Female|2015|||
0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61002024|0-14|All Races|Male and Female|2015|||
6.8|8.2|7.5|454|VIII Malignant bone tumors|61002024|0-14|All Races|Male and Female|2015|||
3.4|4.5|3.9|238|VIII(a) Osteosarcomas|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|VIII(b) Chondrosarcomas|61002024|0-14|All Races|Male and Female|2015|||
2.3|3.1|2.7|162|VIII(c) Ewing tumor and related sarcomas of bone|61002024|0-14|All Races|Male and Female|2015|||
0.3|0.7|0.5|31|VIII(d) Other specified malignant bone tumors|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61002024|0-14|All Races|Male and Female|2015|||
4.9|6.1|5.5|334|X Germ cell, trophoblastic tumors & neoplasms of gonads|61002024|0-14|All Races|Male and Female|2015|||
1.3|1.9|1.6|97|X(a) Intracranial & intraspinal germ cell tumors|61002024|0-14|All Races|Male and Female|2015|||
1.1|1.7|1.3|83|X(b) Malignant extracranial & extragonadal germ cell tumors|61002024|0-14|All Races|Male and Female|2015|||
1.9|2.7|2.3|137|X(c) Malignant gonadal germ cell tumors|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|X(d) Gonadal carcinomas|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61002024|0-14|All Races|Male and Female|2015|||
9.0|10.6|9.8|595|XI Other malignant epithelial neoplasms and malignant melanomas|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61002024|0-14|All Races|Male and Female|2015|||
3.1|4.0|3.5|214|XI(b) Thyroid carcinomas|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61002024|0-14|All Races|Male and Female|2015|||
1.8|2.6|2.2|133|XI(d) Malignant melanomas|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|XI(e) Skin carcinomas|61002024|0-14|All Races|Male and Female|2015|||
3.3|4.3|3.8|228|XI(f) Other and unspecified carcinomas|61002024|0-14|All Races|Male and Female|2015|||
0.5|1.0|0.7|44|XII Other and unspecified malignant neoplasms|61002024|0-14|All Races|Male and Female|2015|||
0.3|0.7|0.5|31|XII(a) Other specified malignant tumors|61002024|0-14|All Races|Male and Female|2015|||
~|~|~|~|XII(b) Other unspecified malignant tumors|61002024|0-14|All Races|Male and Female|2015|||
170.1|176.7|173.4|10597|All ICCC Groups Combined|60976283|0-14|All Races|Male and Female|2016|||
51.9|55.6|53.7|3288|I Leukemias, myeloproliferative & myelodysplastic diseases|60976283|0-14|All Races|Male and Female|2016|||
38.8|42.0|40.4|2474|I(a) Lymphoid leukemias|60976283|0-14|All Races|Male and Female|2016|||
7.2|8.6|7.8|480|I(b) Acute myeloid leukemias|60976283|0-14|All Races|Male and Female|2016|||
1.6|2.3|1.9|115|I(c) Chronic myeloproliferative diseases|60976283|0-14|All Races|Male and Female|2016|||
1.2|1.8|1.5|89|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60976283|0-14|All Races|Male and Female|2016|||
1.8|2.5|2.1|130|I(e) Unspecified and other specified leukemias|60976283|0-14|All Races|Male and Female|2016|||
20.8|23.2|22.0|1338|II Lymphomas and reticuloendothelial neoplasms|60976283|0-14|All Races|Male and Female|2016|||
5.2|6.4|5.8|351|II(a) Hodgkin lymphomas|60976283|0-14|All Races|Male and Female|2016|||
7.6|9.0|8.3|503|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60976283|0-14|All Races|Male and Female|2016|||
2.0|2.8|2.4|145|II(c) Burkitt lymphoma|60976283|0-14|All Races|Male and Female|2016|||
4.8|6.0|5.3|327|II(d) Miscellaneous lymphoreticular neoplasms|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|II(e) Unspecified lymphomas|60976283|0-14|All Races|Male and Female|2016|||
33.0|35.9|34.4|2103|III CNS and misc intracranial and intraspinal neoplasms|60976283|0-14|All Races|Male and Female|2016|||
2.4|3.2|2.8|170|III(a) Ependymomas and choroid plexus tumor|60976283|0-14|All Races|Male and Female|2016|||
15.7|17.8|16.7|1021|III(b) Astrocytomas|60976283|0-14|All Races|Male and Female|2016|||
6.1|7.4|6.7|412|III(c) Intracranial and intraspinal embryonal tumors|60976283|0-14|All Races|Male and Female|2016|||
6.1|7.4|6.8|412|III(d) Other gliomas|60976283|0-14|All Races|Male and Female|2016|||
0.6|1.1|0.8|50|III(e) Other specified intracranial & intraspinal neoplasms|60976283|0-14|All Races|Male and Female|2016|||
0.4|0.9|0.6|38|III(f) Unspecified intracranial and intraspinal neoplasms|60976283|0-14|All Races|Male and Female|2016|||
10.4|12.1|11.3|693|IV Neuroblastoma and other peripheral nervous cell tumors|60976283|0-14|All Races|Male and Female|2016|||
10.3|12.0|11.2|686|IV(a) Neuroblastoma and ganglioneuroblastoma|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60976283|0-14|All Races|Male and Female|2016|||
10.3|12.0|11.1|679|IX Soft tissue and other extraosseous sarcomas|60976283|0-14|All Races|Male and Female|2016|||
5.0|6.2|5.6|340|IX(a) Rhabdomyosarcomas|60976283|0-14|All Races|Male and Female|2016|||
0.7|1.2|1.0|59|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|IX(c) Kaposi sarcoma|60976283|0-14|All Races|Male and Female|2016|||
3.1|4.1|3.6|217|IX(d) Other specified soft tissue sarcomas|60976283|0-14|All Races|Male and Female|2016|||
0.8|1.3|1.0|62|IX(e) Unspecified soft tissue sarcomas|60976283|0-14|All Races|Male and Female|2016|||
0.2|0.5|0.3|19|Not classified by ICCC|60976283|0-14|All Races|Male and Female|2016|||
3.8|4.8|4.2|262|V Retinoblastoma|60976283|0-14|All Races|Male and Female|2016|||
7.9|9.4|8.6|528|VI Renal tumors|60976283|0-14|All Races|Male and Female|2016|||
7.4|8.8|8.1|495|VI(a) Nephroblastoma and other nonepithelial renal tumors|60976283|0-14|All Races|Male and Female|2016|||
0.3|0.7|0.5|31|VI(b) Renal carcinomas|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60976283|0-14|All Races|Male and Female|2016|||
2.7|3.6|3.2|194|VII Hepatic tumors|60976283|0-14|All Races|Male and Female|2016|||
2.5|3.3|2.9|178|VII(a) Hepatoblastoma|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|VII(b) Hepatic carcinomas|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60976283|0-14|All Races|Male and Female|2016|||
7.4|8.8|8.1|489|VIII Malignant bone tumors|60976283|0-14|All Races|Male and Female|2016|||
3.9|5.0|4.4|268|VIII(a) Osteosarcomas|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|VIII(b) Chondrosarcomas|60976283|0-14|All Races|Male and Female|2016|||
2.4|3.3|2.8|173|VIII(c) Ewing tumor and related sarcomas of bone|60976283|0-14|All Races|Male and Female|2016|||
0.3|0.7|0.5|29|VIII(d) Other specified malignant bone tumors|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60976283|0-14|All Races|Male and Female|2016|||
5.2|6.4|5.8|352|X Germ cell, trophoblastic tumors & neoplasms of gonads|60976283|0-14|All Races|Male and Female|2016|||
1.5|2.2|1.8|111|X(a) Intracranial & intraspinal germ cell tumors|60976283|0-14|All Races|Male and Female|2016|||
1.0|1.6|1.3|79|X(b) Malignant extracranial & extragonadal germ cell tumors|60976283|0-14|All Races|Male and Female|2016|||
2.0|2.8|2.4|147|X(c) Malignant gonadal germ cell tumors|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|X(d) Gonadal carcinomas|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60976283|0-14|All Races|Male and Female|2016|||
9.1|10.7|9.9|599|XI Other malignant epithelial neoplasms and malignant melanomas|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60976283|0-14|All Races|Male and Female|2016|||
2.9|3.9|3.4|205|XI(b) Thyroid carcinomas|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60976283|0-14|All Races|Male and Female|2016|||
1.6|2.3|1.9|116|XI(d) Malignant melanomas|60976283|0-14|All Races|Male and Female|2016|||
~|~|~|~|XI(e) Skin carcinomas|60976283|0-14|All Races|Male and Female|2016|||
3.7|4.7|4.2|254|XI(f) Other and unspecified carcinomas|60976283|0-14|All Races|Male and Female|2016|||
0.6|1.1|0.9|53|XII Other and unspecified malignant neoplasms|60976283|0-14|All Races|Male and Female|2016|||
0.4|0.8|0.6|34|XII(a) Other specified malignant tumors|60976283|0-14|All Races|Male and Female|2016|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60976283|0-14|All Races|Male and Female|2016|||
155.8|161.4|158.6|12374|All ICCC Groups Combined|78174581|0-19|All Races|Male and Female|1999|155.5|161.1|158.3
39.2|42.1|40.6|3173|I Leukemias, myeloproliferative & myelodysplastic diseases|78174581|0-19|All Races|Male and Female|1999|39.2|42.0|40.6
28.9|31.3|30.1|2353|I(a) Lymphoid leukemias|78174581|0-19|All Races|Male and Female|1999|28.9|31.3|30.1
7.4|8.7|8.0|625|I(b) Acute myeloid leukemias|78174581|0-19|All Races|Male and Female|1999|7.4|8.6|8.0
0.8|1.2|1.0|78|I(c) Chronic myeloproliferative diseases|78174581|0-19|All Races|Male and Female|1999|0.8|1.2|1.0
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78174581|0-19|All Races|Male and Female|1999|~|~|~
1.1|1.6|1.3|105|I(e) Unspecified and other specified leukemias|78174581|0-19|All Races|Male and Female|1999|1.1|1.6|1.3
22.2|24.3|23.2|1813|II Lymphomas and reticuloendothelial neoplasms|78174581|0-19|All Races|Male and Female|1999|22.1|24.3|23.2
11.1|12.7|11.9|925|II(a) Hodgkin lymphomas|78174581|0-19|All Races|Male and Female|1999|11.1|12.6|11.8
7.0|8.3|7.6|597|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78174581|0-19|All Races|Male and Female|1999|7.0|8.3|7.6
2.1|2.8|2.4|188|II(c) Burkitt lymphoma|78174581|0-19|All Races|Male and Female|1999|2.1|2.8|2.4
0.5|0.9|0.7|54|II(d) Miscellaneous lymphoreticular neoplasms|78174581|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
0.5|0.8|0.6|49|II(e) Unspecified lymphomas|78174581|0-19|All Races|Male and Female|1999|0.5|0.8|0.6
27.5|29.9|28.6|2241|III CNS and misc intracranial and intraspinal neoplasms|78174581|0-19|All Races|Male and Female|1999|27.5|29.9|28.7
2.3|3.0|2.6|206|III(a) Ependymomas and choroid plexus tumor|78174581|0-19|All Races|Male and Female|1999|2.3|3.0|2.6
12.8|14.5|13.6|1065|III(b) Astrocytomas|78174581|0-19|All Races|Male and Female|1999|12.8|14.5|13.6
6.1|7.2|6.6|519|III(c) Intracranial and intraspinal embryonal tumors|78174581|0-19|All Races|Male and Female|1999|6.1|7.2|6.6
4.2|5.2|4.7|365|III(d) Other gliomas|78174581|0-19|All Races|Male and Female|1999|4.2|5.2|4.7
0.4|0.7|0.5|39|III(e) Other specified intracranial & intraspinal neoplasms|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
0.4|0.8|0.6|47|III(f) Unspecified intracranial and intraspinal neoplasms|78174581|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
7.6|8.9|8.2|638|IV Neuroblastoma and other peripheral nervous cell tumors|78174581|0-19|All Races|Male and Female|1999|7.5|8.8|8.2
7.3|8.6|7.9|616|IV(a) Neuroblastoma and ganglioneuroblastoma|78174581|0-19|All Races|Male and Female|1999|7.3|8.5|7.9
0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|78174581|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
10.2|11.7|10.9|854|IX Soft tissue and other extraosseous sarcomas|78174581|0-19|All Races|Male and Female|1999|10.2|11.7|10.9
4.1|5.1|4.6|356|IX(a) Rhabdomyosarcomas|78174581|0-19|All Races|Male and Female|1999|4.1|5.1|4.6
0.9|1.4|1.1|88|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78174581|0-19|All Races|Male and Female|1999|0.9|1.4|1.1
~|~|~|~|IX(c) Kaposi sarcoma|78174581|0-19|All Races|Male and Female|1999|~|~|~
3.5|4.4|4.0|310|IX(d) Other specified soft tissue sarcomas|78174581|0-19|All Races|Male and Female|1999|3.5|4.4|4.0
1.0|1.5|1.2|97|IX(e) Unspecified soft tissue sarcomas|78174581|0-19|All Races|Male and Female|1999|1.0|1.5|1.2
0.2|0.4|0.3|22|Not classified by ICCC|78174581|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
2.8|3.6|3.2|246|V Retinoblastoma|78174581|0-19|All Races|Male and Female|1999|2.8|3.6|3.1
5.8|6.9|6.3|494|VI Renal tumors|78174581|0-19|All Races|Male and Female|1999|5.8|6.9|6.3
5.3|6.3|5.8|451|VI(a) Nephroblastoma and other nonepithelial renal tumors|78174581|0-19|All Races|Male and Female|1999|5.2|6.3|5.8
0.4|0.7|0.5|39|VI(b) Renal carcinomas|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|78174581|0-19|All Races|Male and Female|1999|~|~|~
1.7|2.3|2.0|155|VII Hepatic tumors|78174581|0-19|All Races|Male and Female|1999|1.7|2.3|2.0
1.1|1.6|1.3|102|VII(a) Hepatoblastoma|78174581|0-19|All Races|Male and Female|1999|1.1|1.6|1.3
0.5|0.9|0.7|52|VII(b) Hepatic carcinomas|78174581|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78174581|0-19|All Races|Male and Female|1999|~|~|~
8.2|9.6|8.9|693|VIII Malignant bone tumors|78174581|0-19|All Races|Male and Female|1999|8.2|9.6|8.9
4.6|5.7|5.1|400|VIII(a) Osteosarcomas|78174581|0-19|All Races|Male and Female|1999|4.6|5.6|5.1
0.2|0.5|0.4|28|VIII(b) Chondrosarcomas|78174581|0-19|All Races|Male and Female|1999|0.2|0.5|0.4
2.4|3.1|2.7|213|VIII(c) Ewing tumor and related sarcomas of bone|78174581|0-19|All Races|Male and Female|1999|2.4|3.1|2.7
0.4|0.7|0.5|40|VIII(d) Other specified malignant bone tumors|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|78174581|0-19|All Races|Male and Female|1999|~|~|~
9.4|10.9|10.1|788|X Germ cell, trophoblastic tumors & neoplasms of gonads|78174581|0-19|All Races|Male and Female|1999|9.4|10.8|10.1
1.1|1.7|1.4|109|X(a) Intracranial & intraspinal germ cell tumors|78174581|0-19|All Races|Male and Female|1999|1.1|1.7|1.4
1.1|1.7|1.4|106|X(b) Malignant extracranial & extragonadal germ cell tumors|78174581|0-19|All Races|Male and Female|1999|1.1|1.6|1.4
6.1|7.3|6.7|522|X(c) Malignant gonadal germ cell tumors|78174581|0-19|All Races|Male and Female|1999|6.1|7.3|6.7
0.3|0.6|0.4|32|X(d) Gonadal carcinomas|78174581|0-19|All Races|Male and Female|1999|0.3|0.6|0.4
0.1|0.4|0.2|19|X(e) Other and unspecified malignant gonadal tumors|78174581|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
14.5|16.2|15.3|1193|XI Other malignant epithelial neoplasms and malignant melanomas|78174581|0-19|All Races|Male and Female|1999|14.4|16.2|15.3
0.1|0.4|0.2|18|XI(a) Adrenocortical carcinomas|78174581|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
5.3|6.4|5.9|457|XI(b) Thyroid carcinomas|78174581|0-19|All Races|Male and Female|1999|5.3|6.4|5.8
0.4|0.7|0.5|41|XI(c) Nasopharyngeal carcinomas|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
4.3|5.3|4.8|370|XI(d) Malignant melanomas|78174581|0-19|All Races|Male and Female|1999|4.3|5.2|4.7
~|~|~|~|XI(e) Skin carcinomas|78174581|0-19|All Races|Male and Female|1999|~|~|~
3.4|4.3|3.9|300|XI(f) Other and unspecified carcinomas|78174581|0-19|All Races|Male and Female|1999|3.4|4.3|3.8
0.6|1.0|0.8|64|XII Other and unspecified malignant neoplasms|78174581|0-19|All Races|Male and Female|1999|0.6|1.0|0.8
0.1|0.3|0.2|17|XII(a) Other specified malignant tumors|78174581|0-19|All Races|Male and Female|1999|0.1|0.3|0.2
0.4|0.8|0.6|47|XII(b) Other unspecified malignant tumors|78174581|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
161.1|166.8|163.9|12883|All ICCC Groups Combined|78714159|0-19|All Races|Male and Female|2000|160.9|166.5|163.7
40.0|42.9|41.4|3249|I Leukemias, myeloproliferative & myelodysplastic diseases|78714159|0-19|All Races|Male and Female|2000|39.9|42.7|41.3
30.6|33.1|31.8|2496|I(a) Lymphoid leukemias|78714159|0-19|All Races|Male and Female|2000|30.5|33.0|31.7
6.6|7.8|7.1|561|I(b) Acute myeloid leukemias|78714159|0-19|All Races|Male and Female|2000|6.5|7.7|7.1
0.7|1.2|0.9|74|I(c) Chronic myeloproliferative diseases|78714159|0-19|All Races|Male and Female|2000|0.7|1.2|0.9
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78714159|0-19|All Races|Male and Female|2000|~|~|~
1.1|1.6|1.4|106|I(e) Unspecified and other specified leukemias|78714159|0-19|All Races|Male and Female|2000|1.1|1.6|1.3
23.7|25.9|24.8|1953|II Lymphomas and reticuloendothelial neoplasms|78714159|0-19|All Races|Male and Female|2000|23.7|25.9|24.8
11.5|13.1|12.3|970|II(a) Hodgkin lymphomas|78714159|0-19|All Races|Male and Female|2000|11.6|13.1|12.3
7.5|8.8|8.1|642|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78714159|0-19|All Races|Male and Female|2000|7.5|8.8|8.2
2.3|3.1|2.7|211|II(c) Burkitt lymphoma|78714159|0-19|All Races|Male and Female|2000|2.3|3.1|2.7
0.8|1.2|1.0|78|II(d) Miscellaneous lymphoreticular neoplasms|78714159|0-19|All Races|Male and Female|2000|0.8|1.2|1.0
0.5|0.9|0.7|52|II(e) Unspecified lymphomas|78714159|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
29.1|31.5|30.3|2382|III CNS and misc intracranial and intraspinal neoplasms|78714159|0-19|All Races|Male and Female|2000|29.1|31.5|30.3
2.0|2.7|2.3|184|III(a) Ependymomas and choroid plexus tumor|78714159|0-19|All Races|Male and Female|2000|2.0|2.7|2.3
14.9|16.7|15.8|1243|III(b) Astrocytomas|78714159|0-19|All Races|Male and Female|2000|14.9|16.7|15.8
5.9|7.1|6.5|508|III(c) Intracranial and intraspinal embryonal tumors|78714159|0-19|All Races|Male and Female|2000|5.9|7.0|6.5
4.1|5.0|4.5|358|III(d) Other gliomas|78714159|0-19|All Races|Male and Female|2000|4.1|5.0|4.5
0.3|0.6|0.5|37|III(e) Other specified intracranial & intraspinal neoplasms|78714159|0-19|All Races|Male and Female|2000|0.3|0.6|0.5
0.5|0.9|0.7|52|III(f) Unspecified intracranial and intraspinal neoplasms|78714159|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
7.1|8.3|7.7|598|IV Neuroblastoma and other peripheral nervous cell tumors|78714159|0-19|All Races|Male and Female|2000|7.0|8.2|7.6
6.9|8.2|7.5|588|IV(a) Neuroblastoma and ganglioneuroblastoma|78714159|0-19|All Races|Male and Female|2000|6.9|8.1|7.5
~|~|~|~|IV(b) Other peripheral nervous cell tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
11.2|12.7|11.9|940|IX Soft tissue and other extraosseous sarcomas|78714159|0-19|All Races|Male and Female|2000|11.2|12.7|11.9
4.4|5.4|4.9|383|IX(a) Rhabdomyosarcomas|78714159|0-19|All Races|Male and Female|2000|4.4|5.4|4.9
1.0|1.5|1.2|94|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78714159|0-19|All Races|Male and Female|2000|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|78714159|0-19|All Races|Male and Female|2000|~|~|~
4.0|5.0|4.5|354|IX(d) Other specified soft tissue sarcomas|78714159|0-19|All Races|Male and Female|2000|4.0|5.0|4.5
1.1|1.6|1.3|105|IX(e) Unspecified soft tissue sarcomas|78714159|0-19|All Races|Male and Female|2000|1.1|1.6|1.3
0.1|0.3|0.2|17|Not classified by ICCC|78714159|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
2.9|3.7|3.3|257|V Retinoblastoma|78714159|0-19|All Races|Male and Female|2000|2.9|3.7|3.3
6.3|7.5|6.9|538|VI Renal tumors|78714159|0-19|All Races|Male and Female|2000|6.3|7.4|6.8
5.8|7.0|6.4|499|VI(a) Nephroblastoma and other nonepithelial renal tumors|78714159|0-19|All Races|Male and Female|2000|5.8|6.9|6.3
0.3|0.6|0.5|37|VI(b) Renal carcinomas|78714159|0-19|All Races|Male and Female|2000|0.3|0.6|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
1.6|2.2|1.8|144|VII Hepatic tumors|78714159|0-19|All Races|Male and Female|2000|1.5|2.2|1.8
1.2|1.7|1.4|113|VII(a) Hepatoblastoma|78714159|0-19|All Races|Male and Female|2000|1.2|1.7|1.4
0.2|0.5|0.4|29|VII(b) Hepatic carcinomas|78714159|0-19|All Races|Male and Female|2000|0.2|0.5|0.4
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
7.8|9.1|8.4|663|VIII Malignant bone tumors|78714159|0-19|All Races|Male and Female|2000|7.8|9.1|8.4
4.2|5.2|4.7|372|VIII(a) Osteosarcomas|78714159|0-19|All Races|Male and Female|2000|4.3|5.2|4.7
~|~|~|~|VIII(b) Chondrosarcomas|78714159|0-19|All Races|Male and Female|2000|~|~|~
2.7|3.5|3.1|242|VIII(c) Ewing tumor and related sarcomas of bone|78714159|0-19|All Races|Male and Female|2000|2.7|3.5|3.1
0.1|0.4|0.2|19|VIII(d) Other specified malignant bone tumors|78714159|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|78714159|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
10.0|11.5|10.7|845|X Germ cell, trophoblastic tumors & neoplasms of gonads|78714159|0-19|All Races|Male and Female|2000|10.0|11.5|10.7
1.4|2.0|1.6|130|X(a) Intracranial & intraspinal germ cell tumors|78714159|0-19|All Races|Male and Female|2000|1.4|2.0|1.7
1.1|1.7|1.4|109|X(b) Malignant extracranial & extragonadal germ cell tumors|78714159|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
6.4|7.6|7.0|553|X(c) Malignant gonadal germ cell tumors|78714159|0-19|All Races|Male and Female|2000|6.5|7.6|7.0
0.3|0.6|0.4|34|X(d) Gonadal carcinomas|78714159|0-19|All Races|Male and Female|2000|0.3|0.6|0.4
0.1|0.4|0.2|19|X(e) Other and unspecified malignant gonadal tumors|78714159|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
14.8|16.5|15.6|1232|XI Other malignant epithelial neoplasms and malignant melanomas|78714159|0-19|All Races|Male and Female|2000|14.8|16.6|15.7
0.2|0.5|0.3|25|XI(a) Adrenocortical carcinomas|78714159|0-19|All Races|Male and Female|2000|0.2|0.5|0.3
5.1|6.2|5.6|445|XI(b) Thyroid carcinomas|78714159|0-19|All Races|Male and Female|2000|5.1|6.2|5.7
0.4|0.7|0.5|40|XI(c) Nasopharyngeal carcinomas|78714159|0-19|All Races|Male and Female|2000|0.4|0.7|0.5
4.7|5.8|5.2|412|XI(d) Malignant melanomas|78714159|0-19|All Races|Male and Female|2000|4.7|5.8|5.2
~|~|~|~|XI(e) Skin carcinomas|78714159|0-19|All Races|Male and Female|2000|~|~|~
3.4|4.3|3.9|304|XI(f) Other and unspecified carcinomas|78714159|0-19|All Races|Male and Female|2000|3.4|4.3|3.9
0.6|1.1|0.8|65|XII Other and unspecified malignant neoplasms|78714159|0-19|All Races|Male and Female|2000|0.6|1.1|0.8
~|~|~|~|XII(a) Other specified malignant tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
0.5|0.8|0.6|50|XII(b) Other unspecified malignant tumors|78714159|0-19|All Races|Male and Female|2000|0.5|0.8|0.6
167.5|173.2|170.3|13633|All ICCC Groups Combined|80042731|0-19|All Races|Male and Female|2001|167.5|173.2|170.3
44.1|47.1|45.6|3631|I Leukemias, myeloproliferative & myelodysplastic diseases|80042731|0-19|All Races|Male and Female|2001|43.9|46.9|45.4
31.6|34.2|32.9|2610|I(a) Lymphoid leukemias|80042731|0-19|All Races|Male and Female|2001|31.4|33.9|32.6
7.1|8.4|7.7|619|I(b) Acute myeloid leukemias|80042731|0-19|All Races|Male and Female|2001|7.1|8.4|7.7
1.9|2.6|2.2|180|I(c) Chronic myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001|1.9|2.6|2.2
1.2|1.8|1.5|118|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001|1.2|1.8|1.5
1.1|1.6|1.3|104|I(e) Unspecified and other specified leukemias|80042731|0-19|All Races|Male and Female|2001|1.1|1.6|1.3
23.5|25.7|24.6|1979|II Lymphomas and reticuloendothelial neoplasms|80042731|0-19|All Races|Male and Female|2001|23.6|25.8|24.7
11.7|13.3|12.5|1004|II(a) Hodgkin lymphomas|80042731|0-19|All Races|Male and Female|2001|11.8|13.3|12.5
8.0|9.3|8.7|696|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80042731|0-19|All Races|Male and Female|2001|8.1|9.4|8.7
1.9|2.5|2.2|174|II(c) Burkitt lymphoma|80042731|0-19|All Races|Male and Female|2001|1.9|2.5|2.2
0.6|1.0|0.8|65|II(d) Miscellaneous lymphoreticular neoplasms|80042731|0-19|All Races|Male and Female|2001|0.6|1.0|0.8
0.4|0.7|0.5|40|II(e) Unspecified lymphomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
28.8|31.2|30.0|2394|III CNS and misc intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|28.7|31.1|29.9
2.1|2.8|2.5|196|III(a) Ependymomas and choroid plexus tumor|80042731|0-19|All Races|Male and Female|2001|2.1|2.8|2.4
14.2|15.9|15.1|1203|III(b) Astrocytomas|80042731|0-19|All Races|Male and Female|2001|14.2|15.9|15.0
5.9|7.1|6.5|517|III(c) Intracranial and intraspinal embryonal tumors|80042731|0-19|All Races|Male and Female|2001|5.9|7.0|6.5
4.5|5.5|5.0|400|III(d) Other gliomas|80042731|0-19|All Races|Male and Female|2001|4.5|5.5|5.0
0.5|0.8|0.6|49|III(e) Other specified intracranial & intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|0.5|0.8|0.6
0.2|0.5|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
8.2|9.5|8.9|708|IV Neuroblastoma and other peripheral nervous cell tumors|80042731|0-19|All Races|Male and Female|2001|8.2|9.5|8.8
8.0|9.3|8.7|693|IV(a) Neuroblastoma and ganglioneuroblastoma|80042731|0-19|All Races|Male and Female|2001|8.0|9.3|8.7
~|~|~|~|IV(b) Other peripheral nervous cell tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
11.2|12.7|11.9|956|IX Soft tissue and other extraosseous sarcomas|80042731|0-19|All Races|Male and Female|2001|11.2|12.7|11.9
4.6|5.6|5.0|401|IX(a) Rhabdomyosarcomas|80042731|0-19|All Races|Male and Female|2001|4.5|5.5|5.0
1.2|1.7|1.4|116|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80042731|0-19|All Races|Male and Female|2001|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|80042731|0-19|All Races|Male and Female|2001|~|~|~
3.7|4.6|4.1|333|IX(d) Other specified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001|3.7|4.6|4.2
1.0|1.5|1.3|103|IX(e) Unspecified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001|1.1|1.6|1.3
0.2|0.4|0.2|20|Not classified by ICCC|80042731|0-19|All Races|Male and Female|2001|0.2|0.4|0.2
2.9|3.7|3.3|266|V Retinoblastoma|80042731|0-19|All Races|Male and Female|2001|2.9|3.7|3.3
6.2|7.4|6.8|539|VI Renal tumors|80042731|0-19|All Races|Male and Female|2001|6.2|7.3|6.7
5.7|6.8|6.2|493|VI(a) Nephroblastoma and other nonepithelial renal tumors|80042731|0-19|All Races|Male and Female|2001|5.6|6.7|6.2
0.4|0.7|0.5|43|VI(b) Renal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
1.5|2.1|1.8|145|VII Hepatic tumors|80042731|0-19|All Races|Male and Female|2001|1.5|2.1|1.8
1.0|1.5|1.3|101|VII(a) Hepatoblastoma|80042731|0-19|All Races|Male and Female|2001|1.0|1.5|1.3
0.4|0.7|0.5|43|VII(b) Hepatic carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
8.8|10.2|9.5|766|VIII Malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|8.9|10.3|9.6
4.7|5.7|5.2|417|VIII(a) Osteosarcomas|80042731|0-19|All Races|Male and Female|2001|4.7|5.7|5.2
0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
3.0|3.8|3.4|273|VIII(c) Ewing tumor and related sarcomas of bone|80042731|0-19|All Races|Male and Female|2001|3.0|3.8|3.4
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
9.7|11.1|10.4|835|X Germ cell, trophoblastic tumors & neoplasms of gonads|80042731|0-19|All Races|Male and Female|2001|9.7|11.2|10.4
1.3|1.9|1.6|128|X(a) Intracranial & intraspinal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
1.3|1.9|1.6|129|X(b) Malignant extracranial & extragonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
6.0|7.1|6.6|528|X(c) Malignant gonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|6.0|7.2|6.6
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
0.2|0.4|0.3|24|X(e) Other and unspecified malignant gonadal tumors|80042731|0-19|All Races|Male and Female|2001|0.2|0.4|0.3
15.6|17.3|16.4|1323|XI Other malignant epithelial neoplasms and malignant melanomas|80042731|0-19|All Races|Male and Female|2001|15.6|17.4|16.5
0.1|0.4|0.2|18|XI(a) Adrenocortical carcinomas|80042731|0-19|All Races|Male and Female|2001|0.1|0.4|0.2
5.3|6.3|5.8|467|XI(b) Thyroid carcinomas|80042731|0-19|All Races|Male and Female|2001|5.3|6.4|5.8
0.4|0.7|0.5|44|XI(c) Nasopharyngeal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
5.3|6.3|5.8|464|XI(d) Malignant melanomas|80042731|0-19|All Races|Male and Female|2001|5.3|6.3|5.8
~|~|~|~|XI(e) Skin carcinomas|80042731|0-19|All Races|Male and Female|2001|~|~|~
3.6|4.5|4.0|325|XI(f) Other and unspecified carcinomas|80042731|0-19|All Races|Male and Female|2001|3.6|4.5|4.1
0.7|1.1|0.9|71|XII Other and unspecified malignant neoplasms|80042731|0-19|All Races|Male and Female|2001|0.7|1.1|0.9
0.3|0.5|0.4|30|XII(a) Other specified malignant tumors|80042731|0-19|All Races|Male and Female|2001|0.3|0.5|0.4
0.4|0.7|0.5|41|XII(b) Other unspecified malignant tumors|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
167.8|173.5|170.6|13714|All ICCC Groups Combined|80317363|0-19|All Races|Male and Female|2002|167.9|173.6|170.7
43.3|46.2|44.7|3577|I Leukemias, myeloproliferative & myelodysplastic diseases|80317363|0-19|All Races|Male and Female|2002|43.1|46.0|44.5
30.6|33.1|31.8|2539|I(a) Lymphoid leukemias|80317363|0-19|All Races|Male and Female|2002|30.4|32.9|31.6
7.5|8.8|8.1|655|I(b) Acute myeloid leukemias|80317363|0-19|All Races|Male and Female|2002|7.5|8.8|8.2
1.8|2.4|2.1|166|I(c) Chronic myeloproliferative diseases|80317363|0-19|All Races|Male and Female|2002|1.8|2.4|2.1
1.2|1.8|1.5|119|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80317363|0-19|All Races|Male and Female|2002|1.2|1.8|1.5
1.0|1.5|1.2|98|I(e) Unspecified and other specified leukemias|80317363|0-19|All Races|Male and Female|2002|1.0|1.5|1.2
23.5|25.7|24.6|1987|II Lymphomas and reticuloendothelial neoplasms|80317363|0-19|All Races|Male and Female|2002|23.7|25.9|24.7
11.6|13.1|12.4|1003|II(a) Hodgkin lymphomas|80317363|0-19|All Races|Male and Female|2002|11.7|13.3|12.5
7.6|8.9|8.2|665|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80317363|0-19|All Races|Male and Female|2002|7.7|8.9|8.3
2.4|3.1|2.7|220|II(c) Burkitt lymphoma|80317363|0-19|All Races|Male and Female|2002|2.4|3.1|2.7
0.7|1.1|0.9|71|II(d) Miscellaneous lymphoreticular neoplasms|80317363|0-19|All Races|Male and Female|2002|0.7|1.1|0.9
0.2|0.5|0.3|28|II(e) Unspecified lymphomas|80317363|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
30.2|32.7|31.4|2512|III CNS and misc intracranial and intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002|30.1|32.5|31.3
2.6|3.3|2.9|236|III(a) Ependymomas and choroid plexus tumor|80317363|0-19|All Races|Male and Female|2002|2.6|3.3|2.9
14.5|16.3|15.4|1232|III(b) Astrocytomas|80317363|0-19|All Races|Male and Female|2002|14.5|16.2|15.3
5.8|6.9|6.4|508|III(c) Intracranial and intraspinal embryonal tumors|80317363|0-19|All Races|Male and Female|2002|5.8|6.9|6.3
5.1|6.1|5.6|444|III(d) Other gliomas|80317363|0-19|All Races|Male and Female|2002|5.0|6.1|5.5
0.6|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002|0.6|0.9|0.7
0.3|0.6|0.4|33|III(f) Unspecified intracranial and intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
7.8|9.1|8.5|678|IV Neuroblastoma and other peripheral nervous cell tumors|80317363|0-19|All Races|Male and Female|2002|7.8|9.1|8.4
7.6|8.9|8.2|659|IV(a) Neuroblastoma and ganglioneuroblastoma|80317363|0-19|All Races|Male and Female|2002|7.6|8.9|8.2
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|80317363|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
11.0|12.6|11.8|948|IX Soft tissue and other extraosseous sarcomas|80317363|0-19|All Races|Male and Female|2002|11.1|12.6|11.8
4.4|5.4|4.9|391|IX(a) Rhabdomyosarcomas|80317363|0-19|All Races|Male and Female|2002|4.4|5.4|4.9
0.9|1.4|1.2|94|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80317363|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
~|~|~|~|IX(c) Kaposi sarcoma|80317363|0-19|All Races|Male and Female|2002|~|~|~
4.3|5.3|4.8|385|IX(d) Other specified soft tissue sarcomas|80317363|0-19|All Races|Male and Female|2002|4.3|5.3|4.8
0.8|1.2|1.0|78|IX(e) Unspecified soft tissue sarcomas|80317363|0-19|All Races|Male and Female|2002|0.8|1.2|1.0
0.2|0.5|0.3|26|Not classified by ICCC|80317363|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
2.5|3.2|2.8|225|V Retinoblastoma|80317363|0-19|All Races|Male and Female|2002|2.4|3.2|2.8
6.0|7.1|6.5|519|VI Renal tumors|80317363|0-19|All Races|Male and Female|2002|5.9|7.0|6.5
5.5|6.6|6.1|482|VI(a) Nephroblastoma and other nonepithelial renal tumors|80317363|0-19|All Races|Male and Female|2002|5.5|6.6|6.0
0.3|0.6|0.4|36|VI(b) Renal carcinomas|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
~|~|~|~|VI(c) Unspecified malignant renal tumors|80317363|0-19|All Races|Male and Female|2002|~|~|~
1.4|2.0|1.7|136|VII Hepatic tumors|80317363|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
0.9|1.4|1.2|93|VII(a) Hepatoblastoma|80317363|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
0.4|0.7|0.5|42|VII(b) Hepatic carcinomas|80317363|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80317363|0-19|All Races|Male and Female|2002|~|~|~
8.5|9.8|9.1|739|VIII Malignant bone tumors|80317363|0-19|All Races|Male and Female|2002|8.5|9.9|9.2
4.4|5.4|4.9|398|VIII(a) Osteosarcomas|80317363|0-19|All Races|Male and Female|2002|4.5|5.5|5.0
0.3|0.6|0.5|38|VIII(b) Chondrosarcomas|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.5
2.7|3.5|3.1|250|VIII(c) Ewing tumor and related sarcomas of bone|80317363|0-19|All Races|Male and Female|2002|2.7|3.5|3.1
0.4|0.7|0.5|41|VIII(d) Other specified malignant bone tumors|80317363|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|80317363|0-19|All Races|Male and Female|2002|~|~|~
10.3|11.8|11.0|892|X Germ cell, trophoblastic tumors & neoplasms of gonads|80317363|0-19|All Races|Male and Female|2002|10.4|11.9|11.1
1.4|1.9|1.6|132|X(a) Intracranial & intraspinal germ cell tumors|80317363|0-19|All Races|Male and Female|2002|1.4|1.9|1.6
1.3|1.8|1.5|125|X(b) Malignant extracranial & extragonadal germ cell tumors|80317363|0-19|All Races|Male and Female|2002|1.3|1.9|1.6
6.6|7.8|7.2|581|X(c) Malignant gonadal germ cell tumors|80317363|0-19|All Races|Male and Female|2002|6.7|7.8|7.2
0.2|0.5|0.4|29|X(d) Gonadal carcinomas|80317363|0-19|All Races|Male and Female|2002|0.2|0.5|0.4
0.2|0.5|0.3|25|X(e) Other and unspecified malignant gonadal tumors|80317363|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
16.4|18.2|17.3|1402|XI Other malignant epithelial neoplasms and malignant melanomas|80317363|0-19|All Races|Male and Female|2002|16.6|18.4|17.5
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|80317363|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
5.3|6.4|5.8|472|XI(b) Thyroid carcinomas|80317363|0-19|All Races|Male and Female|2002|5.4|6.4|5.9
0.4|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|80317363|0-19|All Races|Male and Female|2002|0.5|0.8|0.6
5.9|7.1|6.5|526|XI(d) Malignant melanomas|80317363|0-19|All Races|Male and Female|2002|6.0|7.1|6.5
~|~|~|~|XI(e) Skin carcinomas|80317363|0-19|All Races|Male and Female|2002|~|~|~
3.6|4.5|4.0|328|XI(f) Other and unspecified carcinomas|80317363|0-19|All Races|Male and Female|2002|3.7|4.6|4.1
0.7|1.1|0.9|73|XII Other and unspecified malignant neoplasms|80317363|0-19|All Races|Male and Female|2002|0.7|1.1|0.9
0.3|0.6|0.5|37|XII(a) Other specified malignant tumors|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.5
0.3|0.6|0.4|36|XII(b) Other unspecified malignant tumors|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
164.9|170.5|167.7|13692|All ICCC Groups Combined|81425816|0-19|All Races|Male and Female|2003|165.3|171.0|168.2
42.0|44.9|43.4|3522|I Leukemias, myeloproliferative & myelodysplastic diseases|81425816|0-19|All Races|Male and Female|2003|41.8|44.7|43.3
29.5|31.9|30.7|2477|I(a) Lymphoid leukemias|81425816|0-19|All Races|Male and Female|2003|29.2|31.6|30.4
7.2|8.4|7.8|639|I(b) Acute myeloid leukemias|81425816|0-19|All Races|Male and Female|2003|7.3|8.5|7.8
1.9|2.6|2.3|185|I(c) Chronic myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003|2.0|2.6|2.3
1.4|2.0|1.7|137|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003|1.4|2.0|1.7
0.8|1.3|1.0|84|I(e) Unspecified and other specified leukemias|81425816|0-19|All Races|Male and Female|2003|0.8|1.3|1.0
23.2|25.3|24.2|1987|II Lymphomas and reticuloendothelial neoplasms|81425816|0-19|All Races|Male and Female|2003|23.3|25.5|24.4
11.7|13.2|12.4|1027|II(a) Hodgkin lymphomas|81425816|0-19|All Races|Male and Female|2003|11.9|13.4|12.6
7.5|8.7|8.1|659|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81425816|0-19|All Races|Male and Female|2003|7.5|8.7|8.1
2.3|3.0|2.6|212|II(c) Burkitt lymphoma|81425816|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.7|1.1|0.9|72|II(d) Miscellaneous lymphoreticular neoplasms|81425816|0-19|All Races|Male and Female|2003|0.7|1.1|0.9
0.1|0.3|0.2|17|II(e) Unspecified lymphomas|81425816|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
29.0|31.4|30.1|2447|III CNS and misc intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|28.9|31.3|30.1
2.0|2.7|2.3|189|III(a) Ependymomas and choroid plexus tumor|81425816|0-19|All Races|Male and Female|2003|2.0|2.7|2.3
14.4|16.1|15.3|1241|III(b) Astrocytomas|81425816|0-19|All Races|Male and Female|2003|14.4|16.1|15.2
5.6|6.7|6.1|495|III(c) Intracranial and intraspinal embryonal tumors|81425816|0-19|All Races|Male and Female|2003|5.6|6.6|6.1
4.7|5.7|5.2|424|III(d) Other gliomas|81425816|0-19|All Races|Male and Female|2003|4.7|5.7|5.2
0.7|1.1|0.8|68|III(e) Other specified intracranial & intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|0.6|1.1|0.8
0.2|0.5|0.4|30|III(f) Unspecified intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
7.6|8.9|8.2|669|IV Neuroblastoma and other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003|7.6|8.9|8.2
7.4|8.7|8.0|654|IV(a) Neuroblastoma and ganglioneuroblastoma|81425816|0-19|All Races|Male and Female|2003|7.4|8.7|8.0
~|~|~|~|IV(b) Other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
11.4|13.0|12.2|998|IX Soft tissue and other extraosseous sarcomas|81425816|0-19|All Races|Male and Female|2003|11.5|13.0|12.3
4.3|5.3|4.8|390|IX(a) Rhabdomyosarcomas|81425816|0-19|All Races|Male and Female|2003|4.3|5.3|4.8
1.2|1.7|1.4|118|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81425816|0-19|All Races|Male and Female|2003|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81425816|0-19|All Races|Male and Female|2003|~|~|~
4.2|5.2|4.7|385|IX(d) Other specified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003|4.3|5.2|4.7
1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003|1.0|1.5|1.3
0.1|0.4|0.2|19|Not classified by ICCC|81425816|0-19|All Races|Male and Female|2003|0.1|0.4|0.2
2.7|3.5|3.1|251|V Retinoblastoma|81425816|0-19|All Races|Male and Female|2003|2.7|3.5|3.1
6.2|7.3|6.7|543|VI Renal tumors|81425816|0-19|All Races|Male and Female|2003|6.1|7.3|6.7
5.6|6.7|6.1|494|VI(a) Nephroblastoma and other nonepithelial renal tumors|81425816|0-19|All Races|Male and Female|2003|5.5|6.6|6.1
0.4|0.7|0.5|45|VI(b) Renal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.4|0.7|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
1.8|2.5|2.1|174|VII Hepatic tumors|81425816|0-19|All Races|Male and Female|2003|1.8|2.5|2.1
1.3|1.8|1.5|124|VII(a) Hepatoblastoma|81425816|0-19|All Races|Male and Female|2003|1.3|1.8|1.5
0.5|0.8|0.6|50|VII(b) Hepatic carcinomas|81425816|0-19|All Races|Male and Female|2003|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
8.0|9.3|8.7|714|VIII Malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|8.1|9.4|8.8
4.8|5.8|5.3|436|VIII(a) Osteosarcomas|81425816|0-19|All Races|Male and Female|2003|4.9|5.9|5.4
0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.2|2.9|2.6|212|VIII(c) Ewing tumor and related sarcomas of bone|81425816|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.2|0.5|0.3|28|VIII(d) Other specified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.3
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
9.6|11.0|10.3|850|X Germ cell, trophoblastic tumors & neoplasms of gonads|81425816|0-19|All Races|Male and Female|2003|9.7|11.2|10.4
1.1|1.6|1.4|113|X(a) Intracranial & intraspinal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|1.1|1.7|1.4
1.2|1.8|1.5|121|X(b) Malignant extracranial & extragonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|1.2|1.8|1.5
6.2|7.3|6.7|554|X(c) Malignant gonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|6.2|7.4|6.8
0.2|0.5|0.4|30|X(d) Gonadal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
0.3|0.5|0.4|32|X(e) Other and unspecified malignant gonadal tumors|81425816|0-19|All Races|Male and Female|2003|0.3|0.6|0.4
16.4|18.2|17.3|1430|XI Other malignant epithelial neoplasms and malignant melanomas|81425816|0-19|All Races|Male and Female|2003|16.7|18.5|17.6
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.2
5.6|6.7|6.1|509|XI(b) Thyroid carcinomas|81425816|0-19|All Races|Male and Female|2003|5.7|6.8|6.3
0.5|0.9|0.7|54|XI(c) Nasopharyngeal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.5|0.9|0.7
5.4|6.5|5.9|491|XI(d) Malignant melanomas|81425816|0-19|All Races|Male and Female|2003|5.5|6.6|6.0
~|~|~|~|XI(e) Skin carcinomas|81425816|0-19|All Races|Male and Female|2003|~|~|~
3.8|4.7|4.2|347|XI(f) Other and unspecified carcinomas|81425816|0-19|All Races|Male and Female|2003|3.8|4.7|4.3
0.9|1.3|1.1|88|XII Other and unspecified malignant neoplasms|81425816|0-19|All Races|Male and Female|2003|0.9|1.3|1.1
0.3|0.6|0.5|39|XII(a) Other specified malignant tumors|81425816|0-19|All Races|Male and Female|2003|0.3|0.7|0.5
0.4|0.8|0.6|49|XII(b) Other unspecified malignant tumors|81425816|0-19|All Races|Male and Female|2003|0.4|0.8|0.6
171.4|177.1|174.2|14316|All ICCC Groups Combined|81754354|0-19|All Races|Male and Female|2004|172.3|178.0|175.1
44.8|47.7|46.2|3768|I Leukemias, myeloproliferative & myelodysplastic diseases|81754354|0-19|All Races|Male and Female|2004|44.6|47.6|46.1
32.0|34.5|33.2|2700|I(a) Lymphoid leukemias|81754354|0-19|All Races|Male and Female|2004|31.8|34.3|33.0
7.6|8.9|8.2|676|I(b) Acute myeloid leukemias|81754354|0-19|All Races|Male and Female|2004|7.7|8.9|8.3
1.9|2.5|2.2|180|I(c) Chronic myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.9|2.5|2.2
1.1|1.6|1.4|112|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.1|1.6|1.4
1.0|1.5|1.2|100|I(e) Unspecified and other specified leukemias|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
23.1|25.2|24.1|1996|II Lymphomas and reticuloendothelial neoplasms|81754354|0-19|All Races|Male and Female|2004|23.4|25.5|24.4
11.1|12.6|11.8|987|II(a) Hodgkin lymphomas|81754354|0-19|All Races|Male and Female|2004|11.3|12.9|12.1
7.9|9.2|8.5|704|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81754354|0-19|All Races|Male and Female|2004|8.0|9.3|8.6
2.0|2.7|2.3|191|II(c) Burkitt lymphoma|81754354|0-19|All Races|Male and Female|2004|2.0|2.7|2.3
0.9|1.3|1.1|87|II(d) Miscellaneous lymphoreticular neoplasms|81754354|0-19|All Races|Male and Female|2004|0.9|1.3|1.1
0.2|0.5|0.3|27|II(e) Unspecified lymphomas|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
30.9|33.4|32.1|2615|III CNS and misc intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|30.8|33.2|32.0
2.4|3.1|2.7|224|III(a) Ependymomas and choroid plexus tumor|81754354|0-19|All Races|Male and Female|2004|2.4|3.1|2.7
15.6|17.4|16.5|1345|III(b) Astrocytomas|81754354|0-19|All Races|Male and Female|2004|15.6|17.4|16.5
6.0|7.1|6.6|532|III(c) Intracranial and intraspinal embryonal tumors|81754354|0-19|All Races|Male and Female|2004|6.0|7.1|6.5
4.6|5.6|5.1|412|III(d) Other gliomas|81754354|0-19|All Races|Male and Female|2004|4.6|5.6|5.0
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.5|0.9|0.7
0.4|0.7|0.5|43|III(f) Unspecified intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
7.8|9.1|8.5|693|IV Neuroblastoma and other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|7.9|9.1|8.5
7.6|8.8|8.2|670|IV(a) Neuroblastoma and ganglioneuroblastoma|81754354|0-19|All Races|Male and Female|2004|7.6|8.8|8.2
0.2|0.4|0.3|23|IV(b) Other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.4|0.3
11.3|12.8|12.0|991|IX Soft tissue and other extraosseous sarcomas|81754354|0-19|All Races|Male and Female|2004|11.4|12.9|12.1
3.9|4.8|4.3|352|IX(a) Rhabdomyosarcomas|81754354|0-19|All Races|Male and Female|2004|3.9|4.8|4.3
1.1|1.6|1.4|113|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81754354|0-19|All Races|Male and Female|2004|1.1|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81754354|0-19|All Races|Male and Female|2004|~|~|~
4.6|5.6|5.1|422|IX(d) Other specified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
1.0|1.5|1.2|100|IX(e) Unspecified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
0.2|0.4|0.3|25|Not classified by ICCC|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
2.9|3.7|3.2|267|V Retinoblastoma|81754354|0-19|All Races|Male and Female|2004|2.9|3.7|3.3
6.0|7.1|6.5|530|VI Renal tumors|81754354|0-19|All Races|Male and Female|2004|5.9|7.1|6.5
5.4|6.5|5.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|81754354|0-19|All Races|Male and Female|2004|5.4|6.4|5.9
0.4|0.8|0.6|47|VI(b) Renal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
2.1|2.7|2.4|196|VII Hepatic tumors|81754354|0-19|All Races|Male and Female|2004|2.1|2.8|2.4
1.5|2.1|1.8|144|VII(a) Hepatoblastoma|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
0.4|0.8|0.6|48|VII(b) Hepatic carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
8.4|9.7|9.1|750|VIII Malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|8.5|9.9|9.2
4.7|5.7|5.2|427|VIII(a) Osteosarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
0.4|0.7|0.5|41|VIII(b) Chondrosarcomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
2.4|3.1|2.7|227|VIII(c) Ewing tumor and related sarcomas of bone|81754354|0-19|All Races|Male and Female|2004|2.4|3.2|2.8
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
10.4|11.9|11.1|929|X Germ cell, trophoblastic tumors & neoplasms of gonads|81754354|0-19|All Races|Male and Female|2004|10.6|12.1|11.4
1.5|2.1|1.8|148|X(a) Intracranial & intraspinal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
1.1|1.6|1.3|110|X(b) Malignant extracranial & extragonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.1|1.6|1.3
6.7|7.9|7.3|610|X(c) Malignant gonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|6.9|8.1|7.5
0.3|0.6|0.4|33|X(d) Gonadal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.3|0.6|0.4
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
16.9|18.7|17.8|1484|XI Other malignant epithelial neoplasms and malignant melanomas|81754354|0-19|All Races|Male and Female|2004|17.2|19.1|18.2
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|81754354|0-19|All Races|Male and Female|2004|0.1|0.4|0.2
6.3|7.4|6.8|567|XI(b) Thyroid carcinomas|81754354|0-19|All Races|Male and Female|2004|6.4|7.5|6.9
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
5.9|7.0|6.4|537|XI(d) Malignant melanomas|81754354|0-19|All Races|Male and Female|2004|6.0|7.1|6.6
~|~|~|~|XI(e) Skin carcinomas|81754354|0-19|All Races|Male and Female|2004|~|~|~
3.3|4.1|3.7|307|XI(f) Other and unspecified carcinomas|81754354|0-19|All Races|Male and Female|2004|3.3|4.2|3.8
0.7|1.1|0.9|72|XII Other and unspecified malignant neoplasms|81754354|0-19|All Races|Male and Female|2004|0.7|1.1|0.9
0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
0.4|0.7|0.5|44|XII(b) Other unspecified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
169.8|175.4|172.6|14261|All ICCC Groups Combined|82005260|0-19|All Races|Male and Female|2005|171.1|176.8|173.9
43.1|46.0|44.5|3646|I Leukemias, myeloproliferative & myelodysplastic diseases|82005260|0-19|All Races|Male and Female|2005|43.0|45.9|44.5
30.8|33.3|32.0|2612|I(a) Lymphoid leukemias|82005260|0-19|All Races|Male and Female|2005|30.6|33.1|31.9
7.0|8.2|7.5|624|I(b) Acute myeloid leukemias|82005260|0-19|All Races|Male and Female|2005|7.0|8.2|7.6
1.8|2.4|2.1|172|I(c) Chronic myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.8|2.4|2.1
1.3|1.9|1.6|131|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.3|1.9|1.6
1.1|1.6|1.3|107|I(e) Unspecified and other specified leukemias|82005260|0-19|All Races|Male and Female|2005|1.1|1.6|1.3
24.7|26.9|25.8|2152|II Lymphomas and reticuloendothelial neoplasms|82005260|0-19|All Races|Male and Female|2005|25.1|27.4|26.2
11.9|13.5|12.7|1067|II(a) Hodgkin lymphomas|82005260|0-19|All Races|Male and Female|2005|12.2|13.8|13.0
8.4|9.7|9.0|747|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82005260|0-19|All Races|Male and Female|2005|8.5|9.8|9.1
2.2|2.9|2.5|205|II(c) Burkitt lymphoma|82005260|0-19|All Races|Male and Female|2005|2.2|2.9|2.5
1.0|1.5|1.3|104|II(d) Miscellaneous lymphoreticular neoplasms|82005260|0-19|All Races|Male and Female|2005|1.0|1.5|1.3
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.4
29.1|31.5|30.3|2471|III CNS and misc intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|29.0|31.3|30.1
2.6|3.3|2.9|241|III(a) Ependymomas and choroid plexus tumor|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|2.9
14.6|16.3|15.5|1264|III(b) Astrocytomas|82005260|0-19|All Races|Male and Female|2005|14.6|16.3|15.4
5.4|6.5|5.9|479|III(c) Intracranial and intraspinal embryonal tumors|82005260|0-19|All Races|Male and Female|2005|5.3|6.4|5.8
4.4|5.4|4.9|398|III(d) Other gliomas|82005260|0-19|All Races|Male and Female|2005|4.4|5.4|4.9
0.5|0.8|0.6|51|III(e) Other specified intracranial & intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.5
8.4|9.7|9.0|743|IV Neuroblastoma and other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|8.4|9.7|9.1
8.2|9.5|8.8|725|IV(a) Neuroblastoma and ganglioneuroblastoma|82005260|0-19|All Races|Male and Female|2005|8.2|9.5|8.8
0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
11.6|13.1|12.3|1019|IX Soft tissue and other extraosseous sarcomas|82005260|0-19|All Races|Male and Female|2005|11.7|13.2|12.4
4.4|5.4|4.9|400|IX(a) Rhabdomyosarcomas|82005260|0-19|All Races|Male and Female|2005|4.4|5.4|4.9
1.2|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82005260|0-19|All Races|Male and Female|2005|~|~|~
4.4|5.4|4.9|407|IX(d) Other specified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|4.5|5.5|5.0
0.9|1.4|1.1|91|IX(e) Unspecified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|0.9|1.4|1.1
0.2|0.4|0.3|23|Not classified by ICCC|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|2.9|242|V Retinoblastoma|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|3.0
6.2|7.3|6.7|548|VI Renal tumors|82005260|0-19|All Races|Male and Female|2005|6.1|7.3|6.7
5.5|6.6|6.1|494|VI(a) Nephroblastoma and other nonepithelial renal tumors|82005260|0-19|All Races|Male and Female|2005|5.5|6.6|6.0
0.4|0.8|0.6|50|VI(b) Renal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
1.7|2.4|2.0|168|VII Hepatic tumors|82005260|0-19|All Races|Male and Female|2005|1.8|2.4|2.0
1.2|1.7|1.4|117|VII(a) Hepatoblastoma|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|82005260|0-19|All Races|Male and Female|2005|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
8.2|9.5|8.9|737|VIII Malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|8.4|9.7|9.0
4.6|5.5|5.0|418|VIII(a) Osteosarcomas|82005260|0-19|All Races|Male and Female|2005|4.6|5.6|5.1
0.2|0.4|0.3|23|VIII(b) Chondrosarcomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|2.9|243|VIII(c) Ewing tumor and related sarcomas of bone|82005260|0-19|All Races|Male and Female|2005|2.6|3.4|3.0
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
10.7|12.2|11.4|963|X Germ cell, trophoblastic tumors & neoplasms of gonads|82005260|0-19|All Races|Male and Female|2005|11.0|12.5|11.7
1.3|1.9|1.6|133|X(a) Intracranial & intraspinal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
1.3|1.9|1.6|134|X(b) Malignant extracranial & extragonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
6.9|8.1|7.5|636|X(c) Malignant gonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|7.2|8.4|7.8
0.3|0.5|0.4|32|X(d) Gonadal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
16.6|18.4|17.5|1473|XI Other malignant epithelial neoplasms and malignant melanomas|82005260|0-19|All Races|Male and Female|2005|17.1|18.9|18.0
~|~|~|~|XI(a) Adrenocortical carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
5.6|6.6|6.1|515|XI(b) Thyroid carcinomas|82005260|0-19|All Races|Male and Female|2005|5.7|6.8|6.3
0.3|0.5|0.4|33|XI(c) Nasopharyngeal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
6.0|7.1|6.5|550|XI(d) Malignant melanomas|82005260|0-19|All Races|Male and Female|2005|6.2|7.3|6.7
~|~|~|~|XI(e) Skin carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
3.8|4.7|4.2|356|XI(f) Other and unspecified carcinomas|82005260|0-19|All Races|Male and Female|2005|3.9|4.8|4.3
0.7|1.1|0.9|76|XII Other and unspecified malignant neoplasms|82005260|0-19|All Races|Male and Female|2005|0.7|1.2|0.9
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.4|0.7|0.5|44|XII(b) Other unspecified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.4|0.7|0.5
170.1|175.7|172.9|14350|All ICCC Groups Combined|82324418|0-19|All Races|Male and Female|2006|171.5|177.2|174.3
45.4|48.4|46.9|3852|I Leukemias, myeloproliferative & myelodysplastic diseases|82324418|0-19|All Races|Male and Female|2006|45.3|48.3|46.8
32.0|34.6|33.3|2722|I(a) Lymphoid leukemias|82324418|0-19|All Races|Male and Female|2006|31.8|34.3|33.1
7.6|8.8|8.2|679|I(b) Acute myeloid leukemias|82324418|0-19|All Races|Male and Female|2006|7.6|8.9|8.2
2.1|2.7|2.4|199|I(c) Chronic myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|2.1|2.8|2.4
1.4|1.9|1.6|136|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|1.4|2.0|1.7
1.2|1.7|1.4|116|I(e) Unspecified and other specified leukemias|82324418|0-19|All Races|Male and Female|2006|1.2|1.7|1.4
24.0|26.2|25.1|2102|II Lymphomas and reticuloendothelial neoplasms|82324418|0-19|All Races|Male and Female|2006|24.5|26.6|25.5
11.7|13.2|12.5|1056|II(a) Hodgkin lymphomas|82324418|0-19|All Races|Male and Female|2006|12.1|13.6|12.8
8.1|9.4|8.7|726|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82324418|0-19|All Races|Male and Female|2006|8.2|9.5|8.8
2.1|2.8|2.4|200|II(c) Burkitt lymphoma|82324418|0-19|All Races|Male and Female|2006|2.1|2.8|2.4
1.0|1.4|1.2|97|II(d) Miscellaneous lymphoreticular neoplasms|82324418|0-19|All Races|Male and Female|2006|1.0|1.4|1.2
0.2|0.4|0.3|23|II(e) Unspecified lymphomas|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
30.1|32.5|31.3|2562|III CNS and misc intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|29.9|32.3|31.1
2.5|3.2|2.8|233|III(a) Ependymomas and choroid plexus tumor|82324418|0-19|All Races|Male and Female|2006|2.5|3.2|2.8
14.6|16.3|15.4|1265|III(b) Astrocytomas|82324418|0-19|All Races|Male and Female|2006|14.5|16.2|15.4
5.8|6.9|6.4|518|III(c) Intracranial and intraspinal embryonal tumors|82324418|0-19|All Races|Male and Female|2006|5.8|6.9|6.3
5.0|6.0|5.5|448|III(d) Other gliomas|82324418|0-19|All Races|Male and Female|2006|4.9|6.0|5.4
0.4|0.8|0.6|48|III(e) Other specified intracranial & intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.4|0.8|0.6
0.5|0.8|0.6|50|III(f) Unspecified intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
7.3|8.5|7.9|650|IV Neuroblastoma and other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|7.3|8.5|7.9
7.1|8.4|7.7|637|IV(a) Neuroblastoma and ganglioneuroblastoma|82324418|0-19|All Races|Male and Female|2006|7.1|8.4|7.7
~|~|~|~|IV(b) Other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
11.0|12.5|11.7|973|IX Soft tissue and other extraosseous sarcomas|82324418|0-19|All Races|Male and Female|2006|11.1|12.6|11.8
4.1|5.1|4.6|375|IX(a) Rhabdomyosarcomas|82324418|0-19|All Races|Male and Female|2006|4.1|5.0|4.6
1.1|1.6|1.3|110|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82324418|0-19|All Races|Male and Female|2006|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82324418|0-19|All Races|Male and Female|2006|~|~|~
4.1|5.0|4.5|380|IX(d) Other specified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|4.2|5.1|4.6
1.0|1.5|1.2|103|IX(e) Unspecified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|1.0|1.5|1.3
0.2|0.4|0.3|23|Not classified by ICCC|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
2.7|3.5|3.1|254|V Retinoblastoma|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.1
6.2|7.3|6.7|550|VI Renal tumors|82324418|0-19|All Races|Male and Female|2006|6.1|7.3|6.7
5.5|6.5|6.0|487|VI(a) Nephroblastoma and other nonepithelial renal tumors|82324418|0-19|All Races|Male and Female|2006|5.4|6.5|5.9
0.5|0.9|0.7|57|VI(b) Renal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
2.0|2.7|2.3|192|VII Hepatic tumors|82324418|0-19|All Races|Male and Female|2006|2.0|2.7|2.3
1.4|1.9|1.6|135|VII(a) Hepatoblastoma|82324418|0-19|All Races|Male and Female|2006|1.4|1.9|1.6
0.5|0.8|0.6|53|VII(b) Hepatic carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
8.6|10.0|9.3|775|VIII Malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|8.8|10.1|9.4
4.9|5.9|5.4|449|VIII(a) Osteosarcomas|82324418|0-19|All Races|Male and Female|2006|5.0|6.0|5.5
0.1|0.3|0.2|17|VIII(b) Chondrosarcomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
2.7|3.4|3.0|251|VIII(c) Ewing tumor and related sarcomas of bone|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.0
0.4|0.7|0.5|44|VIII(d) Other specified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
9.6|11.0|10.3|873|X Germ cell, trophoblastic tumors & neoplasms of gonads|82324418|0-19|All Races|Male and Female|2006|9.9|11.3|10.6
1.3|1.8|1.5|126|X(a) Intracranial & intraspinal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.8|1.5
1.3|1.8|1.5|129|X(b) Malignant extracranial & extragonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.9|1.6
5.9|6.9|6.4|546|X(c) Malignant gonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|6.1|7.2|6.6
0.4|0.7|0.5|42|X(d) Gonadal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.2|0.5|0.4|30|X(e) Other and unspecified malignant gonadal tumors|82324418|0-19|All Races|Male and Female|2006|0.2|0.5|0.4
16.4|18.2|17.3|1471|XI Other malignant epithelial neoplasms and malignant melanomas|82324418|0-19|All Races|Male and Female|2006|17.0|18.8|17.9
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
6.2|7.3|6.7|574|XI(b) Thyroid carcinomas|82324418|0-19|All Races|Male and Female|2006|6.4|7.6|7.0
0.5|0.8|0.6|54|XI(c) Nasopharyngeal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
4.9|5.9|5.4|461|XI(d) Malignant melanomas|82324418|0-19|All Races|Male and Female|2006|5.1|6.1|5.6
~|~|~|~|XI(e) Skin carcinomas|82324418|0-19|All Races|Male and Female|2006|~|~|~
3.8|4.7|4.2|360|XI(f) Other and unspecified carcinomas|82324418|0-19|All Races|Male and Female|2006|3.9|4.8|4.4
0.7|1.1|0.9|73|XII Other and unspecified malignant neoplasms|82324418|0-19|All Races|Male and Female|2006|0.7|1.1|0.9
0.4|0.7|0.5|41|XII(a) Other specified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.3|0.5|0.4|32|XII(b) Other unspecified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.3|0.5|0.4
174.1|179.9|177.0|14789|All ICCC Groups Combined|82749431|0-19|All Races|Male and Female|2007|175.9|181.6|178.7
45.9|48.8|47.3|3912|I Leukemias, myeloproliferative & myelodysplastic diseases|82749431|0-19|All Races|Male and Female|2007|45.8|48.8|47.3
33.0|35.6|34.3|2816|I(a) Lymphoid leukemias|82749431|0-19|All Races|Male and Female|2007|32.8|35.3|34.0
7.4|8.6|8.0|667|I(b) Acute myeloid leukemias|82749431|0-19|All Races|Male and Female|2007|7.5|8.7|8.1
2.2|2.9|2.5|213|I(c) Chronic myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|2.2|2.9|2.6
1.2|1.7|1.4|121|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.5
0.9|1.4|1.1|95|I(e) Unspecified and other specified leukemias|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
24.0|26.1|25.0|2111|II Lymphomas and reticuloendothelial neoplasms|82749431|0-19|All Races|Male and Female|2007|24.4|26.6|25.5
11.4|12.9|12.1|1037|II(a) Hodgkin lymphomas|82749431|0-19|All Races|Male and Female|2007|11.8|13.3|12.5
8.1|9.4|8.8|732|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82749431|0-19|All Races|Male and Female|2007|8.2|9.5|8.8
2.3|3.0|2.6|215|II(c) Burkitt lymphoma|82749431|0-19|All Races|Male and Female|2007|2.3|3.0|2.6
0.9|1.4|1.1|92|II(d) Miscellaneous lymphoreticular neoplasms|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
0.3|0.6|0.4|35|II(e) Unspecified lymphomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
30.7|33.1|31.9|2625|III CNS and misc intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|30.5|33.0|31.7
2.2|2.9|2.5|209|III(a) Ependymomas and choroid plexus tumor|82749431|0-19|All Races|Male and Female|2007|2.2|2.9|2.5
15.2|16.9|16.0|1321|III(b) Astrocytomas|82749431|0-19|All Races|Male and Female|2007|15.1|16.8|16.0
5.9|7.1|6.5|532|III(c) Intracranial and intraspinal embryonal tumors|82749431|0-19|All Races|Male and Female|2007|5.9|7.0|6.4
5.2|6.3|5.7|468|III(d) Other gliomas|82749431|0-19|All Races|Male and Female|2007|5.2|6.2|5.7
0.5|0.9|0.7|57|III(e) Other specified intracranial & intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.5
8.4|9.7|9.0|754|IV Neuroblastoma and other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|8.5|9.8|9.1
8.2|9.5|8.8|735|IV(a) Neuroblastoma and ganglioneuroblastoma|82749431|0-19|All Races|Male and Female|2007|8.3|9.5|8.9
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|0.1|0.4|0.2
11.8|13.3|12.6|1051|IX Soft tissue and other extraosseous sarcomas|82749431|0-19|All Races|Male and Female|2007|11.9|13.5|12.7
4.7|5.7|5.2|426|IX(a) Rhabdomyosarcomas|82749431|0-19|All Races|Male and Female|2007|4.7|5.7|5.1
1.2|1.7|1.4|118|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82749431|0-19|All Races|Male and Female|2007|~|~|~
4.3|5.3|4.8|404|IX(d) Other specified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|4.4|5.4|4.9
1.0|1.4|1.2|99|IX(e) Unspecified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|1.0|1.5|1.2
0.1|0.3|0.2|18|Not classified by ICCC|82749431|0-19|All Races|Male and Female|2007|0.1|0.3|0.2
2.8|3.6|3.2|271|V Retinoblastoma|82749431|0-19|All Races|Male and Female|2007|2.9|3.7|3.3
6.4|7.5|6.9|570|VI Renal tumors|82749431|0-19|All Races|Male and Female|2007|6.3|7.5|6.9
5.7|6.8|6.2|514|VI(a) Nephroblastoma and other nonepithelial renal tumors|82749431|0-19|All Races|Male and Female|2007|5.7|6.8|6.2
0.5|0.8|0.6|54|VI(b) Renal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
2.0|2.6|2.3|193|VII Hepatic tumors|82749431|0-19|All Races|Male and Female|2007|2.0|2.7|2.3
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|82749431|0-19|All Races|Male and Female|2007|1.4|2.0|1.7
0.4|0.8|0.6|51|VII(b) Hepatic carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
8.2|9.5|8.8|736|VIII Malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|8.3|9.6|8.9
4.3|5.2|4.7|394|VIII(a) Osteosarcomas|82749431|0-19|All Races|Male and Female|2007|4.3|5.3|4.8
0.2|0.5|0.4|31|VIII(b) Chondrosarcomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
2.7|3.5|3.1|257|VIII(c) Ewing tumor and related sarcomas of bone|82749431|0-19|All Races|Male and Female|2007|2.7|3.5|3.1
0.3|0.6|0.4|33|VIII(d) Other specified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
0.2|0.4|0.3|21|VIII(e) Unspecified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
10.5|11.9|11.2|958|X Germ cell, trophoblastic tumors & neoplasms of gonads|82749431|0-19|All Races|Male and Female|2007|10.9|12.3|11.6
1.3|1.9|1.6|134|X(a) Intracranial & intraspinal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.4|1.9|1.6
1.1|1.7|1.4|118|X(b) Malignant extracranial & extragonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
6.9|8.1|7.5|648|X(c) Malignant gonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|7.2|8.5|7.8
0.3|0.5|0.4|32|X(d) Gonadal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
0.2|0.4|0.3|26|X(e) Other and unspecified malignant gonadal tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.3
16.8|18.6|17.7|1521|XI Other malignant epithelial neoplasms and malignant melanomas|82749431|0-19|All Races|Male and Female|2007|17.5|19.3|18.4
~|~|~|~|XI(a) Adrenocortical carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
6.8|7.9|7.3|632|XI(b) Thyroid carcinomas|82749431|0-19|All Races|Male and Female|2007|7.1|8.3|7.6
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
4.9|5.9|5.4|461|XI(d) Malignant melanomas|82749431|0-19|All Races|Male and Female|2007|5.1|6.1|5.6
~|~|~|~|XI(e) Skin carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
3.7|4.6|4.1|353|XI(f) Other and unspecified carcinomas|82749431|0-19|All Races|Male and Female|2007|3.8|4.7|4.3
0.6|1.0|0.8|69|XII Other and unspecified malignant neoplasms|82749431|0-19|All Races|Male and Female|2007|0.6|1.1|0.8
0.2|0.5|0.3|29|XII(a) Other specified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
0.3|0.6|0.5|40|XII(b) Other unspecified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.3|0.7|0.5
176.0|181.7|178.8|15012|All ICCC Groups Combined|83118264|0-19|All Races|Male and Female|2008|177.7|183.5|180.6
47.3|50.3|48.8|4054|I Leukemias, myeloproliferative & myelodysplastic diseases|83118264|0-19|All Races|Male and Female|2008|47.3|50.3|48.8
33.8|36.4|35.1|2903|I(a) Lymphoid leukemias|83118264|0-19|All Races|Male and Female|2008|33.7|36.2|34.9
7.7|8.9|8.3|697|I(b) Acute myeloid leukemias|83118264|0-19|All Races|Male and Female|2008|7.8|9.0|8.4
2.4|3.1|2.7|230|I(c) Chronic myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|2.4|3.1|2.8
1.3|1.9|1.6|132|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|1.3|1.9|1.6
0.9|1.3|1.1|92|I(e) Unspecified and other specified leukemias|83118264|0-19|All Races|Male and Female|2008|0.9|1.4|1.1
24.4|26.6|25.5|2159|II Lymphomas and reticuloendothelial neoplasms|83118264|0-19|All Races|Male and Female|2008|24.9|27.1|26.0
12.2|13.7|12.9|1106|II(a) Hodgkin lymphomas|83118264|0-19|All Races|Male and Female|2008|12.5|14.1|13.3
8.2|9.4|8.8|738|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83118264|0-19|All Races|Male and Female|2008|8.2|9.5|8.9
2.2|2.9|2.6|211|II(c) Burkitt lymphoma|83118264|0-19|All Races|Male and Female|2008|2.2|2.9|2.5
0.7|1.2|0.9|78|II(d) Miscellaneous lymphoreticular neoplasms|83118264|0-19|All Races|Male and Female|2008|0.7|1.2|0.9
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
31.1|33.6|32.3|2674|III CNS and misc intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|31.0|33.4|32.2
2.0|2.7|2.4|196|III(a) Ependymomas and choroid plexus tumor|83118264|0-19|All Races|Male and Female|2008|2.0|2.7|2.4
15.4|17.2|16.3|1350|III(b) Astrocytomas|83118264|0-19|All Races|Male and Female|2008|15.4|17.1|16.2
6.2|7.3|6.7|557|III(c) Intracranial and intraspinal embryonal tumors|83118264|0-19|All Races|Male and Female|2008|6.2|7.3|6.7
5.3|6.3|5.8|480|III(d) Other gliomas|83118264|0-19|All Races|Male and Female|2008|5.3|6.3|5.8
0.5|0.9|0.7|58|III(e) Other specified intracranial & intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.5|0.9|0.7
0.3|0.6|0.4|33|III(f) Unspecified intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
7.8|9.1|8.4|705|IV Neuroblastoma and other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|7.9|9.1|8.5
7.5|8.7|8.1|677|IV(a) Neuroblastoma and ganglioneuroblastoma|83118264|0-19|All Races|Male and Female|2008|7.5|8.8|8.1
0.2|0.5|0.3|28|IV(b) Other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
11.5|13.0|12.3|1029|IX Soft tissue and other extraosseous sarcomas|83118264|0-19|All Races|Male and Female|2008|11.6|13.2|12.4
4.6|5.6|5.1|425|IX(a) Rhabdomyosarcomas|83118264|0-19|All Races|Male and Female|2008|4.6|5.6|5.1
0.9|1.3|1.1|92|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83118264|0-19|All Races|Male and Female|2008|0.9|1.4|1.1
~|~|~|~|IX(c) Kaposi sarcoma|83118264|0-19|All Races|Male and Female|2008|~|~|~
4.1|5.0|4.5|384|IX(d) Other specified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|4.2|5.1|4.6
1.2|1.8|1.5|126|IX(e) Unspecified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|1.3|1.8|1.5
0.2|0.4|0.3|23|Not classified by ICCC|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
2.8|3.6|3.2|267|V Retinoblastoma|83118264|0-19|All Races|Male and Female|2008|2.8|3.6|3.2
6.7|7.8|7.2|601|VI Renal tumors|83118264|0-19|All Races|Male and Female|2008|6.7|7.8|7.2
5.9|7.0|6.5|537|VI(a) Nephroblastoma and other nonepithelial renal tumors|83118264|0-19|All Races|Male and Female|2008|5.9|7.0|6.5
0.5|0.9|0.7|61|VI(b) Renal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.6|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
1.9|2.6|2.3|190|VII Hepatic tumors|83118264|0-19|All Races|Male and Female|2008|2.0|2.6|2.3
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|83118264|0-19|All Races|Male and Female|2008|1.4|2.0|1.7
0.4|0.7|0.6|47|VII(b) Hepatic carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
8.2|9.4|8.8|737|VIII Malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|8.2|9.5|8.9
4.5|5.4|4.9|414|VIII(a) Osteosarcomas|83118264|0-19|All Races|Male and Female|2008|4.5|5.5|5.0
0.3|0.6|0.4|34|VIII(b) Chondrosarcomas|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
2.4|3.2|2.8|232|VIII(c) Ewing tumor and related sarcomas of bone|83118264|0-19|All Races|Male and Female|2008|2.4|3.2|2.8
0.3|0.6|0.4|34|VIII(d) Other specified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
0.2|0.4|0.3|23|VIII(e) Unspecified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
10.3|11.7|11.0|944|X Germ cell, trophoblastic tumors & neoplasms of gonads|83118264|0-19|All Races|Male and Female|2008|10.6|12.1|11.4
1.5|2.1|1.8|147|X(a) Intracranial & intraspinal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.5|2.1|1.8
1.2|1.7|1.4|123|X(b) Malignant extracranial & extragonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.2|1.8|1.5
6.7|7.8|7.3|630|X(c) Malignant gonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|7.0|8.2|7.6
0.2|0.5|0.3|29|X(d) Gonadal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
17.3|19.1|18.2|1566|XI Other malignant epithelial neoplasms and malignant melanomas|83118264|0-19|All Races|Male and Female|2008|17.9|19.8|18.8
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|83118264|0-19|All Races|Male and Female|2008|0.1|0.4|0.2
7.5|8.7|8.1|701|XI(b) Thyroid carcinomas|83118264|0-19|All Races|Male and Female|2008|7.8|9.1|8.4
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.7|0.6
4.4|5.4|4.9|421|XI(d) Malignant melanomas|83118264|0-19|All Races|Male and Female|2008|4.6|5.6|5.1
~|~|~|~|XI(e) Skin carcinomas|83118264|0-19|All Races|Male and Female|2008|~|~|~
3.9|4.8|4.3|373|XI(f) Other and unspecified carcinomas|83118264|0-19|All Races|Male and Female|2008|4.0|5.0|4.5
0.6|1.0|0.7|63|XII Other and unspecified malignant neoplasms|83118264|0-19|All Races|Male and Female|2008|0.6|1.0|0.8
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
0.2|0.5|0.4|31|XII(b) Other unspecified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
175.1|180.9|178.0|14953|All ICCC Groups Combined|83280391|0-19|All Races|Male and Female|2009|176.7|182.5|179.6
45.9|48.9|47.4|3951|I Leukemias, myeloproliferative & myelodysplastic diseases|83280391|0-19|All Races|Male and Female|2009|46.0|48.9|47.4
33.5|36.1|34.8|2887|I(a) Lymphoid leukemias|83280391|0-19|All Races|Male and Female|2009|33.4|36.0|34.7
7.0|8.2|7.6|641|I(b) Acute myeloid leukemias|83280391|0-19|All Races|Male and Female|2009|7.1|8.3|7.7
2.0|2.7|2.3|198|I(c) Chronic myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|2.1|2.7|2.4
1.3|1.8|1.5|128|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|1.3|1.8|1.5
0.9|1.4|1.2|97|I(e) Unspecified and other specified leukemias|83280391|0-19|All Races|Male and Female|2009|0.9|1.4|1.2
24.2|26.4|25.3|2145|II Lymphomas and reticuloendothelial neoplasms|83280391|0-19|All Races|Male and Female|2009|24.7|26.9|25.8
11.9|13.4|12.6|1080|II(a) Hodgkin lymphomas|83280391|0-19|All Races|Male and Female|2009|12.2|13.8|13.0
8.2|9.5|8.9|745|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83280391|0-19|All Races|Male and Female|2009|8.3|9.6|8.9
1.9|2.6|2.2|184|II(c) Burkitt lymphoma|83280391|0-19|All Races|Male and Female|2009|1.9|2.6|2.2
1.1|1.6|1.3|111|II(d) Miscellaneous lymphoreticular neoplasms|83280391|0-19|All Races|Male and Female|2009|1.1|1.6|1.3
0.2|0.4|0.3|25|II(e) Unspecified lymphomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
30.8|33.3|32.0|2657|III CNS and misc intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|30.7|33.1|31.9
2.1|2.8|2.4|203|III(a) Ependymomas and choroid plexus tumor|83280391|0-19|All Races|Male and Female|2009|2.1|2.8|2.4
15.3|17.1|16.2|1345|III(b) Astrocytomas|83280391|0-19|All Races|Male and Female|2009|15.3|17.0|16.2
5.8|6.9|6.4|526|III(c) Intracranial and intraspinal embryonal tumors|83280391|0-19|All Races|Male and Female|2009|5.8|6.9|6.3
5.5|6.6|6.0|497|III(d) Other gliomas|83280391|0-19|All Races|Male and Female|2009|5.5|6.5|6.0
0.4|0.8|0.6|49|III(e) Other specified intracranial & intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
0.3|0.6|0.4|37|III(f) Unspecified intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.3|0.6|0.4
7.6|8.9|8.2|687|IV Neuroblastoma and other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|7.6|8.9|8.2
7.4|8.6|8.0|666|IV(a) Neuroblastoma and ganglioneuroblastoma|83280391|0-19|All Races|Male and Female|2009|7.4|8.6|8.0
0.2|0.4|0.2|21|IV(b) Other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
11.4|12.9|12.2|1020|IX Soft tissue and other extraosseous sarcomas|83280391|0-19|All Races|Male and Female|2009|11.5|13.0|12.2
3.8|4.7|4.2|353|IX(a) Rhabdomyosarcomas|83280391|0-19|All Races|Male and Female|2009|3.8|4.7|4.2
1.3|1.8|1.5|130|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83280391|0-19|All Races|Male and Female|2009|1.3|1.9|1.6
~|~|~|~|IX(c) Kaposi sarcoma|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.5|5.4|4.9|417|IX(d) Other specified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|4.5|5.5|5.0
1.1|1.6|1.3|113|IX(e) Unspecified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|1.1|1.6|1.4
0.2|0.5|0.3|28|Not classified by ICCC|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
3.0|3.8|3.4|283|V Retinoblastoma|83280391|0-19|All Races|Male and Female|2009|3.0|3.8|3.4
6.8|8.0|7.4|616|VI Renal tumors|83280391|0-19|All Races|Male and Female|2009|6.8|8.0|7.4
6.0|7.1|6.6|546|VI(a) Nephroblastoma and other nonepithelial renal tumors|83280391|0-19|All Races|Male and Female|2009|6.0|7.1|6.6
0.6|1.0|0.8|68|VI(b) Renal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
1.7|2.3|2.0|167|VII Hepatic tumors|83280391|0-19|All Races|Male and Female|2009|1.7|2.3|2.0
1.1|1.7|1.4|116|VII(a) Hepatoblastoma|83280391|0-19|All Races|Male and Female|2009|1.2|1.7|1.4
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
8.4|9.7|9.0|758|VIII Malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|8.5|9.8|9.1
4.6|5.6|5.1|425|VIII(a) Osteosarcomas|83280391|0-19|All Races|Male and Female|2009|4.6|5.6|5.1
0.2|0.5|0.3|27|VIII(b) Chondrosarcomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
2.6|3.3|2.9|247|VIII(c) Ewing tumor and related sarcomas of bone|83280391|0-19|All Races|Male and Female|2009|2.6|3.4|3.0
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.7|0.5
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.1|0.3|0.2
10.8|12.3|11.6|993|X Germ cell, trophoblastic tumors & neoplasms of gonads|83280391|0-19|All Races|Male and Female|2009|11.2|12.7|11.9
1.4|2.0|1.7|142|X(a) Intracranial & intraspinal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.4|2.0|1.7
1.1|1.6|1.4|116|X(b) Malignant extracranial & extragonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.2|1.7|1.4
7.0|8.2|7.6|654|X(c) Malignant gonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|7.3|8.5|7.9
0.5|0.8|0.6|53|X(d) Gonadal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.8|0.6
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
17.4|19.2|18.2|1572|XI Other malignant epithelial neoplasms and malignant melanomas|83280391|0-19|All Races|Male and Female|2009|18.0|19.8|18.9
0.2|0.4|0.2|21|XI(a) Adrenocortical carcinomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
7.7|8.9|8.3|717|XI(b) Thyroid carcinomas|83280391|0-19|All Races|Male and Female|2009|8.0|9.3|8.6
0.5|0.9|0.7|59|XI(c) Nasopharyngeal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.9|0.7
4.0|4.9|4.4|382|XI(d) Malignant melanomas|83280391|0-19|All Races|Male and Female|2009|4.1|5.1|4.6
~|~|~|~|XI(e) Skin carcinomas|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.0|4.9|4.5|384|XI(f) Other and unspecified carcinomas|83280391|0-19|All Races|Male and Female|2009|4.2|5.1|4.6
0.7|1.1|0.9|76|XII Other and unspecified malignant neoplasms|83280391|0-19|All Races|Male and Female|2009|0.7|1.1|0.9
0.2|0.5|0.4|30|XII(a) Other specified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.4
0.4|0.7|0.5|46|XII(b) Other unspecified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.7|0.6
179.1|184.9|182.0|15238|All ICCC Groups Combined|83181970|0-19|All Races|Male and Female|2010|180.3|186.1|183.2
47.5|50.6|49.0|4082|I Leukemias, myeloproliferative & myelodysplastic diseases|83181970|0-19|All Races|Male and Female|2010|47.6|50.6|49.1
33.3|35.9|34.6|2872|I(a) Lymphoid leukemias|83181970|0-19|All Races|Male and Female|2010|33.3|35.8|34.5
7.7|9.0|8.4|700|I(b) Acute myeloid leukemias|83181970|0-19|All Races|Male and Female|2010|7.8|9.1|8.4
2.3|3.1|2.7|226|I(c) Chronic myeloproliferative diseases|83181970|0-19|All Races|Male and Female|2010|2.4|3.1|2.7
1.5|2.1|1.8|150|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83181970|0-19|All Races|Male and Female|2010|1.5|2.1|1.8
1.3|1.9|1.6|134|I(e) Unspecified and other specified leukemias|83181970|0-19|All Races|Male and Female|2010|1.3|1.9|1.6
26.4|28.6|27.5|2317|II Lymphomas and reticuloendothelial neoplasms|83181970|0-19|All Races|Male and Female|2010|26.7|29.0|27.9
11.4|12.9|12.1|1032|II(a) Hodgkin lymphomas|83181970|0-19|All Races|Male and Female|2010|11.7|13.2|12.4
8.0|9.3|8.7|725|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83181970|0-19|All Races|Male and Female|2010|8.1|9.4|8.7
2.1|2.8|2.4|203|II(c) Burkitt lymphoma|83181970|0-19|All Races|Male and Female|2010|2.1|2.8|2.4
3.5|4.4|4.0|328|II(d) Miscellaneous lymphoreticular neoplasms|83181970|0-19|All Races|Male and Female|2010|3.5|4.4|3.9
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|83181970|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
31.3|33.8|32.6|2698|III CNS and misc intracranial and intraspinal neoplasms|83181970|0-19|All Races|Male and Female|2010|31.2|33.7|32.4
2.5|3.2|2.9|238|III(a) Ependymomas and choroid plexus tumor|83181970|0-19|All Races|Male and Female|2010|2.5|3.2|2.9
16.2|18.0|17.0|1413|III(b) Astrocytomas|83181970|0-19|All Races|Male and Female|2010|16.1|17.9|17.0
5.5|6.6|6.1|501|III(c) Intracranial and intraspinal embryonal tumors|83181970|0-19|All Races|Male and Female|2010|5.5|6.6|6.0
5.2|6.2|5.7|468|III(d) Other gliomas|83181970|0-19|All Races|Male and Female|2010|5.1|6.2|5.6
0.5|0.8|0.6|51|III(e) Other specified intracranial & intraspinal neoplasms|83181970|0-19|All Races|Male and Female|2010|0.5|0.8|0.6
0.2|0.5|0.3|27|III(f) Unspecified intracranial and intraspinal neoplasms|83181970|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
8.0|9.2|8.6|713|IV Neuroblastoma and other peripheral nervous cell tumors|83181970|0-19|All Races|Male and Female|2010|8.0|9.2|8.6
7.8|9.0|8.4|696|IV(a) Neuroblastoma and ganglioneuroblastoma|83181970|0-19|All Races|Male and Female|2010|7.8|9.0|8.4
0.1|0.3|0.2|17|IV(b) Other peripheral nervous cell tumors|83181970|0-19|All Races|Male and Female|2010|0.1|0.3|0.2
12.1|13.6|12.8|1071|IX Soft tissue and other extraosseous sarcomas|83181970|0-19|All Races|Male and Female|2010|12.1|13.7|12.9
4.8|5.8|5.3|439|IX(a) Rhabdomyosarcomas|83181970|0-19|All Races|Male and Female|2010|4.8|5.8|5.3
0.8|1.3|1.0|88|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83181970|0-19|All Races|Male and Female|2010|0.8|1.3|1.1
~|~|~|~|IX(c) Kaposi sarcoma|83181970|0-19|All Races|Male and Female|2010|~|~|~
4.3|5.2|4.7|396|IX(d) Other specified soft tissue sarcomas|83181970|0-19|All Races|Male and Female|2010|4.3|5.3|4.8
1.4|2.0|1.7|144|IX(e) Unspecified soft tissue sarcomas|83181970|0-19|All Races|Male and Female|2010|1.5|2.0|1.7
0.1|0.4|0.2|20|Not classified by ICCC|83181970|0-19|All Races|Male and Female|2010|0.1|0.4|0.2
3.0|3.9|3.4|285|V Retinoblastoma|83181970|0-19|All Races|Male and Female|2010|3.0|3.8|3.4
6.1|7.3|6.7|556|VI Renal tumors|83181970|0-19|All Races|Male and Female|2010|6.1|7.3|6.7
5.6|6.7|6.2|513|VI(a) Nephroblastoma and other nonepithelial renal tumors|83181970|0-19|All Races|Male and Female|2010|5.6|6.7|6.2
0.3|0.7|0.5|41|VI(b) Renal carcinomas|83181970|0-19|All Races|Male and Female|2010|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|83181970|0-19|All Races|Male and Female|2010|~|~|~
2.3|3.0|2.6|221|VII Hepatic tumors|83181970|0-19|All Races|Male and Female|2010|2.3|3.0|2.7
1.6|2.2|1.9|160|VII(a) Hepatoblastoma|83181970|0-19|All Races|Male and Female|2010|1.6|2.2|1.9
0.5|0.9|0.7|59|VII(b) Hepatic carcinomas|83181970|0-19|All Races|Male and Female|2010|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83181970|0-19|All Races|Male and Female|2010|~|~|~
7.8|9.0|8.4|700|VIII Malignant bone tumors|83181970|0-19|All Races|Male and Female|2010|7.8|9.1|8.4
4.3|5.2|4.8|398|VIII(a) Osteosarcomas|83181970|0-19|All Races|Male and Female|2010|4.3|5.3|4.8
0.3|0.5|0.4|32|VIII(b) Chondrosarcomas|83181970|0-19|All Races|Male and Female|2010|0.3|0.5|0.4
2.3|3.0|2.6|219|VIII(c) Ewing tumor and related sarcomas of bone|83181970|0-19|All Races|Male and Female|2010|2.3|3.0|2.6
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|83181970|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|83181970|0-19|All Races|Male and Female|2010|~|~|~
10.8|12.3|11.6|983|X Germ cell, trophoblastic tumors & neoplasms of gonads|83181970|0-19|All Races|Male and Female|2010|11.1|12.6|11.8
1.7|2.3|2.0|167|X(a) Intracranial & intraspinal germ cell tumors|83181970|0-19|All Races|Male and Female|2010|1.7|2.3|2.0
1.1|1.6|1.3|112|X(b) Malignant extracranial & extragonadal germ cell tumors|83181970|0-19|All Races|Male and Female|2010|1.1|1.6|1.3
6.7|7.9|7.3|627|X(c) Malignant gonadal germ cell tumors|83181970|0-19|All Races|Male and Female|2010|7.0|8.2|7.5
0.4|0.7|0.5|43|X(d) Gonadal carcinomas|83181970|0-19|All Races|Male and Female|2010|0.4|0.7|0.5
0.3|0.6|0.4|34|X(e) Other and unspecified malignant gonadal tumors|83181970|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
17.0|18.9|17.9|1535|XI Other malignant epithelial neoplasms and malignant melanomas|83181970|0-19|All Races|Male and Female|2010|17.5|19.4|18.5
0.2|0.4|0.3|21|XI(a) Adrenocortical carcinomas|83181970|0-19|All Races|Male and Female|2010|0.2|0.4|0.3
8.0|9.2|8.6|735|XI(b) Thyroid carcinomas|83181970|0-19|All Races|Male and Female|2010|8.2|9.5|8.8
0.4|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|83181970|0-19|All Races|Male and Female|2010|0.4|0.8|0.6
3.6|4.5|4.0|344|XI(d) Malignant melanomas|83181970|0-19|All Races|Male and Female|2010|3.7|4.6|4.1
~|~|~|~|XI(e) Skin carcinomas|83181970|0-19|All Races|Male and Female|2010|~|~|~
4.0|4.9|4.4|377|XI(f) Other and unspecified carcinomas|83181970|0-19|All Races|Male and Female|2010|4.1|5.0|4.5
0.5|0.9|0.7|57|XII Other and unspecified malignant neoplasms|83181970|0-19|All Races|Male and Female|2010|0.5|0.9|0.7
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|83181970|0-19|All Races|Male and Female|2010|0.3|0.5|0.4
0.2|0.4|0.3|25|XII(b) Other unspecified malignant tumors|83181970|0-19|All Races|Male and Female|2010|0.2|0.4|0.3
180.8|186.6|183.7|15301|All ICCC Groups Combined|82830017|0-19|All Races|Male and Female|2011|181.8|187.7|184.7
47.7|50.7|49.2|4078|I Leukemias, myeloproliferative & myelodysplastic diseases|82830017|0-19|All Races|Male and Female|2011|47.7|50.8|49.2
34.5|37.1|35.8|2960|I(a) Lymphoid leukemias|82830017|0-19|All Races|Male and Female|2011|34.5|37.0|35.7
7.7|9.0|8.3|694|I(b) Acute myeloid leukemias|82830017|0-19|All Races|Male and Female|2011|7.8|9.0|8.4
2.0|2.7|2.3|196|I(c) Chronic myeloproliferative diseases|82830017|0-19|All Races|Male and Female|2011|2.0|2.7|2.4
1.1|1.6|1.3|107|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82830017|0-19|All Races|Male and Female|2011|1.1|1.6|1.3
1.2|1.7|1.5|121|I(e) Unspecified and other specified leukemias|82830017|0-19|All Races|Male and Female|2011|1.2|1.7|1.5
26.8|29.1|27.9|2334|II Lymphomas and reticuloendothelial neoplasms|82830017|0-19|All Races|Male and Female|2011|27.0|29.3|28.2
11.1|12.6|11.8|1000|II(a) Hodgkin lymphomas|82830017|0-19|All Races|Male and Female|2011|11.3|12.8|12.1
7.8|9.1|8.4|705|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82830017|0-19|All Races|Male and Female|2011|7.9|9.2|8.5
2.2|2.9|2.5|207|II(c) Burkitt lymphoma|82830017|0-19|All Races|Male and Female|2011|2.2|2.9|2.5
4.3|5.3|4.8|392|II(d) Miscellaneous lymphoreticular neoplasms|82830017|0-19|All Races|Male and Female|2011|4.3|5.2|4.7
0.2|0.5|0.4|30|II(e) Unspecified lymphomas|82830017|0-19|All Races|Male and Female|2011|0.2|0.5|0.4
32.0|34.5|33.2|2745|III CNS and misc intracranial and intraspinal neoplasms|82830017|0-19|All Races|Male and Female|2011|31.9|34.4|33.1
2.5|3.3|2.9|239|III(a) Ependymomas and choroid plexus tumor|82830017|0-19|All Races|Male and Female|2011|2.5|3.3|2.9
16.3|18.1|17.2|1426|III(b) Astrocytomas|82830017|0-19|All Races|Male and Female|2011|16.3|18.1|17.2
5.6|6.7|6.1|507|III(c) Intracranial and intraspinal embryonal tumors|82830017|0-19|All Races|Male and Female|2011|5.6|6.7|6.1
5.4|6.5|6.0|492|III(d) Other gliomas|82830017|0-19|All Races|Male and Female|2011|5.4|6.5|5.9
0.4|0.7|0.6|46|III(e) Other specified intracranial & intraspinal neoplasms|82830017|0-19|All Races|Male and Female|2011|0.4|0.7|0.6
0.3|0.6|0.4|35|III(f) Unspecified intracranial and intraspinal neoplasms|82830017|0-19|All Races|Male and Female|2011|0.3|0.6|0.4
7.9|9.2|8.6|709|IV Neuroblastoma and other peripheral nervous cell tumors|82830017|0-19|All Races|Male and Female|2011|7.9|9.2|8.6
7.7|9.0|8.3|688|IV(a) Neuroblastoma and ganglioneuroblastoma|82830017|0-19|All Races|Male and Female|2011|7.7|9.0|8.3
0.2|0.4|0.3|21|IV(b) Other peripheral nervous cell tumors|82830017|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
11.5|13.0|12.2|1016|IX Soft tissue and other extraosseous sarcomas|82830017|0-19|All Races|Male and Female|2011|11.5|13.0|12.3
4.3|5.2|4.7|392|IX(a) Rhabdomyosarcomas|82830017|0-19|All Races|Male and Female|2011|4.3|5.2|4.7
1.1|1.6|1.3|110|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82830017|0-19|All Races|Male and Female|2011|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82830017|0-19|All Races|Male and Female|2011|~|~|~
4.3|5.3|4.8|401|IX(d) Other specified soft tissue sarcomas|82830017|0-19|All Races|Male and Female|2011|4.4|5.3|4.8
1.0|1.5|1.3|106|IX(e) Unspecified soft tissue sarcomas|82830017|0-19|All Races|Male and Female|2011|1.0|1.5|1.3
0.2|0.4|0.3|23|Not classified by ICCC|82830017|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
2.8|3.5|3.1|261|V Retinoblastoma|82830017|0-19|All Races|Male and Female|2011|2.8|3.6|3.2
6.6|7.8|7.2|597|VI Renal tumors|82830017|0-19|All Races|Male and Female|2011|6.6|7.8|7.2
6.0|7.1|6.5|540|VI(a) Nephroblastoma and other nonepithelial renal tumors|82830017|0-19|All Races|Male and Female|2011|6.0|7.1|6.5
0.5|0.9|0.7|56|VI(b) Renal carcinomas|82830017|0-19|All Races|Male and Female|2011|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82830017|0-19|All Races|Male and Female|2011|~|~|~
2.3|3.0|2.6|216|VII Hepatic tumors|82830017|0-19|All Races|Male and Female|2011|2.3|3.0|2.6
1.7|2.4|2.0|168|VII(a) Hepatoblastoma|82830017|0-19|All Races|Male and Female|2011|1.7|2.4|2.0
0.4|0.7|0.5|44|VII(b) Hepatic carcinomas|82830017|0-19|All Races|Male and Female|2011|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82830017|0-19|All Races|Male and Female|2011|~|~|~
8.3|9.6|9.0|745|VIII Malignant bone tumors|82830017|0-19|All Races|Male and Female|2011|8.4|9.7|9.0
4.6|5.6|5.1|422|VIII(a) Osteosarcomas|82830017|0-19|All Races|Male and Female|2011|4.6|5.6|5.1
0.2|0.4|0.2|21|VIII(b) Chondrosarcomas|82830017|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
2.8|3.6|3.2|263|VIII(c) Ewing tumor and related sarcomas of bone|82830017|0-19|All Races|Male and Female|2011|2.8|3.6|3.2
0.2|0.5|0.3|26|VIII(d) Other specified malignant bone tumors|82830017|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82830017|0-19|All Races|Male and Female|2011|~|~|~
10.1|11.5|10.7|908|X Germ cell, trophoblastic tumors & neoplasms of gonads|82830017|0-19|All Races|Male and Female|2011|10.3|11.7|11.0
1.4|2.0|1.7|139|X(a) Intracranial & intraspinal germ cell tumors|82830017|0-19|All Races|Male and Female|2011|1.4|2.0|1.7
1.1|1.6|1.4|115|X(b) Malignant extracranial & extragonadal germ cell tumors|82830017|0-19|All Races|Male and Female|2011|1.1|1.7|1.4
6.6|7.7|7.1|607|X(c) Malignant gonadal germ cell tumors|82830017|0-19|All Races|Male and Female|2011|6.8|7.9|7.3
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|82830017|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.2|0.4|0.2|21|X(e) Other and unspecified malignant gonadal tumors|82830017|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
18.1|20.0|19.0|1612|XI Other malignant epithelial neoplasms and malignant melanomas|82830017|0-19|All Races|Male and Female|2011|18.5|20.4|19.5
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|82830017|0-19|All Races|Male and Female|2011|0.1|0.4|0.2
8.7|10.0|9.3|792|XI(b) Thyroid carcinomas|82830017|0-19|All Races|Male and Female|2011|8.9|10.3|9.6
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82830017|0-19|All Races|Male and Female|2011|0.5|0.8|0.6
3.9|4.8|4.3|363|XI(d) Malignant melanomas|82830017|0-19|All Races|Male and Female|2011|3.9|4.9|4.4
~|~|~|~|XI(e) Skin carcinomas|82830017|0-19|All Races|Male and Female|2011|~|~|~
4.0|4.9|4.5|379|XI(f) Other and unspecified carcinomas|82830017|0-19|All Races|Male and Female|2011|4.1|5.1|4.6
0.5|0.9|0.7|57|XII Other and unspecified malignant neoplasms|82830017|0-19|All Races|Male and Female|2011|0.5|0.9|0.7
0.2|0.5|0.3|27|XII(a) Other specified malignant tumors|82830017|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.2|0.5|0.4|30|XII(b) Other unspecified malignant tumors|82830017|0-19|All Races|Male and Female|2011|0.2|0.5|0.4
182.1|187.9|185.0|15327|All ICCC Groups Combined|82487297|0-19|All Races|Male and Female|2012|182.9|188.8|185.8
46.2|49.2|47.7|3938|I Leukemias, myeloproliferative & myelodysplastic diseases|82487297|0-19|All Races|Male and Female|2012|46.3|49.3|47.7
32.8|35.4|34.1|2810|I(a) Lymphoid leukemias|82487297|0-19|All Races|Male and Female|2012|32.8|35.3|34.1
7.3|8.5|7.9|652|I(b) Acute myeloid leukemias|82487297|0-19|All Races|Male and Female|2012|7.3|8.5|7.9
2.2|2.9|2.5|208|I(c) Chronic myeloproliferative diseases|82487297|0-19|All Races|Male and Female|2012|2.2|2.9|2.5
1.3|1.8|1.5|124|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82487297|0-19|All Races|Male and Female|2012|1.3|1.8|1.5
1.5|2.0|1.7|144|I(e) Unspecified and other specified leukemias|82487297|0-19|All Races|Male and Female|2012|1.5|2.1|1.7
28.7|31.1|29.9|2484|II Lymphomas and reticuloendothelial neoplasms|82487297|0-19|All Races|Male and Female|2012|28.9|31.3|30.1
11.7|13.3|12.5|1045|II(a) Hodgkin lymphomas|82487297|0-19|All Races|Male and Female|2012|11.9|13.5|12.7
9.1|10.5|9.8|813|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82487297|0-19|All Races|Male and Female|2012|9.2|10.6|9.9
2.0|2.7|2.3|191|II(c) Burkitt lymphoma|82487297|0-19|All Races|Male and Female|2012|2.0|2.7|2.3
4.3|5.3|4.8|395|II(d) Miscellaneous lymphoreticular neoplasms|82487297|0-19|All Races|Male and Female|2012|4.3|5.3|4.8
0.3|0.7|0.5|40|II(e) Unspecified lymphomas|82487297|0-19|All Races|Male and Female|2012|0.3|0.7|0.5
30.9|33.4|32.1|2648|III CNS and misc intracranial and intraspinal neoplasms|82487297|0-19|All Races|Male and Female|2012|30.9|33.3|32.1
2.3|3.1|2.7|222|III(a) Ependymomas and choroid plexus tumor|82487297|0-19|All Races|Male and Female|2012|2.3|3.1|2.7
16.3|18.1|17.2|1419|III(b) Astrocytomas|82487297|0-19|All Races|Male and Female|2012|16.3|18.1|17.2
5.3|6.4|5.8|480|III(c) Intracranial and intraspinal embryonal tumors|82487297|0-19|All Races|Male and Female|2012|5.3|6.4|5.8
4.7|5.7|5.2|429|III(d) Other gliomas|82487297|0-19|All Races|Male and Female|2012|4.7|5.7|5.2
0.4|0.7|0.5|45|III(e) Other specified intracranial & intraspinal neoplasms|82487297|0-19|All Races|Male and Female|2012|0.4|0.7|0.5
0.5|0.8|0.6|53|III(f) Unspecified intracranial and intraspinal neoplasms|82487297|0-19|All Races|Male and Female|2012|0.5|0.8|0.6
8.2|9.5|8.8|725|IV Neuroblastoma and other peripheral nervous cell tumors|82487297|0-19|All Races|Male and Female|2012|8.2|9.5|8.8
7.9|9.2|8.5|704|IV(a) Neuroblastoma and ganglioneuroblastoma|82487297|0-19|All Races|Male and Female|2012|7.9|9.2|8.5
0.2|0.4|0.3|21|IV(b) Other peripheral nervous cell tumors|82487297|0-19|All Races|Male and Female|2012|0.2|0.4|0.3
11.0|12.5|11.8|973|IX Soft tissue and other extraosseous sarcomas|82487297|0-19|All Races|Male and Female|2012|11.1|12.6|11.8
4.1|5.0|4.6|376|IX(a) Rhabdomyosarcomas|82487297|0-19|All Races|Male and Female|2012|4.1|5.0|4.6
1.0|1.5|1.2|103|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82487297|0-19|All Races|Male and Female|2012|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|82487297|0-19|All Races|Male and Female|2012|~|~|~
4.0|5.0|4.5|372|IX(d) Other specified soft tissue sarcomas|82487297|0-19|All Races|Male and Female|2012|4.1|5.0|4.5
1.2|1.7|1.4|116|IX(e) Unspecified soft tissue sarcomas|82487297|0-19|All Races|Male and Female|2012|1.2|1.7|1.4
0.1|0.4|0.2|20|Not classified by ICCC|82487297|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
2.9|3.7|3.3|274|V Retinoblastoma|82487297|0-19|All Races|Male and Female|2012|2.9|3.7|3.3
6.5|7.6|7.0|582|VI Renal tumors|82487297|0-19|All Races|Male and Female|2012|6.5|7.7|7.1
5.7|6.8|6.3|516|VI(a) Nephroblastoma and other nonepithelial renal tumors|82487297|0-19|All Races|Male and Female|2012|5.7|6.8|6.3
0.6|0.9|0.7|61|VI(b) Renal carcinomas|82487297|0-19|All Races|Male and Female|2012|0.6|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82487297|0-19|All Races|Male and Female|2012|~|~|~
2.4|3.2|2.8|230|VII Hepatic tumors|82487297|0-19|All Races|Male and Female|2012|2.4|3.2|2.8
1.8|2.5|2.1|176|VII(a) Hepatoblastoma|82487297|0-19|All Races|Male and Female|2012|1.8|2.5|2.1
0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82487297|0-19|All Races|Male and Female|2012|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82487297|0-19|All Races|Male and Female|2012|~|~|~
8.4|9.7|9.0|748|VIII Malignant bone tumors|82487297|0-19|All Races|Male and Female|2012|8.4|9.7|9.1
4.7|5.7|5.2|431|VIII(a) Osteosarcomas|82487297|0-19|All Races|Male and Female|2012|4.7|5.7|5.2
0.2|0.5|0.3|28|VIII(b) Chondrosarcomas|82487297|0-19|All Races|Male and Female|2012|0.2|0.5|0.3
2.5|3.2|2.8|235|VIII(c) Ewing tumor and related sarcomas of bone|82487297|0-19|All Races|Male and Female|2012|2.5|3.2|2.8
0.3|0.6|0.4|34|VIII(d) Other specified malignant bone tumors|82487297|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.1|0.4|0.2|20|VIII(e) Unspecified malignant bone tumors|82487297|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
10.9|12.4|11.6|975|X Germ cell, trophoblastic tumors & neoplasms of gonads|82487297|0-19|All Races|Male and Female|2012|11.1|12.6|11.8
1.3|1.9|1.6|131|X(a) Intracranial & intraspinal germ cell tumors|82487297|0-19|All Races|Male and Female|2012|1.3|1.9|1.6
1.4|2.0|1.7|141|X(b) Malignant extracranial & extragonadal germ cell tumors|82487297|0-19|All Races|Male and Female|2012|1.4|2.0|1.7
7.0|8.2|7.6|641|X(c) Malignant gonadal germ cell tumors|82487297|0-19|All Races|Male and Female|2012|7.2|8.4|7.8
0.3|0.6|0.4|35|X(d) Gonadal carcinomas|82487297|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|82487297|0-19|All Races|Male and Female|2012|0.2|0.5|0.3
18.7|20.6|19.7|1649|XI Other malignant epithelial neoplasms and malignant melanomas|82487297|0-19|All Races|Male and Female|2012|19.0|21.0|20.0
0.2|0.4|0.3|22|XI(a) Adrenocortical carcinomas|82487297|0-19|All Races|Male and Female|2012|0.2|0.4|0.3
9.0|10.4|9.7|813|XI(b) Thyroid carcinomas|82487297|0-19|All Races|Male and Female|2012|9.2|10.6|9.9
0.3|0.6|0.5|38|XI(c) Nasopharyngeal carcinomas|82487297|0-19|All Races|Male and Female|2012|0.3|0.6|0.5
3.8|4.7|4.2|355|XI(d) Malignant melanomas|82487297|0-19|All Races|Male and Female|2012|3.9|4.8|4.3
~|~|~|~|XI(e) Skin carcinomas|82487297|0-19|All Races|Male and Female|2012|~|~|~
4.5|5.4|4.9|413|XI(f) Other and unspecified carcinomas|82487297|0-19|All Races|Male and Female|2012|4.5|5.5|5.0
0.8|1.2|1.0|81|XII Other and unspecified malignant neoplasms|82487297|0-19|All Races|Male and Female|2012|0.8|1.2|1.0
0.3|0.6|0.4|36|XII(a) Other specified malignant tumors|82487297|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.4|0.7|0.5|45|XII(b) Other unspecified malignant tumors|82487297|0-19|All Races|Male and Female|2012|0.4|0.7|0.5
187.4|190.1|188.7|77849|All ICCC Groups Combined|411080354|0-19|All Races|Male and Female|2012-2016|188.0|190.7|189.4
47.6|49.0|48.3|19863|I Leukemias, myeloproliferative & myelodysplastic diseases|411080354|0-19|All Races|Male and Female|2012-2016|47.6|49.0|48.3
33.5|34.6|34.1|14006|I(a) Lymphoid leukemias|411080354|0-19|All Races|Male and Female|2012-2016|33.5|34.6|34.1
8.0|8.5|8.3|3404|I(b) Acute myeloid leukemias|411080354|0-19|All Races|Male and Female|2012-2016|8.0|8.6|8.3
2.4|2.7|2.5|1045|I(c) Chronic myeloproliferative diseases|411080354|0-19|All Races|Male and Female|2012-2016|2.4|2.7|2.5
1.4|1.6|1.5|619|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|411080354|0-19|All Races|Male and Female|2012-2016|1.4|1.6|1.5
1.8|2.1|1.9|789|I(e) Unspecified and other specified leukemias|411080354|0-19|All Races|Male and Female|2012-2016|1.8|2.1|1.9
29.5|30.5|30.0|12394|II Lymphomas and reticuloendothelial neoplasms|411080354|0-19|All Races|Male and Female|2012-2016|29.6|30.7|30.1
11.8|12.5|12.1|5040|II(a) Hodgkin lymphomas|411080354|0-19|All Races|Male and Female|2012-2016|11.9|12.6|12.3
9.7|10.3|10.0|4112|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|411080354|0-19|All Races|Male and Female|2012-2016|9.7|10.3|10.0
2.3|2.6|2.4|1003|II(c) Burkitt lymphoma|411080354|0-19|All Races|Male and Female|2012-2016|2.3|2.6|2.4
4.8|5.3|5.1|2072|II(d) Miscellaneous lymphoreticular neoplasms|411080354|0-19|All Races|Male and Female|2012-2016|4.8|5.3|5.0
0.3|0.5|0.4|167|II(e) Unspecified lymphomas|411080354|0-19|All Races|Male and Female|2012-2016|0.3|0.5|0.4
31.6|32.7|32.2|13214|III CNS and misc intracranial and intraspinal neoplasms|411080354|0-19|All Races|Male and Female|2012-2016|31.6|32.7|32.1
2.5|2.8|2.7|1093|III(a) Ependymomas and choroid plexus tumor|411080354|0-19|All Races|Male and Female|2012-2016|2.5|2.8|2.7
16.4|17.2|16.8|6890|III(b) Astrocytomas|411080354|0-19|All Races|Male and Female|2012-2016|16.4|17.2|16.8
5.6|6.1|5.8|2391|III(c) Intracranial and intraspinal embryonal tumors|411080354|0-19|All Races|Male and Female|2012-2016|5.6|6.1|5.8
5.4|5.9|5.6|2306|III(d) Other gliomas|411080354|0-19|All Races|Male and Female|2012-2016|5.4|5.8|5.6
0.7|0.8|0.7|307|III(e) Other specified intracranial & intraspinal neoplasms|411080354|0-19|All Races|Male and Female|2012-2016|0.7|0.8|0.7
0.5|0.6|0.6|227|III(f) Unspecified intracranial and intraspinal neoplasms|411080354|0-19|All Races|Male and Female|2012-2016|0.5|0.6|0.6
8.8|9.4|9.1|3734|IV Neuroblastoma and other peripheral nervous cell tumors|411080354|0-19|All Races|Male and Female|2012-2016|8.8|9.4|9.1
8.5|9.1|8.8|3624|IV(a) Neuroblastoma and ganglioneuroblastoma|411080354|0-19|All Races|Male and Female|2012-2016|8.5|9.1|8.8
0.2|0.3|0.3|110|IV(b) Other peripheral nervous cell tumors|411080354|0-19|All Races|Male and Female|2012-2016|0.2|0.3|0.3
11.8|12.5|12.2|5008|IX Soft tissue and other extraosseous sarcomas|411080354|0-19|All Races|Male and Female|2012-2016|11.8|12.5|12.2
4.5|4.9|4.7|1941|IX(a) Rhabdomyosarcomas|411080354|0-19|All Races|Male and Female|2012-2016|4.5|4.9|4.7
1.2|1.4|1.3|535|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|411080354|0-19|All Races|Male and Female|2012-2016|1.2|1.4|1.3
0.0|0.1|0.0|18|IX(c) Kaposi sarcoma|411080354|0-19|All Races|Male and Female|2012-2016|0.0|0.1|0.0
4.5|4.9|4.7|1943|IX(d) Other specified soft tissue sarcomas|411080354|0-19|All Races|Male and Female|2012-2016|4.5|4.9|4.7
1.3|1.5|1.4|571|IX(e) Unspecified soft tissue sarcomas|411080354|0-19|All Races|Male and Female|2012-2016|1.3|1.5|1.4
0.2|0.3|0.3|110|Not classified by ICCC|411080354|0-19|All Races|Male and Female|2012-2016|0.2|0.3|0.3
3.2|3.5|3.3|1370|V Retinoblastoma|411080354|0-19|All Races|Male and Female|2012-2016|3.2|3.5|3.3
7.0|7.6|7.3|3006|VI Renal tumors|411080354|0-19|All Races|Male and Female|2012-2016|7.1|7.6|7.3
6.2|6.7|6.5|2669|VI(a) Nephroblastoma and other nonepithelial renal tumors|411080354|0-19|All Races|Male and Female|2012-2016|6.2|6.7|6.5
0.7|0.9|0.8|322|VI(b) Renal carcinomas|411080354|0-19|All Races|Male and Female|2012-2016|0.7|0.9|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|411080354|0-19|All Races|Male and Female|2012-2016|~|~|~
2.5|2.8|2.6|1088|VII Hepatic tumors|411080354|0-19|All Races|Male and Female|2012-2016|2.5|2.8|2.6
1.9|2.2|2.0|836|VII(a) Hepatoblastoma|411080354|0-19|All Races|Male and Female|2012-2016|1.9|2.2|2.0
0.5|0.7|0.6|243|VII(b) Hepatic carcinomas|411080354|0-19|All Races|Male and Female|2012-2016|0.5|0.7|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|411080354|0-19|All Races|Male and Female|2012-2016|~|~|~
9.0|9.6|9.3|3830|VIII Malignant bone tumors|411080354|0-19|All Races|Male and Female|2012-2016|9.0|9.6|9.3
4.9|5.3|5.1|2109|VIII(a) Osteosarcomas|411080354|0-19|All Races|Male and Female|2012-2016|4.9|5.4|5.1
0.3|0.4|0.3|141|VIII(b) Chondrosarcomas|411080354|0-19|All Races|Male and Female|2012-2016|0.3|0.4|0.3
2.9|3.3|3.1|1277|VIII(c) Ewing tumor and related sarcomas of bone|411080354|0-19|All Races|Male and Female|2012-2016|2.9|3.3|3.1
0.5|0.6|0.5|217|VIII(d) Other specified malignant bone tumors|411080354|0-19|All Races|Male and Female|2012-2016|0.5|0.6|0.5
0.2|0.3|0.2|86|VIII(e) Unspecified malignant bone tumors|411080354|0-19|All Races|Male and Female|2012-2016|0.2|0.3|0.2
11.2|11.8|11.5|4788|X Germ cell, trophoblastic tumors & neoplasms of gonads|411080354|0-19|All Races|Male and Female|2012-2016|11.3|12.0|11.6
1.7|1.9|1.8|741|X(a) Intracranial & intraspinal germ cell tumors|411080354|0-19|All Races|Male and Female|2012-2016|1.7|1.9|1.8
1.4|1.6|1.5|616|X(b) Malignant extracranial & extragonadal germ cell tumors|411080354|0-19|All Races|Male and Female|2012-2016|1.4|1.6|1.5
7.1|7.6|7.4|3077|X(c) Malignant gonadal germ cell tumors|411080354|0-19|All Races|Male and Female|2012-2016|7.2|7.8|7.5
0.4|0.5|0.5|199|X(d) Gonadal carcinomas|411080354|0-19|All Races|Male and Female|2012-2016|0.4|0.6|0.5
0.3|0.4|0.4|155|X(e) Other and unspecified malignant gonadal tumors|411080354|0-19|All Races|Male and Female|2012-2016|0.3|0.4|0.4
21.4|22.3|21.8|9082|XI Other malignant epithelial neoplasms and malignant melanomas|411080354|0-19|All Races|Male and Female|2012-2016|21.6|22.6|22.1
0.2|0.2|0.2|81|XI(a) Adrenocortical carcinomas|411080354|0-19|All Races|Male and Female|2012-2016|0.2|0.2|0.2
10.0|10.6|10.3|4299|XI(b) Thyroid carcinomas|411080354|0-19|All Races|Male and Female|2012-2016|10.1|10.8|10.5
0.4|0.6|0.5|199|XI(c) Nasopharyngeal carcinomas|411080354|0-19|All Races|Male and Female|2012-2016|0.4|0.6|0.5
3.9|4.3|4.1|1697|XI(d) Malignant melanomas|411080354|0-19|All Races|Male and Female|2012-2016|3.9|4.3|4.1
0.1|0.1|0.1|33|XI(e) Skin carcinomas|411080354|0-19|All Races|Male and Female|2012-2016|0.1|0.1|0.1
6.4|6.9|6.7|2773|XI(f) Other and unspecified carcinomas|411080354|0-19|All Races|Male and Female|2012-2016|6.5|7.0|6.7
0.8|1.0|0.9|362|XII Other and unspecified malignant neoplasms|411080354|0-19|All Races|Male and Female|2012-2016|0.8|1.0|0.9
0.4|0.5|0.5|191|XII(a) Other specified malignant tumors|411080354|0-19|All Races|Male and Female|2012-2016|0.4|0.5|0.5
0.4|0.5|0.4|171|XII(b) Other unspecified malignant tumors|411080354|0-19|All Races|Male and Female|2012-2016|0.4|0.5|0.4
181.4|187.3|184.3|15200|All ICCC Groups Combined|82252861|0-19|All Races|Male and Female|2013|181.9|187.8|184.8
45.4|48.3|46.8|3852|I Leukemias, myeloproliferative & myelodysplastic diseases|82252861|0-19|All Races|Male and Female|2013|45.4|48.3|46.8
31.3|33.8|32.5|2671|I(a) Lymphoid leukemias|82252861|0-19|All Races|Male and Female|2013|31.3|33.7|32.5
7.7|8.9|8.3|682|I(b) Acute myeloid leukemias|82252861|0-19|All Races|Male and Female|2013|7.7|8.9|8.3
2.1|2.8|2.4|201|I(c) Chronic myeloproliferative diseases|82252861|0-19|All Races|Male and Female|2013|2.1|2.8|2.4
1.4|1.9|1.6|134|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82252861|0-19|All Races|Male and Female|2013|1.4|1.9|1.6
1.7|2.3|2.0|164|I(e) Unspecified and other specified leukemias|82252861|0-19|All Races|Male and Female|2013|1.7|2.3|2.0
27.2|29.5|28.3|2342|II Lymphomas and reticuloendothelial neoplasms|82252861|0-19|All Races|Male and Female|2013|27.3|29.7|28.5
10.8|12.3|11.6|962|II(a) Hodgkin lymphomas|82252861|0-19|All Races|Male and Female|2013|11.0|12.5|11.7
8.4|9.7|9.1|749|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82252861|0-19|All Races|Male and Female|2013|8.5|9.8|9.1
2.0|2.6|2.3|188|II(c) Burkitt lymphoma|82252861|0-19|All Races|Male and Female|2013|2.0|2.6|2.3
4.6|5.6|5.0|413|II(d) Miscellaneous lymphoreticular neoplasms|82252861|0-19|All Races|Male and Female|2013|4.5|5.5|5.0
0.2|0.5|0.4|30|II(e) Unspecified lymphomas|82252861|0-19|All Races|Male and Female|2013|0.2|0.5|0.4
31.8|34.3|33.0|2710|III CNS and misc intracranial and intraspinal neoplasms|82252861|0-19|All Races|Male and Female|2013|31.7|34.2|32.9
2.3|3.0|2.7|219|III(a) Ependymomas and choroid plexus tumor|82252861|0-19|All Races|Male and Female|2013|2.3|3.0|2.7
16.8|18.6|17.7|1453|III(b) Astrocytomas|82252861|0-19|All Races|Male and Female|2013|16.8|18.6|17.7
5.2|6.3|5.7|469|III(c) Intracranial and intraspinal embryonal tumors|82252861|0-19|All Races|Male and Female|2013|5.2|6.2|5.7
5.2|6.3|5.7|469|III(d) Other gliomas|82252861|0-19|All Races|Male and Female|2013|5.2|6.2|5.7
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|82252861|0-19|All Races|Male and Female|2013|0.5|0.9|0.7
0.4|0.7|0.5|41|III(f) Unspecified intracranial and intraspinal neoplasms|82252861|0-19|All Races|Male and Female|2013|0.4|0.7|0.5
8.6|10.0|9.3|762|IV Neuroblastoma and other peripheral nervous cell tumors|82252861|0-19|All Races|Male and Female|2013|8.6|9.9|9.3
8.3|9.7|9.0|737|IV(a) Neuroblastoma and ganglioneuroblastoma|82252861|0-19|All Races|Male and Female|2013|8.3|9.6|9.0
0.2|0.4|0.3|25|IV(b) Other peripheral nervous cell tumors|82252861|0-19|All Races|Male and Female|2013|0.2|0.4|0.3
11.2|12.7|11.9|980|IX Soft tissue and other extraosseous sarcomas|82252861|0-19|All Races|Male and Female|2013|11.2|12.7|11.9
4.4|5.3|4.8|398|IX(a) Rhabdomyosarcomas|82252861|0-19|All Races|Male and Female|2013|4.4|5.3|4.8
1.0|1.5|1.3|105|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82252861|0-19|All Races|Male and Female|2013|1.0|1.5|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82252861|0-19|All Races|Male and Female|2013|~|~|~
4.1|5.0|4.5|374|IX(d) Other specified soft tissue sarcomas|82252861|0-19|All Races|Male and Female|2013|4.1|5.0|4.5
1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|82252861|0-19|All Races|Male and Female|2013|1.0|1.5|1.2
0.2|0.4|0.3|23|Not classified by ICCC|82252861|0-19|All Races|Male and Female|2013|0.2|0.4|0.3
2.9|3.6|3.2|265|V Retinoblastoma|82252861|0-19|All Races|Male and Female|2013|2.8|3.6|3.2
6.8|8.0|7.4|605|VI Renal tumors|82252861|0-19|All Races|Male and Female|2013|6.8|8.0|7.4
5.9|7.0|6.5|531|VI(a) Nephroblastoma and other nonepithelial renal tumors|82252861|0-19|All Races|Male and Female|2013|5.9|7.0|6.5
0.7|1.1|0.9|71|VI(b) Renal carcinomas|82252861|0-19|All Races|Male and Female|2013|0.7|1.1|0.9
~|~|~|~|VI(c) Unspecified malignant renal tumors|82252861|0-19|All Races|Male and Female|2013|~|~|~
2.1|2.8|2.5|203|VII Hepatic tumors|82252861|0-19|All Races|Male and Female|2013|2.1|2.8|2.5
1.5|2.1|1.8|149|VII(a) Hepatoblastoma|82252861|0-19|All Races|Male and Female|2013|1.5|2.1|1.8
0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82252861|0-19|All Races|Male and Female|2013|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82252861|0-19|All Races|Male and Female|2013|~|~|~
8.5|9.8|9.2|755|VIII Malignant bone tumors|82252861|0-19|All Races|Male and Female|2013|8.5|9.9|9.2
4.5|5.5|5.0|409|VIII(a) Osteosarcomas|82252861|0-19|All Races|Male and Female|2013|4.5|5.5|5.0
0.2|0.5|0.3|29|VIII(b) Chondrosarcomas|82252861|0-19|All Races|Male and Female|2013|0.2|0.5|0.4
2.8|3.6|3.1|259|VIII(c) Ewing tumor and related sarcomas of bone|82252861|0-19|All Races|Male and Female|2013|2.8|3.6|3.1
0.4|0.7|0.5|44|VIII(d) Other specified malignant bone tumors|82252861|0-19|All Races|Male and Female|2013|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82252861|0-19|All Races|Male and Female|2013|~|~|~
11.2|12.7|11.9|990|X Germ cell, trophoblastic tumors & neoplasms of gonads|82252861|0-19|All Races|Male and Female|2013|11.3|12.8|12.0
1.6|2.3|1.9|159|X(a) Intracranial & intraspinal germ cell tumors|82252861|0-19|All Races|Male and Female|2013|1.6|2.3|1.9
1.1|1.7|1.4|114|X(b) Malignant extracranial & extragonadal germ cell tumors|82252861|0-19|All Races|Male and Female|2013|1.1|1.7|1.4
7.0|8.2|7.6|636|X(c) Malignant gonadal germ cell tumors|82252861|0-19|All Races|Male and Female|2013|7.1|8.4|7.7
0.4|0.7|0.6|47|X(d) Gonadal carcinomas|82252861|0-19|All Races|Male and Female|2013|0.4|0.8|0.6
0.3|0.6|0.4|34|X(e) Other and unspecified malignant gonadal tumors|82252861|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
18.8|20.7|19.7|1643|XI Other malignant epithelial neoplasms and malignant melanomas|82252861|0-19|All Races|Male and Female|2013|19.0|21.0|20.0
~|~|~|~|XI(a) Adrenocortical carcinomas|82252861|0-19|All Races|Male and Female|2013|~|~|~
8.8|10.1|9.5|788|XI(b) Thyroid carcinomas|82252861|0-19|All Races|Male and Female|2013|8.9|10.3|9.6
0.5|0.8|0.6|53|XI(c) Nasopharyngeal carcinomas|82252861|0-19|All Races|Male and Female|2013|0.5|0.8|0.6
3.8|4.7|4.2|352|XI(d) Malignant melanomas|82252861|0-19|All Races|Male and Female|2013|3.8|4.8|4.3
~|~|~|~|XI(e) Skin carcinomas|82252861|0-19|All Races|Male and Female|2013|~|~|~
4.7|5.7|5.2|434|XI(f) Other and unspecified carcinomas|82252861|0-19|All Races|Male and Female|2013|4.8|5.8|5.3
0.7|1.1|0.8|70|XII Other and unspecified malignant neoplasms|82252861|0-19|All Races|Male and Female|2013|0.7|1.1|0.9
0.3|0.6|0.4|36|XII(a) Other specified malignant tumors|82252861|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
0.3|0.6|0.4|34|XII(b) Other unspecified malignant tumors|82252861|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
187.0|193.0|190.0|15643|All ICCC Groups Combined|82116071|0-19|All Races|Male and Female|2014|187.5|193.5|190.5
46.5|49.5|48.0|3947|I Leukemias, myeloproliferative & myelodysplastic diseases|82116071|0-19|All Races|Male and Female|2014|46.6|49.6|48.1
32.2|34.7|33.5|2748|I(a) Lymphoid leukemias|82116071|0-19|All Races|Male and Female|2014|32.2|34.7|33.5
7.9|9.2|8.6|705|I(b) Acute myeloid leukemias|82116071|0-19|All Races|Male and Female|2014|8.0|9.2|8.6
2.1|2.8|2.4|202|I(c) Chronic myeloproliferative diseases|82116071|0-19|All Races|Male and Female|2014|2.1|2.8|2.5
1.3|1.8|1.5|127|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82116071|0-19|All Races|Male and Female|2014|1.3|1.8|1.5
1.7|2.3|2.0|165|I(e) Unspecified and other specified leukemias|82116071|0-19|All Races|Male and Female|2014|1.7|2.3|2.0
30.0|32.4|31.2|2574|II Lymphomas and reticuloendothelial neoplasms|82116071|0-19|All Races|Male and Female|2014|30.1|32.6|31.3
11.2|12.7|11.9|987|II(a) Hodgkin lymphomas|82116071|0-19|All Races|Male and Female|2014|11.3|12.8|12.0
10.2|11.6|10.9|897|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82116071|0-19|All Races|Male and Female|2014|10.2|11.7|10.9
2.3|3.0|2.7|218|II(c) Burkitt lymphoma|82116071|0-19|All Races|Male and Female|2014|2.3|3.0|2.7
4.9|5.9|5.4|440|II(d) Miscellaneous lymphoreticular neoplasms|82116071|0-19|All Races|Male and Female|2014|4.9|5.9|5.4
0.3|0.5|0.4|32|II(e) Unspecified lymphomas|82116071|0-19|All Races|Male and Female|2014|0.3|0.6|0.4
31.7|34.2|33.0|2703|III CNS and misc intracranial and intraspinal neoplasms|82116071|0-19|All Races|Male and Female|2014|31.7|34.2|32.9
2.4|3.2|2.8|228|III(a) Ependymomas and choroid plexus tumor|82116071|0-19|All Races|Male and Female|2014|2.4|3.2|2.8
16.6|18.4|17.4|1432|III(b) Astrocytomas|82116071|0-19|All Races|Male and Female|2014|16.5|18.4|17.4
5.5|6.6|6.0|492|III(c) Intracranial and intraspinal embryonal tumors|82116071|0-19|All Races|Male and Female|2014|5.5|6.5|6.0
4.8|5.8|5.3|436|III(d) Other gliomas|82116071|0-19|All Races|Male and Female|2014|4.8|5.8|5.3
0.6|1.0|0.8|68|III(e) Other specified intracranial & intraspinal neoplasms|82116071|0-19|All Races|Male and Female|2014|0.6|1.0|0.8
0.4|0.8|0.6|47|III(f) Unspecified intracranial and intraspinal neoplasms|82116071|0-19|All Races|Male and Female|2014|0.4|0.8|0.6
8.6|9.9|9.2|760|IV Neuroblastoma and other peripheral nervous cell tumors|82116071|0-19|All Races|Male and Female|2014|8.6|9.9|9.3
8.3|9.6|8.9|732|IV(a) Neuroblastoma and ganglioneuroblastoma|82116071|0-19|All Races|Male and Female|2014|8.3|9.6|8.9
0.2|0.5|0.3|28|IV(b) Other peripheral nervous cell tumors|82116071|0-19|All Races|Male and Female|2014|0.2|0.5|0.3
11.6|13.1|12.3|1014|IX Soft tissue and other extraosseous sarcomas|82116071|0-19|All Races|Male and Female|2014|11.6|13.1|12.3
3.9|4.8|4.4|359|IX(a) Rhabdomyosarcomas|82116071|0-19|All Races|Male and Female|2014|3.9|4.8|4.4
1.2|1.8|1.5|123|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82116071|0-19|All Races|Male and Female|2014|1.2|1.8|1.5
~|~|~|~|IX(c) Kaposi sarcoma|82116071|0-19|All Races|Male and Female|2014|~|~|~
4.5|5.5|5.0|413|IX(d) Other specified soft tissue sarcomas|82116071|0-19|All Races|Male and Female|2014|4.6|5.5|5.0
1.1|1.7|1.4|114|IX(e) Unspecified soft tissue sarcomas|82116071|0-19|All Races|Male and Female|2014|1.1|1.7|1.4
0.2|0.5|0.3|26|Not classified by ICCC|82116071|0-19|All Races|Male and Female|2014|0.2|0.5|0.3
2.9|3.6|3.2|266|V Retinoblastoma|82116071|0-19|All Races|Male and Female|2014|2.9|3.7|3.2
6.7|7.9|7.3|601|VI Renal tumors|82116071|0-19|All Races|Male and Female|2014|6.7|7.9|7.3
6.1|7.2|6.6|546|VI(a) Nephroblastoma and other nonepithelial renal tumors|82116071|0-19|All Races|Male and Female|2014|6.1|7.2|6.6
0.5|0.8|0.6|53|VI(b) Renal carcinomas|82116071|0-19|All Races|Male and Female|2014|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82116071|0-19|All Races|Male and Female|2014|~|~|~
2.2|2.9|2.5|208|VII Hepatic tumors|82116071|0-19|All Races|Male and Female|2014|2.2|2.9|2.5
1.7|2.3|1.9|160|VII(a) Hepatoblastoma|82116071|0-19|All Races|Male and Female|2014|1.7|2.3|1.9
0.4|0.8|0.6|47|VII(b) Hepatic carcinomas|82116071|0-19|All Races|Male and Female|2014|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82116071|0-19|All Races|Male and Female|2014|~|~|~
8.8|10.2|9.5|778|VIII Malignant bone tumors|82116071|0-19|All Races|Male and Female|2014|8.8|10.2|9.5
4.8|5.8|5.3|432|VIII(a) Osteosarcomas|82116071|0-19|All Races|Male and Female|2014|4.8|5.8|5.3
0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|82116071|0-19|All Races|Male and Female|2014|0.2|0.5|0.4
2.7|3.5|3.1|252|VIII(c) Ewing tumor and related sarcomas of bone|82116071|0-19|All Races|Male and Female|2014|2.7|3.5|3.1
0.4|0.7|0.5|44|VIII(d) Other specified malignant bone tumors|82116071|0-19|All Races|Male and Female|2014|0.4|0.7|0.5
0.2|0.4|0.3|21|VIII(e) Unspecified malignant bone tumors|82116071|0-19|All Races|Male and Female|2014|0.2|0.4|0.3
10.5|12.0|11.3|933|X Germ cell, trophoblastic tumors & neoplasms of gonads|82116071|0-19|All Races|Male and Female|2014|10.6|12.1|11.4
1.4|2.0|1.7|137|X(a) Intracranial & intraspinal germ cell tumors|82116071|0-19|All Races|Male and Female|2014|1.4|2.0|1.7
1.4|2.0|1.7|140|X(b) Malignant extracranial & extragonadal germ cell tumors|82116071|0-19|All Races|Male and Female|2014|1.4|2.0|1.7
6.4|7.6|7.0|581|X(c) Malignant gonadal germ cell tumors|82116071|0-19|All Races|Male and Female|2014|6.5|7.7|7.1
0.3|0.7|0.5|40|X(d) Gonadal carcinomas|82116071|0-19|All Races|Male and Female|2014|0.3|0.7|0.5
0.3|0.6|0.4|35|X(e) Other and unspecified malignant gonadal tumors|82116071|0-19|All Races|Male and Female|2014|0.3|0.6|0.4
20.5|22.5|21.5|1779|XI Other malignant epithelial neoplasms and malignant melanomas|82116071|0-19|All Races|Male and Female|2014|20.7|22.7|21.7
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|82116071|0-19|All Races|Male and Female|2014|0.1|0.4|0.2
9.9|11.3|10.6|880|XI(b) Thyroid carcinomas|82116071|0-19|All Races|Male and Female|2014|10.0|11.4|10.7
0.2|0.5|0.4|30|XI(c) Nasopharyngeal carcinomas|82116071|0-19|All Races|Male and Female|2014|0.2|0.5|0.4
3.7|4.6|4.2|345|XI(d) Malignant melanomas|82116071|0-19|All Races|Male and Female|2014|3.8|4.7|4.2
~|~|~|~|XI(e) Skin carcinomas|82116071|0-19|All Races|Male and Female|2014|~|~|~
5.5|6.6|6.0|498|XI(f) Other and unspecified carcinomas|82116071|0-19|All Races|Male and Female|2014|5.5|6.6|6.1
0.5|0.9|0.7|54|XII Other and unspecified malignant neoplasms|82116071|0-19|All Races|Male and Female|2014|0.5|0.9|0.7
0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|82116071|0-19|All Races|Male and Female|2014|0.2|0.5|0.3
0.2|0.5|0.3|26|XII(b) Other unspecified malignant tumors|82116071|0-19|All Races|Male and Female|2014|0.2|0.5|0.3
191.2|197.2|194.2|15998|All ICCC Groups Combined|82096458|0-19|All Races|Male and Female|2015|191.9|197.9|194.9
48.4|51.5|49.9|4103|I Leukemias, myeloproliferative & myelodysplastic diseases|82096458|0-19|All Races|Male and Female|2015|48.5|51.5|50.0
34.3|36.9|35.5|2918|I(a) Lymphoid leukemias|82096458|0-19|All Races|Male and Female|2015|34.3|36.9|35.5
7.7|9.0|8.3|686|I(b) Acute myeloid leukemias|82096458|0-19|All Races|Male and Female|2015|7.7|9.0|8.4
2.4|3.1|2.7|224|I(c) Chronic myeloproliferative diseases|82096458|0-19|All Races|Male and Female|2015|2.4|3.1|2.7
1.2|1.7|1.4|117|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82096458|0-19|All Races|Male and Female|2015|1.2|1.7|1.4
1.6|2.2|1.9|158|I(e) Unspecified and other specified leukemias|82096458|0-19|All Races|Male and Female|2015|1.6|2.2|1.9
29.5|31.9|30.7|2534|II Lymphomas and reticuloendothelial neoplasms|82096458|0-19|All Races|Male and Female|2015|29.7|32.1|30.9
11.6|13.1|12.3|1022|II(a) Hodgkin lymphomas|82096458|0-19|All Races|Male and Female|2015|11.7|13.2|12.4
9.2|10.6|9.9|815|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82096458|0-19|All Races|Male and Female|2015|9.3|10.6|9.9
2.1|2.8|2.5|201|II(c) Burkitt lymphoma|82096458|0-19|All Races|Male and Female|2015|2.1|2.8|2.4
5.1|6.2|5.6|461|II(d) Miscellaneous lymphoreticular neoplasms|82096458|0-19|All Races|Male and Female|2015|5.1|6.2|5.6
0.3|0.6|0.4|35|II(e) Unspecified lymphomas|82096458|0-19|All Races|Male and Female|2015|0.3|0.6|0.4
30.7|33.2|31.9|2619|III CNS and misc intracranial and intraspinal neoplasms|82096458|0-19|All Races|Male and Female|2015|30.7|33.1|31.9
2.4|3.1|2.7|224|III(a) Ependymomas and choroid plexus tumor|82096458|0-19|All Races|Male and Female|2015|2.4|3.1|2.7
15.4|17.1|16.2|1330|III(b) Astrocytomas|82096458|0-19|All Races|Male and Female|2015|15.3|17.1|16.2
5.5|6.6|6.0|495|III(c) Intracranial and intraspinal embryonal tumors|82096458|0-19|All Races|Male and Female|2015|5.5|6.6|6.0
5.2|6.2|5.7|468|III(d) Other gliomas|82096458|0-19|All Races|Male and Female|2015|5.2|6.2|5.7
0.6|1.0|0.8|64|III(e) Other specified intracranial & intraspinal neoplasms|82096458|0-19|All Races|Male and Female|2015|0.6|1.0|0.8
0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|82096458|0-19|All Races|Male and Female|2015|0.3|0.6|0.5
8.8|10.1|9.5|779|IV Neuroblastoma and other peripheral nervous cell tumors|82096458|0-19|All Races|Male and Female|2015|8.8|10.2|9.5
8.5|9.8|9.2|755|IV(a) Neuroblastoma and ganglioneuroblastoma|82096458|0-19|All Races|Male and Female|2015|8.6|9.9|9.2
0.2|0.4|0.3|24|IV(b) Other peripheral nervous cell tumors|82096458|0-19|All Races|Male and Female|2015|0.2|0.4|0.3
11.6|13.2|12.4|1020|IX Soft tissue and other extraosseous sarcomas|82096458|0-19|All Races|Male and Female|2015|11.7|13.2|12.4
4.3|5.3|4.8|392|IX(a) Rhabdomyosarcomas|82096458|0-19|All Races|Male and Female|2015|4.3|5.3|4.8
1.1|1.7|1.4|114|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82096458|0-19|All Races|Male and Female|2015|1.1|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82096458|0-19|All Races|Male and Female|2015|~|~|~
4.3|5.2|4.7|390|IX(d) Other specified soft tissue sarcomas|82096458|0-19|All Races|Male and Female|2015|4.3|5.2|4.8
1.2|1.7|1.5|120|IX(e) Unspecified soft tissue sarcomas|82096458|0-19|All Races|Male and Female|2015|1.2|1.7|1.5
~|~|~|~|Not classified by ICCC|82096458|0-19|All Races|Male and Female|2015|~|~|~
3.3|4.1|3.7|303|V Retinoblastoma|82096458|0-19|All Races|Male and Female|2015|3.3|4.1|3.7
7.3|8.5|7.9|647|VI Renal tumors|82096458|0-19|All Races|Male and Female|2015|7.3|8.5|7.9
6.5|7.6|7.0|578|VI(a) Nephroblastoma and other nonepithelial renal tumors|82096458|0-19|All Races|Male and Female|2015|6.5|7.6|7.0
0.6|1.0|0.8|67|VI(b) Renal carcinomas|82096458|0-19|All Races|Male and Female|2015|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|82096458|0-19|All Races|Male and Female|2015|~|~|~
2.4|3.2|2.8|231|VII Hepatic tumors|82096458|0-19|All Races|Male and Female|2015|2.5|3.2|2.8
1.8|2.4|2.1|173|VII(a) Hepatoblastoma|82096458|0-19|All Races|Male and Female|2015|1.8|2.4|2.1
0.5|0.9|0.7|56|VII(b) Hepatic carcinomas|82096458|0-19|All Races|Male and Female|2015|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82096458|0-19|All Races|Male and Female|2015|~|~|~
8.4|9.8|9.1|746|VIII Malignant bone tumors|82096458|0-19|All Races|Male and Female|2015|8.4|9.8|9.1
4.4|5.4|4.9|402|VIII(a) Osteosarcomas|82096458|0-19|All Races|Male and Female|2015|4.4|5.4|4.9
0.2|0.5|0.4|30|VIII(b) Chondrosarcomas|82096458|0-19|All Races|Male and Female|2015|0.2|0.5|0.4
2.7|3.5|3.1|252|VIII(c) Ewing tumor and related sarcomas of bone|82096458|0-19|All Races|Male and Female|2015|2.7|3.5|3.1
0.4|0.7|0.5|44|VIII(d) Other specified malignant bone tumors|82096458|0-19|All Races|Male and Female|2015|0.4|0.7|0.5
0.1|0.3|0.2|18|VIII(e) Unspecified malignant bone tumors|82096458|0-19|All Races|Male and Female|2015|0.1|0.3|0.2
10.9|12.4|11.6|966|X Germ cell, trophoblastic tumors & neoplasms of gonads|82096458|0-19|All Races|Male and Female|2015|11.0|12.5|11.8
1.6|2.2|1.8|151|X(a) Intracranial & intraspinal germ cell tumors|82096458|0-19|All Races|Male and Female|2015|1.6|2.2|1.8
1.1|1.6|1.4|113|X(b) Malignant extracranial & extragonadal germ cell tumors|82096458|0-19|All Races|Male and Female|2015|1.1|1.7|1.4
7.0|8.2|7.6|631|X(c) Malignant gonadal germ cell tumors|82096458|0-19|All Races|Male and Female|2015|7.1|8.3|7.7
0.3|0.7|0.5|40|X(d) Gonadal carcinomas|82096458|0-19|All Races|Male and Female|2015|0.3|0.7|0.5
0.3|0.5|0.4|31|X(e) Other and unspecified malignant gonadal tumors|82096458|0-19|All Races|Male and Female|2015|0.3|0.5|0.4
22.7|24.8|23.7|1966|XI Other malignant epithelial neoplasms and malignant melanomas|82096458|0-19|All Races|Male and Female|2015|22.9|25.0|23.9
~|~|~|~|XI(a) Adrenocortical carcinomas|82096458|0-19|All Races|Male and Female|2015|~|~|~
10.1|11.6|10.8|900|XI(b) Thyroid carcinomas|82096458|0-19|All Races|Male and Female|2015|10.3|11.7|11.0
0.4|0.8|0.6|50|XI(c) Nasopharyngeal carcinomas|82096458|0-19|All Races|Male and Female|2015|0.5|0.8|0.6
3.5|4.4|3.9|327|XI(d) Malignant melanomas|82096458|0-19|All Races|Male and Female|2015|3.6|4.4|4.0
~|~|~|~|XI(e) Skin carcinomas|82096458|0-19|All Races|Male and Female|2015|~|~|~
7.5|8.7|8.1|672|XI(f) Other and unspecified carcinomas|82096458|0-19|All Races|Male and Female|2015|7.6|8.8|8.2
0.6|1.1|0.8|69|XII Other and unspecified malignant neoplasms|82096458|0-19|All Races|Male and Female|2015|0.7|1.1|0.8
0.4|0.7|0.5|44|XII(a) Other specified malignant tumors|82096458|0-19|All Races|Male and Female|2015|0.4|0.7|0.5
0.2|0.4|0.3|25|XII(b) Other unspecified malignant tumors|82096458|0-19|All Races|Male and Female|2015|0.2|0.4|0.3
187.3|193.2|190.2|15681|All ICCC Groups Combined|82127667|0-19|All Races|Male and Female|2016|188.0|193.9|190.9
47.4|50.5|48.9|4023|I Leukemias, myeloproliferative & myelodysplastic diseases|82127667|0-19|All Races|Male and Female|2016|47.5|50.5|49.0
33.6|36.1|34.8|2859|I(a) Lymphoid leukemias|82127667|0-19|All Races|Male and Female|2016|33.5|36.1|34.8
7.6|8.9|8.2|679|I(b) Acute myeloid leukemias|82127667|0-19|All Races|Male and Female|2016|7.7|8.9|8.3
2.2|2.9|2.5|210|I(c) Chronic myeloproliferative diseases|82127667|0-19|All Races|Male and Female|2016|2.2|2.9|2.6
1.2|1.7|1.4|117|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82127667|0-19|All Races|Male and Female|2016|1.2|1.7|1.4
1.6|2.3|1.9|158|I(e) Unspecified and other specified leukemias|82127667|0-19|All Races|Male and Female|2016|1.6|2.2|1.9
28.6|31.0|29.8|2460|II Lymphomas and reticuloendothelial neoplasms|82127667|0-19|All Races|Male and Female|2016|28.8|31.2|30.0
11.6|13.1|12.3|1024|II(a) Hodgkin lymphomas|82127667|0-19|All Races|Male and Female|2016|11.7|13.3|12.5
9.5|10.9|10.2|838|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82127667|0-19|All Races|Male and Female|2016|9.5|10.9|10.2
2.2|2.9|2.5|205|II(c) Burkitt lymphoma|82127667|0-19|All Races|Male and Female|2016|2.2|2.9|2.5
4.0|4.9|4.4|363|II(d) Miscellaneous lymphoreticular neoplasms|82127667|0-19|All Races|Male and Female|2016|4.0|4.9|4.4
0.2|0.5|0.4|30|II(e) Unspecified lymphomas|82127667|0-19|All Races|Male and Female|2016|0.2|0.5|0.4
29.7|32.1|30.9|2534|III CNS and misc intracranial and intraspinal neoplasms|82127667|0-19|All Races|Male and Female|2016|29.7|32.1|30.9
2.1|2.8|2.4|200|III(a) Ependymomas and choroid plexus tumor|82127667|0-19|All Races|Male and Female|2016|2.1|2.8|2.4
14.5|16.2|15.3|1256|III(b) Astrocytomas|82127667|0-19|All Races|Male and Female|2016|14.5|16.2|15.3
5.1|6.1|5.6|455|III(c) Intracranial and intraspinal embryonal tumors|82127667|0-19|All Races|Male and Female|2016|5.0|6.1|5.5
5.6|6.7|6.2|504|III(d) Other gliomas|82127667|0-19|All Races|Male and Female|2016|5.6|6.7|6.1
0.7|1.1|0.9|71|III(e) Other specified intracranial & intraspinal neoplasms|82127667|0-19|All Races|Male and Female|2016|0.7|1.1|0.9
0.4|0.8|0.6|48|III(f) Unspecified intracranial and intraspinal neoplasms|82127667|0-19|All Races|Male and Female|2016|0.4|0.8|0.6
8.0|9.3|8.6|708|IV Neuroblastoma and other peripheral nervous cell tumors|82127667|0-19|All Races|Male and Female|2016|8.0|9.3|8.6
7.8|9.1|8.5|696|IV(a) Neuroblastoma and ganglioneuroblastoma|82127667|0-19|All Races|Male and Female|2016|7.9|9.1|8.5
~|~|~|~|IV(b) Other peripheral nervous cell tumors|82127667|0-19|All Races|Male and Female|2016|~|~|~
11.6|13.2|12.4|1021|IX Soft tissue and other extraosseous sarcomas|82127667|0-19|All Races|Male and Female|2016|11.7|13.2|12.4
4.6|5.6|5.1|416|IX(a) Rhabdomyosarcomas|82127667|0-19|All Races|Male and Female|2016|4.6|5.6|5.1
0.9|1.3|1.1|90|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82127667|0-19|All Races|Male and Female|2016|0.9|1.3|1.1
~|~|~|~|IX(c) Kaposi sarcoma|82127667|0-19|All Races|Male and Female|2016|~|~|~
4.3|5.3|4.8|394|IX(d) Other specified soft tissue sarcomas|82127667|0-19|All Races|Male and Female|2016|4.3|5.3|4.8
1.2|1.7|1.4|119|IX(e) Unspecified soft tissue sarcomas|82127667|0-19|All Races|Male and Female|2016|1.2|1.7|1.4
0.2|0.5|0.3|26|Not classified by ICCC|82127667|0-19|All Races|Male and Female|2016|0.2|0.5|0.3
2.8|3.6|3.2|262|V Retinoblastoma|82127667|0-19|All Races|Male and Female|2016|2.8|3.6|3.2
6.4|7.5|6.9|571|VI Renal tumors|82127667|0-19|All Races|Male and Female|2016|6.4|7.5|7.0
5.5|6.6|6.1|498|VI(a) Nephroblastoma and other nonepithelial renal tumors|82127667|0-19|All Races|Male and Female|2016|5.5|6.6|6.1
0.7|1.1|0.8|70|VI(b) Renal carcinomas|82127667|0-19|All Races|Male and Female|2016|0.7|1.1|0.9
~|~|~|~|VI(c) Unspecified malignant renal tumors|82127667|0-19|All Races|Male and Female|2016|~|~|~
2.3|3.0|2.6|216|VII Hepatic tumors|82127667|0-19|All Races|Male and Female|2016|2.3|3.0|2.6
1.9|2.5|2.2|178|VII(a) Hepatoblastoma|82127667|0-19|All Races|Male and Female|2016|1.9|2.5|2.2
0.3|0.6|0.4|36|VII(b) Hepatic carcinomas|82127667|0-19|All Races|Male and Female|2016|0.3|0.6|0.4
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82127667|0-19|All Races|Male and Female|2016|~|~|~
9.1|10.5|9.8|803|VIII Malignant bone tumors|82127667|0-19|All Races|Male and Female|2016|9.1|10.5|9.8
4.8|5.8|5.3|435|VIII(a) Osteosarcomas|82127667|0-19|All Races|Male and Female|2016|4.8|5.8|5.3
0.2|0.4|0.3|25|VIII(b) Chondrosarcomas|82127667|0-19|All Races|Male and Female|2016|0.2|0.4|0.3
3.0|3.8|3.4|279|VIII(c) Ewing tumor and related sarcomas of bone|82127667|0-19|All Races|Male and Female|2016|3.0|3.8|3.4
0.5|0.8|0.6|51|VIII(d) Other specified malignant bone tumors|82127667|0-19|All Races|Male and Female|2016|0.5|0.8|0.6
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82127667|0-19|All Races|Male and Female|2016|~|~|~
10.4|11.9|11.1|924|X Germ cell, trophoblastic tumors & neoplasms of gonads|82127667|0-19|All Races|Male and Female|2016|10.5|12.0|11.3
1.7|2.3|2.0|163|X(a) Intracranial & intraspinal germ cell tumors|82127667|0-19|All Races|Male and Female|2016|1.7|2.3|2.0
1.1|1.6|1.3|108|X(b) Malignant extracranial & extragonadal germ cell tumors|82127667|0-19|All Races|Male and Female|2016|1.1|1.6|1.3
6.5|7.6|7.1|588|X(c) Malignant gonadal germ cell tumors|82127667|0-19|All Races|Male and Female|2016|6.6|7.8|7.2
0.3|0.6|0.4|37|X(d) Gonadal carcinomas|82127667|0-19|All Races|Male and Female|2016|0.3|0.6|0.5
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|82127667|0-19|All Races|Male and Female|2016|0.2|0.5|0.3
23.5|25.7|24.6|2045|XI Other malignant epithelial neoplasms and malignant melanomas|82127667|0-19|All Races|Male and Female|2016|23.8|26.0|24.9
~|~|~|~|XI(a) Adrenocortical carcinomas|82127667|0-19|All Races|Male and Female|2016|~|~|~
10.3|11.7|11.0|918|XI(b) Thyroid carcinomas|82127667|0-19|All Races|Male and Female|2016|10.5|11.9|11.2
0.2|0.5|0.3|28|XI(c) Nasopharyngeal carcinomas|82127667|0-19|All Races|Male and Female|2016|0.2|0.5|0.3
3.4|4.3|3.8|318|XI(d) Malignant melanomas|82127667|0-19|All Races|Male and Female|2016|3.5|4.3|3.9
~|~|~|~|XI(e) Skin carcinomas|82127667|0-19|All Races|Male and Female|2016|~|~|~
8.5|9.8|9.1|756|XI(f) Other and unspecified carcinomas|82127667|0-19|All Races|Male and Female|2016|8.6|9.9|9.2
0.9|1.3|1.1|88|XII Other and unspecified malignant neoplasms|82127667|0-19|All Races|Male and Female|2016|0.9|1.3|1.1
0.4|0.8|0.6|47|XII(a) Other specified malignant tumors|82127667|0-19|All Races|Male and Female|2016|0.4|0.8|0.6
0.4|0.7|0.5|41|XII(b) Other unspecified malignant tumors|82127667|0-19|All Races|Male and Female|2016|0.4|0.7|0.5
